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A B S T R A C T
Background
Motivational Interviewing (MI) is a directive patient-centred style of counselling, designed to help people to explore and resolve ambiva-
lence about behaviour change. It was developed as a treatment for alcohol abuse, but may help people to a make a successful attempt
to stop smoking.
Objectives
To evaluate the efficacy of MI for smoking cessation compared with no treatment, in addition to another form of smoking cessation treat-
ment, and compared with other types of smoking cessation treatment. We also investigated whether more intensive MI is more effective
than less intensive MI for smoking cessation.
Search methods
We searched the Cochrane Tobacco Addiction Group Specialised Register for studies using the term motivat* NEAR2 (interview* OR en-
hanc* OR session* OR counsel* OR practi* OR behav*) in the title or abstract, or motivation* as a keyword. We also searched trial registries
to identify unpublished studies. Date of the most recent search: August 2018.
Selection criteria
Randomised controlled trials in which MI or its variants were offered to smokers to assist smoking cessation. We excluded trials that did not
assess cessation as an outcome, with follow-up less than six months, and with additional non-MI intervention components not matched
between arms. We excluded trials in pregnant women as these are covered elsewhere.
Data collection and analysis
We followed standard Cochrane methods. Smoking cessation was measured after at least six months, using the most rigorous definition
available, on an intention-to-treat basis. We calculated risk ratios (RR) and 95% confidence intervals (CI) for smoking cessation for each
study, where possible. We grouped eligible studies according to the type of comparison. We carried out meta-analyses where appropriate,
using Mantel-Haenszel random-effects models. We extracted data on mental health outcomes and quality of life and summarised these
narratively.
Main results
We identified 37 eligible studies involving over 15,000 participants who smoked tobacco. The majority of studies recruited participants
with particular characteristics, often from groups of people who are less likely to seek support to stop smoking than the general population.
Although a few studies recruited participants who intended to stop smoking soon or had no intentions to quit, most recruited a population
without regard to their intention to quit. MI was conducted in one to 12 sessions, with the total duration of MI ranging from five to 315
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minutes across studies. We judged four of the 37 studies to be at low risk of bias, and 11 to be at high risk, but restricting the analysis
only to those studies at low or unclear risk did not significantly alter results, apart from in one case - our analysis comparing higher to
lower intensity MI.
We found low-certainty evidence, limited by risk of bias and imprecision, comparing the effect of MI to no treatment for smoking cessation
(RR = 0.84, 95% CI 0.63 to 1.12; I2 = 0%; adjusted N = 684). One study was excluded from this analysis as the participants recruited (incar-
cerated men) were not comparable to the other participants included in the analysis, resulting in substantial statistical heterogeneity
when all studies were pooled (I2 = 87%). Enhancing existing smoking cessation support with additional MI, compared with existing support
alone, gave an RR of 1.07 (95% CI 0.85 to 1.36; adjusted N = 4167; I2 = 47%), and MI compared with other forms of smoking cessation support
gave an RR of 1.24 (95% CI 0.91 to 1.69; I2 = 54%; N = 5192). We judged both of these estimates to be of low certainty due to heterogeneity
and imprecision. Low-certainty evidence detected a benefit of higher intensity MI when compared with lower intensity MI (RR 1.23, 95%
CI 1.11 to 1.37; adjusted N = 5620; I2 = 0%). The evidence was limited because three of the five studies in this comparison were at risk of
bias. Excluding them gave an RR of 1.00 (95% CI 0.65 to 1.54; I2 = n/a; N = 482), changing the interpretation of the results.
Mental health and quality of life outcomes were reported in only one study, providing little evidence on whether MI improves mental well-
being.
Authors' conclusions
There is insufficient evidence to show whether or not MI helps people to stop smoking compared with no intervention, as an addition to
other types of behavioural support for smoking cessation, or compared with other types of behavioural support for smoking cessation. It
is also unclear whether more intensive MI is more effective than less intensive MI. All estimates of treatment effect were of low certainty
because of concerns about bias in the trials, imprecision and inconsistency. Consequently, future trials are likely to change these conclu-
sions. There is almost no evidence on whether MI for smoking cessation improves mental well-being.
P L A I N   L A N G U A G E   S U M M A R Y
Does motivational interviewing help people to quit smoking?
Background
Motivational interviewing is a type of counselling that can be used to help people to stop smoking. It aims to help people explore the
reasons that they may feel unsure about quitting and find ways to make them feel more willing and able to stop smoking. Rather than telling
the person why and how they should change their behaviour, counsellors try to help people to choose to change their own behaviour,
increasing their confidence that they can succeed. This review explores whether motivational interviewing helps more people to stop
smoking than no treatment, or other types of stop smoking treatment. It also looks at whether longer motivational interviewing, with more
counselling sessions, helps more people to quit than shorter motivational interviewing with fewer sessions.
Study characteristics
This review included 37 trials covering over 15,000 people who smoked tobacco. Studies were conducted in a lot of different types of
people, including people with health problems or drug use problems, young people, homeless people, and people who had been arrested
or were in prison. Some people felt ready to quit smoking and others did not. Motivational interviewing was provided in one to 12 sessions
and took from as little as five minutes, to as much as eight hours, to deliver. Studies lasted for at least six months. The evidence is up to
date to August 2018.
Key results
There was not enough information available to decide whether motivational interviewing helped more people to stop smoking than no
stop smoking treatment. People were slightly more likely to stop smoking if they were provided with motivational interviewing rather
than another type of treatment to stop smoking, but our findings suggest that there is still a chance that motivational interviewing could
also reduce a person's chances of quitting compared with other stop smoking treatments. This means more research is needed to decide
whether motivational interviewing can help more people to quit than other types of treatment. Using longer motivational interviewing with
more treatment sessions may help more people to give up smoking than shorter motivational interviewing with fewer sessions, however
more research is needed to be sure that this is the case.
We also looked at whether being provided with motivational interviewing to quit smoking increased people's well-being. Most studies did
not provide any information about this, and so more studies are needed to answer this question.
Quality of the evidence
There is low-quality evidence looking at whether motivational interviewing helps more people to quit smoking than no treatment. This
means it is difficult to know whether motivational interviewing helps people to quit smoking or not, and more studies are needed. The
quality of the evidence was also low for all of the other questions we asked about quitting smoking, which means that our findings may
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change when new research is carried out. The quality of the research is rated as low because there were problems with the design of
studies, findings of studies were very different to one another, and there were not enough data, making it difficult to determine whether
motivational interviewing or more intense motivational interviewing helped people to quit smoking or not.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings for the main comparison.   Motivational interviewing compared with no treatment for smoking cessation
Motivational interviewing compared with no treatment for smoking cessation
Patient or population: tobacco smokers (adolescents, university students, adult primary care patients)
Setting: high schools, university & primary care (USA)
Intervention: motivational interviewing
Comparison: no smoking cessation treatment
Anticipated absolute effects*
(95% CI)
Outcomes
Risk with no
treatment
Risk with MI
Relative ef-
fect
(95% CI)
№ of partici-
pants
(studies)
Certainty of
the evidence
(GRADE)
Comments
Study populationSmoking ces-
sation at ≥ 6
months fol-
low-up
22 per 100 19 per 100 (14
to 25)
RR 0.84
(0.63 to 1.12)
adjusted N =
684
(4 RCTs)
⊕⊕⊝⊝
LOW 1, 2
One eligible study (Naik 2014) has been excluded from this pooled
analysis as it recruited a substantially different population (in-
carcerated men) compared with the other studies, which recruit-
ed adults and adolescents from the general population. When in-
cluded in the analysis, it resulted in substantial heterogeneity - re-
moval of Naik 2014 decreased statistical heterogeneity to zero.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1 Downgraded one level as all studies were at high or unclear risk of bias; removing the studies at high risk changed the direction of the effect estimate so that it favoured MI,
however the CIs still spanned one and suffered substantial imprecision
2 Downgraded one level due to imprecision: the upper and lower limits of the confidence intervals included both meaningful benefit and harm, and the overall number of events
was low (n = 144)
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Summary of findings 2.   Motivational interviewing in addition to other smoking cessation treatment for smoking cessation
Motivational interviewing in addition to other smoking cessation treatment for smoking cessation
Patient or population: tobacco smokers (general population, low income, inpatients and outpatients with mixed diagnoses)
Setting: community, hospital, healthcare clinics (Australia, Brazil, South Africa, USA)
Intervention: motivational interviewing in addition to other smoking cessation (SC) treatment
Comparison: other smoking cessation treatment alone
Anticipated absolute effects* (95% CI)Outcomes
Risk with other SC treat-
ment only
Risk with MI in addition to
other SC treatment
Relative effect
(95% CI)
№ of participants
(studies)
Certainty of the
evidence
(GRADE)
Comments
Study populationSmoking cessation
at ≥ 6 months fol-
low-up 15 per 100 16 per 100
(13 to 20)
RR 1.07
(0.85 to 1.36)
adjusted N = 4167
(12 RCTs)
⊕⊕⊝⊝
LOW 1, 2, 3
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1 Five studies judged to be at high risk of bias, however sensitivity analysis suggested this is unlikely to impact on the result - not downgraded
2 Downgraded one level due to inconsistency: study effects differed across studies, demonstrated by moderate unexplained statistical heterogeneity (I2 = 47%)
3 Downgraded one level due to imprecision: the upper and lower limits of the confidence intervals included both meaningful benefit and harm
 
 
Summary of findings 3.   Motivational interviewing compared with another smoking cessation intervention for smoking cessation
Motivational interviewing compared with another smoking cessation intervention for smoking cessation
Patient or population: tobacco smokers (general population, adolescents, offenders, homeless, substance users, hospital inpatients, HIV-positive)
Setting: community, universities, homeless shelters, inpatient and outpatient healthcare clinics, primary care (Australia, Brazil, China, Spain, UK, USA)
Intervention: motivational interviewing
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Comparison: another SC intervention
Anticipated absolute effects* (95% CI)Outcomes
Risk with other SC
intervention
Risk with MI
Relative effect
(95% CI)
№ of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Study populationSmoking cessation at ≥
6 months follow-up
9 per 100 11 per 100
(8 to 15)
RR 1.24
(0.91 to 1.69)
5192
(19 RCTs)
⊕⊕⊝⊝
LOW 1, 2, 3
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1 Three studies judged at high risk of bias, however sensitivity analysis suggested this was unlikely to impact on the result - not downgraded
2 Downgraded one level due to inconsistency: study effects differ across studies, demonstrated by moderate unexplained statistical heterogeneity (I2 = 54%)
3 Downgraded one level due to imprecision: the upper and lower limits of the confidence intervals included both meaningful benefit and harm
 
 
Summary of findings 4.   Higher compared with lower intensity motivational interviewing for smoking cessation
Higher compared with lower intensity motivational interviewing for smoking cessation
Patient or population: tobacco smokers (general population, hospital inpatients with mixed diagnoses)
Setting: community-based telephone quit-line, primary care, hospital, inpatient substance abuse treatment centre (USA)
Intervention: higher intensity motivational interviewing
Comparison: lower intensity motivational interviewing
Anticipated absolute effects* (95% CI)Outcomes
Risk with lower intensity MI Risk with higher in-
tensity MI
Relative effect
(95% CI)
№ of participants
(studies)
Certainty of the
evidence
(GRADE)
Comments
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Study populationSmoking cessation at
≥ 6 months follow-up
17 per 100 21 per 100
(19 to 23)
RR 1.23
(1.11 to 1.37)
adjusted N = 5620
(5 RCTs)
⊕⊕⊝⊝
LOW 1
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1 Downgraded two levels due to risk of bias: three of the five studies were judged to be at high risk of bias and removing these studies in a sensitivity analysis changed the
interpretation of the effect, so that the confidence intervals encompassed both appreciable benefit and harm of higher intensity motivational interviewing for smoking cessation
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B A C K G R O U N D
Description of the condition
Tobacco use is one of the leading causes of preventable illness and
death worldwide, accounting for over seven million deaths annual-
ly (GBD 2015 Risk Factors Collaborators 2016). Extrapolation based
on current smoking trends suggests that, without widespread quit-
ting, approximately 400 million tobacco-related deaths will occur
between 2010 and 2050, mostly among current smokers (Jha 2011).
Most smokers would like to stop (CDC 2017); however, quitting is
difficult.
Description of the intervention
The concept of motivational interviewing (MI) evolved from expe-
riences in treating alcohol abuse, and was first described by Miller
in 1983. It is defined as "a directive, client-centred counselling style
for eliciting behaviour change by helping clients to explore and re-
solve ambivalence" (Miller 1983). The four guiding principles: (a) ex-
pressing empathy, (b) developing discrepancy, (c) rolling with re-
sistance, (d) supporting self efficacy, have been detailed elsewhere
(Miller 2002).
The MI process is a brief psychotherapeutic intervention intend-
ed to increase the likelihood that a person will make an attempt
to change their harmful behaviour. Adaptations of MI have ranged
from brief 20-minute office interventions (motivational consulting)
to Motivation Enhancement Therapy (MET), a multi-session course
of treatment, including a lengthy assessment, personalised feed-
back and follow-up interviews (Lawendowski 1998; Rollnick 1992).
MI has also been provided by telephone consultations and in a
group format. MI and its various forms have been applied both as a
stand-alone intervention or with other treatments, and in a range
of settings. These include health settings such as general hospi-
tal wards, emergency departments, and general medical practice
(Britt 2002).
How the intervention might work
Miller 1994 suggests that motivation may fluctuate over time or
from one situation to another, and can be influenced to change
in a particular direction. Thus, lack of motivation (or resistance to
change) is seen as something fluid, that is open to change. There-
fore, the main focus of MI is facilitating behaviour change using a di-
rective approach, by helping people to explore and resolve any am-
bivalence they may have toward this change (Rollnick 1995), and in
turn making them more likely to choose to change their behaviour
in the desired direction. In this case, that behaviour is smoking and
so the goal of MI is to increase motivation to quit, making smoking
cessation more likely. Rollnick 1995 also suggests that adopting an
aggressive or confrontational style is likely to produce negative re-
sponses from people (such as arguing), which may be interpreted
by the practitioner as denial or resistance. MI guides people to ex-
plore and confront their behaviour, instead of telling them what to
do.
Why it is important to do this review
MI has been used primarily for the management of health behav-
iours in those with behavioural disorders, such as alcohol abuse,
drug addiction, weight loss, and treatment compliance, as well as
for smoking cessation. Systematic reviews have shown some ben-
eficial effects of MI on these behaviours (Cheng 2015; Cowlishaw
2012; Foxcroft 2016; Gates 2016; Heckman 2010; Hettema 2010; Kli-
mas 2018; Mbuagbaw 2012; Morton 2015; Smedslund 2011). How-
ever, these effects are minimal or non-existent at long-term fol-
low-up and included studies are generally deemed to be of limit-
ed quality, making it difficult to draw clear conclusions. For exam-
ple, Morton 2015 concluded that the design of many studies - incor-
porating multi-component interventions - made it very difficult to
isolate the effects of MI. The previous version of this review (Lind-
son-Hawley 2015) resulted in a modest but significant increase in
quitting smoking when MI was used in comparison to brief advice or
usual care. However, this review encountered the same challenges
described by Morton 2015 above, pooled studies with a range of
different comparator types, and only included studies that report-
ed providing a form of MI fidelity monitoring. This may have biased
the inclusion of studies and thus the results. Therefore, inclusion
criteria for this version of the review have been revised to reduce
bias (although still control for fidelity monitoring), attempt to iso-
late the effects of MI, and to be mindful of the comparator group
when pooling studies, to allow a range of useful comparisons.
O B J E C T I V E S
To evaluate the efficacy of MI for smoking cessation compared with
no treatment, in addition to another form of smoking cessation
treatment, and compared with other types of smoking cessation
treatment. We also investigated whether more intensive MI is more
effective than less intensive MI for smoking cessation.
We explored whether motivational interviewing for smoking cessa-
tion could enhance well-being.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and cluster RCTs.
Types of participants
Tobacco smokers, excluding pregnant women. We excluded tri-
als that only recruited pregnant women, as their particular needs
and circumstances warrant them being treated as a separate pop-
ulation. Studies in pregnant women are covered in a separate
Cochrane Review (Chamberlain 2017).
Types of interventions
Interventions labelled as either MI or MET, targeted at tobacco
smoking cessation. Eligible interventions were based on the prin-
ciples and practices of MI (e.g. engaging, focussing, evoking, plan-
ning, exploring ambivalence, assessment of motivation and confi-
dence to quit, eliciting 'change talk' and supporting self-efficacy) as
described in Miller 2013, and, in the opinion of the review authors,
complied with these principles and practices beyond simply refer-
ring to the concepts. We included studies testing interventions that
claimed to be based on both MI and another theoretical approach
to counselling, such as cognitive behavioural therapy (CBT). How-
ever, we tested the effect of including these studies using sensitiv-
ity analysis.
MI is a specific motivational intervention, which has been incor-
rectly linked to other interventions or theories, such as the trans-
theoretical model of change, the decisional balance technique,
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and client-centred counselling (Miller 2009). MI is conceptually and
practically distinct from these interventions and principles. There-
fore, we did not include trials that primarily tested these distinct ap-
proaches. Stage-based interventions, such as the transtheoretical
model for smoking cessation, are covered in a separate Cochrane
Review (Cahill 2010).
We included studies where the intervention arm included MI as part
of a multi-component intervention (that may or may not have in-
cluded pharmacotherapy), provided that the additional elements
were also included in the control arm, and thus were not being test-
ed. No exclusions were made based on the modality of the inter-
vention.
Eligible studies included a comparison (control) intervention of ei-
ther 1) no smoking cessation treatment, 2) another smoking cessa-
tion intervention, of any length or intensity (including usual care),
or 3) another type of MI intervention (e.g. MI of a lower intensity).
Types of outcome measures
Primary outcomes
Our primary outcome was smoking cessation. We preferred con-
tinuous/prolonged cessation over point prevalence cessation, and
biochemically validated over self-reported cessation, where multi-
ple measures were available in included studies. We reported ces-
sation at the longest follow-up, and excluded trials that did not
include data on smoking cessation rates at least six months after
baseline.
Secondary outcomes
MI has been linked to self-determination theory. Markland 2005
proposed that MI can provide the circumstances under which peo-
ple can initiate and action their own behaviour through 'self-de-
termination'. Self-determination theory hypothesises that this self-
determination can lead to positive consequences, such as en-
hanced well-being (Ryan 2000). This suggests that MI may increase
well-being as well as promote behaviour change. Therefore, we at-
tempted to collect data on the following secondary outcomes:
• Mental health and well-being. Any measure of mental health and
well-being as defined by included studies
• Quality of life (QOL). Any validated QOL scale reported in includ-
ed studies. For example, the Quality of Life Scale (QOLS) (Burck-
hardt 2003); the Euro–Quality of Life Questionnaire (EQ-5D) (Eu-
roQol Group 1990)
We considered including adverse events as an outcome but de-
cided against this. MI and comparator interventions comprise talk
about smoking, which rarely gives rise to strong emotions and at-
tendance for counselling is voluntary. Thus, it is unlikely that peo-
ple who find such talk distressing will attend MI. As a result, we be-
lieve that few or no trials will have assessed adverse events, making
assessment impossible.
Search methods for identification of studies
Electronic searches
We conducted a search of the Cochrane Tobacco Addiction Group's
Specialised Register in August 2018. The search strategy is avail-
able in Appendix 1. The Register has been developed from electron-
ic searching of the Cochrane Central Register of Controlled trials
(CENTRAL), MEDLINE, Embase and PsycINFO, together with hand-
searching of specialist journals, conference proceedings and refer-
ence lists of previous trials and overviews. See the Tobacco Addic-
tion Group's website for full details of how the Register is compiled.
At the time of the Register search, results from the following data-
bases were included:
• Cochrane Central Register of Controlled trials (CENTRAL), issue
1, 2018;
• MEDLINE (via OVID) to update 20180726;
• Embase (via OVID) to week 201831;
• PsycINFO (via OVID) to update 20180723.
We also searched the following online trial registries to identify un-
published studies: ClinicalTrials.gov and the International Clinical
Trials Registry Platform (ICTRP).
Although this review is an update of a previous review, we carried
out full searches of the literature, from database inception. This
was because inclusion criteria were updated for this version and we
wanted to ensure we identified relevant studies that may have been
excluded in previous versions.
Data collection and analysis
Selection of studies
Two authors (of AF, JL, NL, TT) independently screened the title and
abstract of each record returned for eligibility. Where there was un-
certainty, the record was put forward to the next round of screen-
ing. We then acquired the full-text reports of any trials deemed po-
tentially relevant. Two authors (of AF, JL, NL, TT) independently as-
sessed the full texts for inclusion, and any disagreements were re-
ferred to a third author.
Data extraction and management
Two authors (of AF, JL, NL, TT) independently extracted the follow-
ing information about each eligible trial, where available:
• Details of study design, including methods of randomisation
and recruitment
• Location and setting of the trial, e.g. hospital-based, clin-
ic-based, community-based
• Participant characteristics, e.g. level of motivation, pre-existing
conditions, demographic descriptors
• Intervention provider characteristics: e.g. type of provider and
MI training provision
• Description of the intervention(s), including the nature, frequen-
cy and duration of MI, and any co-interventions used
• Description of comparator(s), including the nature, frequency
and duration of MI, and any co-interventions used
• Any procedures followed to ensure MI fidelity, and the results of
any monitoring
• Primary outcome measures: definition of smoking cessation
used for primary outcome, timing of longest follow-up, any bio-
chemical validation
• Secondary outcome measures: whether mental health and QoL
were measured, definitions of outcomes (where measured), out-
come data (where measured)
• Loss to follow-up
• Funding source
Motivational interviewing for smoking cessation (Review)
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• Declarations of interest
Extraction was then compared and amalgamated for each study,
with disagreements referred to a third author.
Assessment of risk of bias in included studies
We evaluated studies on the basis of randomisation procedure, al-
location concealment, incomplete outcome data, and any other
bias using standard Cochrane methods (Higgins 2011). We also as-
sessed detection bias based on the outcome measure, according
to standard methods of the Cochrane Tobacco Addiction Group. If
the outcome was objective (i.e. biochemically validated) and/or if
contact was matched between arms, we judged the studies as be-
ing at low risk of bias, but if the outcome was self-reported and the
intervention arm received more support than the control arm, we
judged differential misreport to be possible and rated these studies
as being at high risk of bias. For trials of behavioural interventions
(such as those included here), it is deemed inappropriate to assess
performance bias, as blinding of participants and personnel is not
feasible due to the nature of the intervention.
Two authors (of AF, JL, NL, TT) independently rated each domain as
being at high, low or unclear risk of bias, for each study. We resolved
any disagreement between authors through discussion with a third
author.
Measures of treatment e;ect
For our primary outcome, we extracted the most stringent defini-
tion of smoking cessation for each study (i.e. longest follow-up, con-
tinuous/prolonged versus point prevalence, and biochemically val-
idated versus self-report). Where appropriate, we expressed trial ef-
fects as a risk ratio (RR), calculated as: (quitters in treatment group/
total randomised to treatment group)/(quitters in control group/
total randomised to control group), alongside 95% confidence in-
tervals (CI). A risk ratio greater than 1 indicates a potentially better
outcome in the intervention group than in the control group.
Secondary outcomes (mental health and QoL) were discussed nar-
ratively.
Unit of analysis issues
We included both individually and cluster-randomised trials. For
cluster RCTs, we considered whether authors had accounted for
clustering in their reported analyses. Where possible and appropri-
ate, we adjusted for clustering using the trial's reported intra-class
correlation (ICC), calculated an ICC from the information provided,
or applied the reported ICC from a similar trial.
Dealing with missing data
We conducted our analyses on an intention-to-treat basis, i.e. us-
ing all participants randomised to their original groups as denomi-
nators where data were available, and assuming that those lost to
follow-up were continuing to smoke. We extracted numbers lost to
follow-up from study reports and used these to assess the risk of
attrition bias. Where any required primary outcome data were not
available in study reports, we contacted the authors in an attempt
to obtain these.
Assessment of heterogeneity
Before pooling studies, we considered both methodological and
clinical variance between studies. Where pooling was deemed ap-
propriate, we investigated statistical heterogeneity using the I2 sta-
tistic (Higgins 2003). This describes the percentage of the variabili-
ty in effect estimates that is due to heterogeneity rather than sam-
pling error (chance).
Assessment of reporting biases
We used funnel plots to assess small-study effects and investigate
the possibility of publication bias for the 'MI as an adjunct' and
'MI versus other smoking cessation treatment' comparisons. There
were not enough studies (fewer than ten) included in the other
analyses to create funnel plots.
Data synthesis
For the primary outcome - smoking cessation - we synthesised
groups of studies using Mantel-Haenszel random-effects models to
estimate separate pooled treatment effects (as RRs and 95% CIs),
for four types of comparison:
• MI versus no smoking cessation intervention (comparison 1)
• MI in addition to another smoking cessation treatment versus
that smoking cessation treatment alone (comparison 2)
• MI alone versus another smoking cessation intervention (com-
parison 3)
• Higher intensity MI versus lower intensity MI (comparison 4)
Secondary outcomes - mental health and QoL - were reported
sparsely and so were summarised narratively.
Subgroup analysis and investigation of heterogeneity
In view of possible heterogeneity between studies, where relevant
and there were sufficient studies, we analysed the trials in the fol-
lowing subgroups:
• Stratified by whether intensity of smoking cessation support
was matched between trial arms, or differed between the MI and
comparison group. Intensity was defined as a combination of
the number of treatment sessions provided and the overall in-
tervention/comparator contact time.
• Stratified by age of participant: adult versus adolescent
• Stratified by intervention provider: GP, nurse, counsellor/psy-
chologist, lay healthcare worker
• Stratified by counselling modality: face-to-face contact (includ-
ing interventions delivered completely face-to-face or partially
face-to-face) versus no face-to-face contact (i.e. via telephone,
text messages, virtual reality setting)
• Stratified by whether MI fidelity monitoring was reported or not
• Stratified by the participants' motivation to quit at baseline, i.e.
whether those recruited were motivated to quit, were not moti-
vated to quit, or had not been selected based on their motiva-
tion to quit
Sensitivity analysis
We carried out the following sensitivity analyses to see if the pooled
results of analyses were sensitive to the removal of:
• Studies judged to be at high risk of bias
• Studies that measured the fidelity of MI and found that the re-
quirements of MI were not met (fidelity subgroup analyses only)
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• Studies where the MI intervention was also based on another
theoretical approach, such as CBT
'Summary of Findings' table
Following standard Cochrane methodology (Higgins 2011), we cre-
ated 'Summary of findings' tables for all comparisons:
• MI versus no smoking cessation intervention
• MI in addition to another smoking cessation treatment versus
that smoking cessation treatment alone
• MI versus another smoking cessation intervention
• Higher intensity MI versus lower intensity MI
We used the five GRADE considerations (study limitations, consis-
tency of effect, imprecision, indirectness and publication bias) to
assess the certainty of the body of evidence for the smoking cessa-
tion outcome, and to draw conclusions about the certainty of the
evidence within the text of the review.
R E S U L T S
Description of studies
See Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies; Characteristics of stud-
ies awaiting classification; .
Results of the search
Our searches resulted in 1325 records. After duplicates were re-
moved, 1299 records remained for title and abstract screening. We
ruled out 1139 records at this stage, leaving 160 for full-text screen-
ing. We identified 37 completed studies, five ongoing studies, one
study awaiting classification, and excluded 117 studies at the full-
text screening stage. See Figure 1 for study flow information relat-
ing to the most recent search.
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Figure 1.   Study flow diagram for this update
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Included studies
Included studies
This review includes 37 RCTs, including over 15,000 participants.
Trials were conducted in Australia (two studies), Brazil (two stud-
ies), the USA (28 studies), China, India, South Africa, Spain and the
UK (one study each).
Participants
All participants were tobacco smokers. Eleven of the 37 included
studies (Butler 1999; Catley 2016; Cook 2016; Davis 2011; Demétrio
Faustino-Silva 2018; Ellerbeck 2009; Hollis 2007; NCT02645838; So-
ria 2006; Vidrine 2019; Wu 2009) recruited from the general popula-
tion, through advertisements, attendance at primary care or other
community venues, or through calling a smoking quit-line. Howev-
er, the majority of studies in this review recruited from specialist
populations:
• Adolescents or young people (eight studies; Audrain-McGovern
2011; Colby 2005; Colby 2012; Harris 2010; Helstrom 2007; Kelly
2006; Tevyaw 2009; WoodruC 2007). One of these studies specif-
ically recruited adolescent offenders (Helstrom 2007). Partici-
pants had been arrested or given notice to appear in court for
a variety of offences and had been given the option for a diver-
sionary program, but were not incarcerated.
• People with substance abuse problems (three studies):
Rohsenow 2015 recruited people with a range of substance
abuse issues, whereas Rohsenow 2014 specifically recruited
people with alcohol dependency and Stein 2006 recruited opoid
dependent people receiving methadone treatment.
• People attending, or who had attended screening, for smok-
ing-related cancers (two studies): Marshall 2016 recruited peo-
ple who were being screened for lung cancer, and McClure 2005
recruited women who had attended for cervical screening, and
had been told that they had an elevated risk of cervical cancer.
• Patients with a variety of acute health problems (eight studies):
In four studies, participants were being treated as hospital in-
patients, for unspecified, varied health issues (De Azevedo 2010;
Lewis 1998; Sherman 2016) or operative fractures (Matuszewski
2018). In the remaining four studies, patients were attending the
emergency department for chest pain (Bock 2008), or receiving
outpatient treatment for post traumatic stress disorder (PTSD)
(Battaglia 2016), HIV (Lloyd-Richardson 2009), or tuberculosis
(Louwagie 2014).
• African-American/black light smokers: defined as smoking ten
or fewer cigarettes per day (Ahluwalia 2006)
• Incarcerated men in a prison in India (Naik 2014)
• Homeless adults recruited from homeless shelters (Okuyemi
2013)
• Friends and family of people who had been diagnosed with lung
cancer (Bastian 2013)
• People with a low income: defined as primary care patients who
were uninsured or receiving healthcare benefits (Bock 2014)
The majority of the included studies (29 of 37) did not recruit partic-
ipants specifically based on their motivation to quit at baseline, i.e.
there was not an eligibility criterion that specified that participants
needed to be motivated to quit or not; however five studies only
recruited participants motivated to quit (Ahluwalia 2006; Demétrio
Faustino-Silva 2018; Hollis 2007; Lewis 1998; Vidrine 2019) and
three studies specifically recruited participants who were not moti-
vated to quit (Catley 2016; Cook 2016; Davis 2011). The studies that
recruited people motivated to quit had an eligibility criteria spec-
ifying that participants had to be willing to quit smoking within a
specific time period (e.g. the next two weeks, within a month); re-
cruited people based on their willingness to receive smoking cessa-
tion treatment; or recruited people because they had expressed an
interest in quitting. The studies that recruited people not motivated
to quit advertised for participants who were not ready to quit smok-
ing; had an eligibility criterion specifying that participants should
have no interest in quitting over the next month; or participants
were not told that the aim of the study was smoking cessation and,
when asked about their quitting plans, were excluded if they said
they were ready to quit.
Intervention
Motivational Interviewing (MI)
All of the studies included in this review made explicit reference
to using MI principles defined by Miller and Rollnick (as described
in Miller 2013). Most studies merely specified that the intervention
was carried out according to established MI techniques, rather than
providing a more detailed description of counselling content. Three
studies reported that the counselling in the intervention arm was
based on another theoretical approach in addition to MI: Bastian
2013 combined the principles of MI with adaptive coping skills, and
both Lewis 1998 and Vidrine 2019 combined MI with principles of
cognitive behavioural therapy (CBT). Another study combined the
adolescent participant MI intervention with a parent MI interven-
tion in the intervention arm only (Colby 2012). Researchers dis-
cussed participants' quit attempts and supporting it with their par-
ents, using MI principles.This study was borderline for inclusion as
one of our eligibility criteria was to exclude studies where extra
non-MI components were not matched between study arms. How-
ever, we decided to include this study, as the extra component com-
plied with the principles of MI, and we went on to test whether its
exclusion impacted upon the results of meta-analysis using sensi-
tivity analysis.
MI fidelity monitoring
Twenty-one of the 37 studies reported that they carried out MI
fidelity monitoring during the study to assess whether the prin-
ciples of MI were adhered to, to improve adherence to the prin-
ciples, or both (Ahluwalia 2006; Audrain-McGovern 2011; Bastian
2013; Battaglia 2016; Bock 2008; Bock 2014; Catley 2016; Colby
2005; Colby 2012; Davis 2011; De Azevedo 2010; Ellerbeck 2009;
Harris 2010; Hollis 2007; Kelly 2006; Lloyd-Richardson 2009; Okuye-
mi 2013; Rohsenow 2014; Rohsenow 2015; Sherman 2016; Tevyaw
2009). This usually comprised one or a range of the following meth-
ods: the observation of all or a subset of sessions by clinicians or
the study lead; rating sessions on their adherence to MI using fideli-
ty scales, such as the Motivational Interviewing Treatment Integri-
ty (MITI) code (Pierson 2007) or study specific scales; supervision
meetings with counselling providers to reflect on practice and learn
and improve based on these experiences. Only ten of these 21 stud-
ies then went on to report on the results of this fidelity monitor-
ing (Audrain-McGovern 2011; Catley 2016; Colby 2005; Colby 2012;
Davis 2011; Harris 2010; Lloyd-Richardson 2009; Rohsenow 2014;
Rohsenow 2015; Tevyaw 2009). Only one of these studies reported
that some of the benchmarks for competency were not widely met
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(Audrain-McGovern 2011), and we accounted for this using sensitiv-
ity analysis; however, criteria were very close to being met. As fideli-
ty monitoring and benchmarks for fidelity differed across studies,
it is plausible that studies that met their own adherence standards
may not have met the standards of other studies and vice versa. For
further details of fidelity monitoring (where this occurred) see Ta-
ble 1.
Pharmacotherapy
Twenty of the 37 studies offered or recommended the use of phar-
macotherapy for smoking cessation to all, or a subset of partici-
pants, in the study groups of interest for this review. This was typ-
ically nicotine replacement therapy (NRT) only (Ahluwalia 2006;
Bastian 2013; Bock 2008; Bock 2014; Cook 2016; Hollis 2007; Lloyd-
Richardson 2009; Okuyemi 2013; Rohsenow 2014; Rohsenow 2015;
Sherman 2016; Stein 2006; Vidrine 2019; Wu 2009), however one
study offered bupropion only (Soria 2006), and some studies pro-
vided a choice of pharmacotherapies from two or all three of the fol-
lowing: NRT, varenicline or bupropion (Battaglia 2016; Catley 2016;
Ellerbeck 2009; Harris 2010; McClure 2005). In all cases, pharma-
cotherapy was offered or recommended in all relevant trial arms,
and so the use and type of pharmacotherapy was not being test-
ed. Where included studies did have trial arms testing additional
components to MI, these study arms were not included in analyses
(Ellerbeck 2009; Lewis 1998).
Modality
MI was delivered in face-to-face sessions in 17 of the 37 studies;
in another 12 studies, the counselling was delivered in a combina-
tion of face-to-face and telephone sessions, usually with an initial
session or sessions conducted face-to-face, followed by follow-up
counselling over the phone. Six studies provided counselling over
the phone only (Bastian 2013; Battaglia 2016; Ellerbeck 2009; Hol-
lis 2007; McClure 2005; Sherman 2016); a further study had an MI
intervention group that received calls and text messages based on
CBT and MI and another MI group that received text messages on-
ly (Vidrine 2019), and a final study provided MI counselling for ado-
lescents in an online virtual environment (WoodruC 2007). Partic-
ipants were represented by an avatar in the online world and re-
ceived MI group counselling with other participants and a counsel-
lor within a virtual shopping mall.
Intensity
Nine studies provided a single session of MI in at least one of the MI
intervention groups (Butler 1999; Davis 2011; Helstrom 2007; Kelly
2006; Louwagie 2014; Marshall 2016; Matuszewski 2018; Rohsenow
2014; Vidrine 2019); the number of sessions offered ranged from
one to 12 across studies. Some studies had more than one MI inter-
vention group of different intensities (Ellerbeck 2009; Hollis 2007;
Matuszewski 2018; Rohsenow 2014; Sherman 2016; Vidrine 2019).
These studies compared a lower intensity MI intervention com-
prised of one to two sessions to a higher intensity MI intervention
which ranged from two to 11 sessions. The total duration of MI in-
terventions varied greatly across studies, from five minutes to 315
minutes; however length of sessions was not reported in a minority
of cases. For further detail on the content and intensity of interven-
tions, see Table 2.
Provider
MI was delivered by physicians (Butler 1999; Marshall 2016;
NCT02645838; Soria 2006), nurses (Battaglia 2016; Davis 2011;
Lewis 1998), counsellors/psychologists (Ahluwalia 2006; Audrain-
McGovern 2011; Bastian 2013; Bock 2008; Bock 2014; Catley
2016; Colby 2005; Colby 2012; Cook 2016; Ellerbeck 2009; Harris
2010; Kelly 2006; Lloyd-Richardson 2009; McClure 2005; Okuye-
mi 2013; Rohsenow 2014; Rohsenow 2015; Sherman 2016; Stein
2006; Tevyaw 2009; Vidrine 2019; WoodruC 2007; Wu 2009), some
of whom were described as specialist smoking cessation advisors
(De Azevedo 2010; Demétrio Faustino-Silva 2018; Hollis 2007; Ma-
tuszewski 2018), and lay healthcare workers (Louwagie 2014). Hel-
strom 2007 and Naik 2014 did not specify the type of provider de-
livering support.
Comparator
We grouped studies dependent on the nature of the relevant
comparator. Comparators either consisted of no smoking cessa-
tion interventions (Cook 2016; Harris 2010; Naik 2014; Tevyaw
2009; WoodruC 2007), a non-MI smoking cessation intervention
(Ahluwalia 2006; Audrain-McGovern 2011; Bastian 2013; Battaglia
2016; Bock 2008; Bock 2014; Butler 1999; Catley 2016; Colby 2005;
Colby 2012; Cook 2016; Davis 2011; De Azevedo 2010; Demétrio
Faustino-Silva 2018; Helstrom 2007; Kelly 2006; Lewis 1998; Lloyd-
Richardson 2009; Louwagie 2014; Marshall 2016; Matuszewski
2018; McClure 2005; NCT02645838; Okuyemi 2013; Rohsenow 2014;
Rohsenow 2015; Soria 2006; Stein 2006; Tevyaw 2009; Vidrine 2019;
Wu 2009), or another MI intervention of lower intensity (Ellerbeck
2009; Hollis 2007; Matuszewski 2018; Rohsenow 2014; Sherman
2016; Vidrine 2019). Some studies had multiple study arms and so
fell into more than one category. We further split the studies with
a non-MI smoking cessation intervention into two groups - those
where the MI interventions stood alone and were directly compared
with the other cessation interventions, and those where the inter-
vention groups received the MI interventions in addition to the non-
MI smoking cessation interventions, which were also offered in the
comparator groups.
No smoking cessation treatment comparator
Three of the five studies that compared MI to no smoking cessa-
tion treatment provided no intervention (Cook 2016; Naik 2014;
WoodruC 2007). Participants were simply followed up to assess the
outcome. Naik 2014 offered participants in the comparator the op-
portunity to receive the MI intervention following the initial treat-
ment period. Two of the studies provided participants with a 'dum-
my' intervention designed to match the intensity of the MI smok-
ing cessation intervention. In Harris 2010, this was MI counselling
focussed on increasing participants' fruit and vegetable consump-
tion; both study arms received counselling over four sessions for an
average duration of 100 minutes. In Tevyaw 2009, participants in
the comparison group received 'progressive muscle relation train-
ing' over three sessions for an overall duration of 120 minutes.
Non-MI smoking cessation intervention comparator
In the minority of cases (7 of 31; Ahluwalia 2006; Catley 2016;
Davis 2011; Demétrio Faustino-Silva 2018; Helstrom 2007; Kelly
2006; Wu 2009), the comparator group (or one of the comparator
groups in the study) received smoking cessation counselling that
was matched in intensity to the MI counselling in the intervention
group. This was either described simply as smoking cessation coun-
selling with information giving or advice, or as a specific approach,
i.e. prescriptive interviewing (Davis 2011), CBT (Demétrio Fausti-
no-Silva 2018), or the psychoeducation model (Kelly 2006). Wu 2009
provided participants in the comparator group with general health
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education counselling, which covered smoking cessation, as well
as nutrition and exercise.
In most cases, the support provided in the comparator group was of
lower intensity than the MI intervention arm and consisted of brief
advice on cessation, self-help materials (such as printed materials
and contact details for smoking cessation services or quit-lines), or
both. In one study, one of the comparator interventions was more
intensive than the MI intervention (Cook 2016). Cook 2016 was a 16-
arm factorial trial where some study arms were provided with a be-
havioural smoking reduction intervention. This reduction interven-
tion was delivered over seven sessions with a total duration of 80
minutes, whereas the MI intervention was delivered over four ses-
sions with a total duration of 50 minutes.
Two studies offered half of their participants payments contingent
on them being abstinent from smoking (Rohsenow 2015; Tevyaw
2009). In both cases, these contingency payments were matched in
the intervention arm.
Outcomes
The majority of studies measured cessation at six months follow-up
(25 of 37); however, nine studies measured cessation at 12 months
follow-up (Bastian 2013; Bock 2014; Hollis 2007; Marshall 2016; Mc-
Clure 2005; Rohsenow 2014; Rohsenow 2015; Soria 2006; WoodruC
2007), and one study each measured cessation at nine months
(Battaglia 2016), 11 months (Demétrio Faustino-Silva 2018) and 24
months (Ellerbeck 2009) follow-up. It was possible to use biochem-
ically validated (using expired carbon monoxide or urinary/salivary
cotinine) cessation rates for 22 of the 37 studies. We were unsure
whether the rates reported in Naik 2014 and Demétrio Faustino-Sil-
va 2018 were biochemically verified. The Naik 2014 study report
stated that carbon monoxide was measured; however, it was un-
clear whether this was used to motivate participants, verify cessa-
tion rates, or both.
Only one study measured one of our secondary outcomes - men-
tal health. Battaglia 2016 recruited veterans with PTSD attending
Veterans Health Administration (VHA) healthcare clinics and inves-
tigated the effect of integrating MI smoking cessation counselling
into the standard telehealth programme already provided (which
included access to pharmacological and behavioural smoking ces-
sation treatments). Throughout the study, PTSD symptoms were
assessed using the PTSD Checklist (range of 17 to 85 with a score
> 50, indicating PTSD diagnosis), depression was monitored using
the 15-item Geriatric Depression Scale-Short Form (GDS-SF), where
a score greater than 6 indicated probable depression, and suici-
dal thoughts were assessed every 30 sessions via a single question.
Some of the other studies measured markers of mental health or
well-being at baseline or reported mental health at follow-up over-
all; however, only Battaglia 2016 measured mental health at fol-
low-up and presented the results by study group.
Excluded studies
We listed 117 studies that were potentially relevant but exclud-
ed, with reasons, in the Characteristics of excluded studies table.
Reasons that studies were excluded at full-text stage are also sum-
marised in Figure 1. The reason why most studies were excluded
at full-text screening stage was because the intervention group re-
ceived non-MI intervention components that were not included in
the comparator arm, such as pharmacotherapy, a text messaging
intervention, or incentives.
We also classified five studies as ongoing (Lloyd-Richardson 2003;
NCT01387516; NCT02905656; NCT03002883; Salgado Garcia 2018),
which are likely to be relevant for inclusion once completed and/or
reported. We classified Zhou 2014 as 'awaiting classification' as on-
ly a conference abstract was available and it was impossible to de-
termine from this whether smoking cessation was definitely mea-
sured (reduction in cigarette consumption was reported) and at
what time points. Attempts to contact the authors were unsuccess-
ful.
Risk of bias in included studies
Full details of 'Risk of bias' assessments are given for each trial with-
in the Characteristics of included studies tables. Overall, we judged
four studies to be at low risk of bias (low risk of bias across all do-
mains), 11 at high risk of bias (high risk of bias in at least one do-
main), and the remaining 22 at unclear risk of bias. A summary illus-
tration of the 'Risk of bias' profile across trials is shown in Figure 2.
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Figure 2.   Methodological quality summary: review authors' judgements about each methodological quality item
for each included study.
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Figure 2.   (Continued)
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Allocation
We assessed selection bias through investigating methods of ran-
dom sequence generation and allocation concealment for each
study. We rated 15 studies as having low risk for random sequence
generation, and the remaining 22 as having unclear risk. We judged
nine studies to be at low risk for allocation concealment, 27 at un-
clear risk, and one study at high risk (WoodruC 2007). WoodruC
2007 was judged as having high risk as clusters were randomised
to treatments, and study personnel knew which condition a clus-
ter was in before participant recruitment began. Recruitment was
then tailored to this, using different recruitment materials depen-
dent on assigned condition. This meant that participants may not
have been equivalent across groups. We judged studies as having
unclear risk of bias when authors provided insufficient information
about methods used.
Outcome assessment (detection bias)
We did not formally assign a risk of performance bias for each tri-
al. It is almost always impossible to blind providers of behaviour-
al support to treatment allocation. Moreover, nonspecific effects of
being in treatment are part of the intervention effect that studies
were aiming to assess.
We judged detection bias on the basis of biochemical validation
and, where biochemical validation was not provided, on the ba-
sis of differential levels of contact between participants and the
study team across relevant study groups. We judged ten studies
to be at high risk of detection bias as outcomes were defined as
self-report only and the intervention and control arms received dif-
ferent levels of support, making differential misreporting possible
(Bastian 2013; Bock 2008; Cook 2016; De Azevedo 2010; Hollis 2007;
Kelly 2006; Marshall 2016; Sherman 2016; Vidrine 2019; WoodruC
2007). We judged two studies to be at unclear risk of detection
bias (Demétrio Faustino-Silva 2018; Naik 2014) as we were unsure
whether the rates reported were biochemically verified. We judged
the remaining 25 studies to be at low risk of detection bias.
Incomplete outcome data
We judged studies to be at a low risk of attrition bias where the
numbers of participants lost to follow-up were clearly reported, the
overall number lost to follow-up was not more than 50%, and the
difference in loss to follow-up between groups was no greater than
20%. This is in accordance with 'Risk of bias' guidance produced by
the Cochrane Tobacco Addiction Group for assessing smoking ces-
sation studies. We judged 29 of the studies to be at low risk of bias,
six at unclear risk (Lewis 1998; Matuszewski 2018; McClure 2005;
Naik 2014; Stein 2006; WoodruC 2007) and two at high risk (Bast-
ian 2013; Bock 2014). These two studies were judged to be at high
risk because overall loss to follow-up was more than 50%. Judge-
ments of unclear risk were made either because information on fol-
low-up was not reported in the sources available to us (Lewis 1998;
Matuszewski 2018; McClure 2005; Naik 2014), or because loss to fol-
low-up was reported for the relevant time point overall, but not
split by study group (Stein 2006; WoodruC 2007).
Other potential sources of bias
Two sources of other bias were identified for two of the includ-
ed studies (Cook 2016; Naik 2014). The comparator intervention in
Naik 2014 was a 'waiting list' to receive the MI intervention treat-
ment following the intervention group (verified through contact
with author); however, it was unclear whether participants knew
that they were on a waiting list. We contacted the authors a second
time to verify whether the intervention was delivered to the com-
parator group after the six-month assessment time point and re-
ceived no further reply. However, the quit rates were much higher
in the intervention group than in the comparator group (48/300 and
6/300, respectively), suggesting that this was the case. Due to this
uncertainty, we have assigned this study a rating of unclear risk for
'other potential sources of bias'. Cook 2016 was a factorial trial with
four factors: 1) MI/no MI; behavioural reduction counselling/no be-
havioural reduction counselling; nicotine gum/no nicotine gum;
and nicotine patch/no nicotine patch. The authors reported an un-
expected interaction between MI and nicotine gum, where the com-
bination of the two resulted in lower quit rates than any other inter-
ventions or combinations. As a result, we have assigned Cook 2016
a rating of high risk of other bias. For details of how data from Cook
2016 have been entered into meta-analyses, see the Characteristics
of included studies table.
E;ects of interventions
See: Summary of findings for the main comparison Motivational
interviewing compared with no treatment for smoking cessation;
Summary of findings 2 Motivational interviewing in addition to
other smoking cessation treatment for smoking cessation; Sum-
mary of findings 3 Motivational interviewing compared with an-
other smoking cessation intervention for smoking cessation; Sum-
mary of findings 4 Higher compared with lower intensity motiva-
tional interviewing for smoking cessation
MI versus no smoking cessation treatment (comparison 1)
Smoking cessation outcome
We pooled five studies, including an adjusted N of 1284 (adjusted
for clustering in one study - Harris 2010), comparing an MI smoking
cessation intervention with no smoking cessation treatment. How-
ever, heterogeneity was substantial (I2 = 87%; Analysis 1.1), and
so we did not deem it appropriate to present the pooled result of
this analysis. Examining the forest plots, individual RRs and 95% CIs
provided evidence that this heterogeneity was due to the large pos-
itive effect of MI in Naik 2014 (RR 8.00; 95% CI 3.48 to 18.41; N = 600).
This was confirmed by a sensitivity analysis removing Naik 2014
(Analysis 1.2; I2 = 0%). None of the four remaining studies (Cook
2016; Harris 2010; Tevyaw 2009; WoodruC 2007) demonstrated a
clear benefit of MI, as the confidence intervals spanned both clini-
cal benefit and harm (pooled RR 0.84, 95% CI 0.63 to 1.12; I2 = 0%;
adjusted N = 684). The heterogeneity introduced by Naik 2014 can
potentially be explained by the nature of the population recruited,
which differs substantially to the populations studied in Cook 2016,
Harris 2010, Tevyaw 2009 and WoodruC 2007. Naik 2014 recruited
incarcerated male smokers and, as a result, took place in a prison
setting where participants were potentially unable to drop out, and
also very unlikely to try to quit smoking in the no treatment group;
whereas Cook 2016 recruited adults in a primary care setting, Har-
ris 2010 and Tevyaw 2009 recruited young college and university
students (aged 18 to 24 years) and WoodruC 2007 recruited adoles-
cents (aged 14 to 19 years).
Harris 2010 cluster-randomised 30 university fraternities and soror-
ities rather than individuals. They reported an ICC of 0.003, allowing
us to adjust for this in our analysis. Cook 2016 was a four factor, 16-
arm, factorial RCT included in this comparison, as well as compar-
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isons 2 and 3. Please refer to the Characteristics of included studies
table for full details of how this study was included in all analyses.
Removing the two studies judged to be at high risk of bias in the
pooled analysis (Cook 2016; WoodruC 2007) changed the direction
of the pooled estimate so that it was in favour of motivational inter-
viewing; however, confidence intervals still incorporated evidence
of both benefit and harm, and so this did not change our interpreta-
tion of the result. The estimate resulting from this sensitivity analy-
sis should be treated with caution as it was based on only two stud-
ies (Harris 2010; Tevyaw 2009) and there was substantial impreci-
sion due to a paucity of participants and events (RR 1.50, 95% CI
0.22 to 10.14; I2 = n/a; adjusted N = 434).
We did not carry out any subgroup analyses on the presented
pooled analysis (Analysis 1.2) as there were insufficient data to
draw meaningful conclusions.
Mental health and QoL outcomes
None of the studies relevant to this comparison measured mental
health or QoL at any follow-up, by study group.
MI in addition to another smoking cessation treatment versus
that smoking cessation treatment alone (comparison 2)
Smoking cessation outcome
We pooled twelve studies comparing a smoking cessation interven-
tion supplemented by MI with the same smoking cessation inter-
vention without the MI component (Analysis 2.1). This resulted in
a pooled RR of 1.07 (95% CI 0.85 to 1.36; adjusted N = 4167). The
point estimate suggests a small potential benefit of MI when of-
fered in addition to other smoking cessation treatment; however,
CIs spanned one and moderate heterogeneity was detected (I2 =
47%).
Two cluster RCTs were included in the analysis; Vidrine 2019 ran-
domised neighbourhood sites and conducted adjusted analyses,
accounting for the type of site (church, housing complex or commu-
nity centre) and the individual site (46 sites). This allowed us to cal-
culate an ICC of 0.06 and adjust for this in our analysis. We were un-
sure whether Demétrio Faustino-Silva 2018 carried out adjustment
for clustering and an ICC was not reported. As a result, we entered
the data from the abstract into our main analysis and performed
a sensitivity analysis replacing this data with data adjusted for the
ICC calculated for Vidrine 2019 (0.06). This sensitivity analysis had
no effect on the interpretation of the result (RR 1.06, 95% CI 0.83 to
1.36; I2 = 46%; adjusted N = 3965).
We also carried out sensitivity analyses removing three studies with
interventions based on other theoretical approaches alongside MI
(Bastian 2013 - MI + Adaptive coping skills; Lewis 1998 - MI + CBT;
Vidrine 2019 - MI + CBT), and removing six studies judged to be at
high risk of bias (Bastian 2013; Bock 2008; Bock 2014; Cook 2016;
Marshall 2016; Vidrine 2019). In neither case did this significantly
affect the interpretation of the result, as confidence intervals con-
tinued to encompass both harm and benefit (RR 1.02; 95% CI 0.75
to 1.40; I2 = 53%; N = 3145; and RR 1.17; 95% CI 0.71 to 1.93; I2 = 65%;
N = 1366, respectively).
Intensity of the comparator
We split the twelve included studies into two groups dependent
on whether the intensities of the interventions provided to the MI
groups and the comparator groups were matched, or whether the
intensity of the intervention received by the MI group exceeded that
in the comparator group (Analysis 2.2). One study matched the in-
tensity of the intervention and comparator treatments (Demétrio
Faustino-Silva 2018), and provided evidence of an effect of MI. Both
groups received the standard CBT-based smoking cessation sup-
port advocated by the Brazilian Ministry of Health, but the interven-
tion providers in the MI arm were also taught MI as an additional
resource to use in their treatment sessions. However, in most stud-
ies the intervention provided in the comparator group was of a low-
er intensity, as the MI intervention was being offered as an addi-
tional element to a standard smoking cessation intervention. These
eleven studies resulted in a pooled estimate of 1.01, with CIs en-
compassing both harm and benefit of MI in addition to other smok-
ing cessation treatment. There was no evidence of statistically sig-
nificant subgroup differences (I2 = 47.3%, P = 0.17).
Intervention provider
Interventions were provided by physicians (one study; N = 55), nurs-
es (two studies; N = 298), counsellors (including those specifically
trained as smoking cessation advisors; eight studies; N = 3405), or
lay healthcare workers (one study; N = 409). When studies were split
into these groups, there was evidence of moderate subgroup dif-
ferences (I2 = 66.2%, P = 0.03); with some evidence of a benefit of
MI when delivered by lay healthcare workers (Analysis 2.3). Howev-
er, the number of participants and events in most subgroups were
low, resulting in imprecise effects, which should be treated with
caution.
Counselling modality
We grouped studies into those where the intervention was deliv-
ered either wholly or partially face-to-face and those where none
of the intervention was delivered face-to-face (Analysis 2.4). Eight
studies involved face-to-face contact and four no face-to-face con-
tact (interventions were delivered either solely by telephone or via
telephone and text message). There was very little heterogeneity
between subgroup effects (I2 = 4.1%, P = 0.31).
MI fidelity monitoring
Some included studies reported study mechanisms to monitor or
ensure the fidelity of the MI intervention, or both; therefore, we split
those that did and did not into separate subgroups (Analysis 2.5).
For this comparison, five of the 12 studies reported that they had
used a form of fidelity monitoring. There was no evidence of sta-
tistically significant heterogeneity between subgroups (I2 = 16.9%,
P = 0.27). The point estimate favoured the comparator in the stud-
ies that included fidelity monitoring and favoured MI in those that
did not include fidelity monitoring; however, in both cases, CIs in-
corporated both potential benefit and harm of the intervention. We
planned a sensitivity analysis to test the effect of removing stud-
ies that monitored fidelity and discovered fidelity to the principles
of MI was low; however, only one of the five studies that report-
ed they carried out monitoring reported on the results, and fidelity
was deemed to be high (Table 1).
Baseline participant motivation
Three studies in this comparison recruited participants who were
already motivated to quit smoking at baseline, one recruited par-
ticipants who were not motivated to quit, and the remaining eight
studies recruited people regardless of motivation to quit. Although
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there was some heterogeneity between subgroups this did not
reach statistical significance (I2 = 47.6%, P = 0.15) (Analysis 2.6).
Age of participants
We also planned to carry out subgroup analyses investigating the
effects of MI in addition to another form of smoking cessation sup-
port in adolescent participants versus adult participants, howev-
er, all of the studies included in the analysis for this comparison re-
cruited adults.
Mental health and QoL outcomes
One study relevant to this comparison, which recruited military vet-
erans with PTSD, measured and reported on mental health out-
comes (Battaglia 2016). At end of treatment, the MI intervention
group had a mean score of 54.5 (SD = 13.2, N = 62) on the PTSD
Checklist (range 17 to 85) and the comparator group had an aver-
age score of 55.9 (SD = 13.5, N = 59). However, at final follow-up, six
months after the end of treatment (nine months post-baseline), the
MI intervention group had a statistically significantly (P < 0.05 for
analysis adjusting for covariates) lower PTSD symptom score (58.4;
SD = 11.4, N = 61) compared with the comparator group (62.4; SD =
10.9, N = 59). For both groups, there had been an increase in PTSD
scores between the end of treatment and final follow-up, however,
this increase was smaller in the intervention group. At both the end
of treatment and final follow-up, the average depression score was
significantly higher in the comparator group than the MI group (P <
0.05 for analyses adjusting for covariates). In both groups, all scores
indicated probable depression. There was no significant difference
in the frequency of reported suicidal thoughts between groups dur-
ing the intervention period (3.4% (n = 3) of the MI group and 10.5%
(n = 9) of the comparator group reported thoughts of self-harm) and
no participants died by suicide during the study.
MI versus another smoking cessation intervention
(comparison 3)
Smoking cessation outcome
We pooled 19 studies comparing MI to another type of smoking ces-
sation intervention (Analysis 3.1). The point estimate was in favour
of MI; however the confidence intervals were compatible with po-
tential harm as well as substantial benefit (RR 1.24, 95% CI 0.91 to
1.69; I2 = 54%; N = 5192). In sensitivity analyses, we 1) removed Col-
by 2012, as parents also received an MI intervention to motivate
them to support their child's quit attempt, making the intervention
different to the other interventions included (RR 1.24, 95% CI 0.90
to 1.70; I2 = 56%; N = 5030); and 2) removed Cook 2016, De Azevedo
2010 and Kelly 2006 as we judged these studies to be at high risk
of bias (RR 1.32, 95% CI 0.89 to 1.98; I2 = 63%; N = 4602). Neither of
these analyses meaningfully changed the summary estimates.
Intensity of the comparator
In 14 studies, the treatment provided in the comparator group (or in
some of the comparator groups) was of a lower intensity than in the
MI intervention group. In one study, the comparator group in some
of the study arms received a higher intensity treatment than the in-
tervention group (Cook 2016 - behavioural reduction counselling);
and in six studies the intensity of the treatments was similar in the
intervention and comparator groups. In both Catley 2016 and Cook
2016, there was more than one comparator arm and the intensity of
the comparators varied. Therefore, both studies were included in
more than one subgroup and the total participants and number of
events in the intervention group were split across subgroups. There
was no evidence of heterogeneity between subgroups (I2 = 0%, P =
0.93; Analysis 3.2).
Age of participants
Of the 19 studies comparing MI to another type of smoking cessa-
tion intervention, five recruited adolescents only. There was no ev-
idence of a subgroup difference for the effect of MI in adolescents
compared with adult participants (I2 = 0%, P = 0.73; Analysis 3.3).
Intervention provider
Across the studies in this comparison, interventions were provid-
ed by physicians (three studies), nurses (one study), or counsel-
lors/psychologists (including those specialised in smoking cessa-
tion; 14 studies). Helstrom 2007 was not included in this subgroup
analysis because they did not report the treatment providers' main
role. There was no evidence that the effect size differed by these
subgroups (I2 = 17.2%, P = 0.30; Analysis 3.4).
MI fidelity monitoring
For this comparison, 12 of the 19 studies reported that they had
monitored the fidelity of MI. There was evidence that this modified
the effectiveness of MI relative to comparators in this subgroup (I2
= 84.0%, P = 0.01; Analysis 3.5). There was no evidence that MI out-
performed the comparator in studies where fidelity monitoring had
taken place (RR 0.98, 95% CI 0.71 to 1.37; I2 = 41%; N = 3382), with
stronger evidence of a benefit of MI in studies where fidelity was not
assessed (RR 1.83, 95% CI 1.28 to 2.60; I2 = 9%; N = 1810). However,
this latter effect appears to be partly driven by only two of the six
studies in the group (Soria 2006; Wu 2009), which suggest a stronger
benefit than the other studies in the subgroup. Eight of the 12 stud-
ies that reported they had carried out fidelity monitoring provid-
ed results of fidelity assessment (Audrain-McGovern 2011; Catley
2016; Colby 2005; Colby 2012; Davis 2011; Lloyd-Richardson 2009;
Rohsenow 2014; Rohsenow 2015); all but one of these appeared to
meet the study defined thresholds for good fidelity. The one study
that did not meet prespecified thresholds only narrowly missed
these (Audrain-McGovern 2011); removing this single study did not
meaningfully change the subgroup estimate nor the difference be-
tween subgroups.
Baseline participant motivation
One study in this comparison recruited only participants motivated
to quit smoking at baseline, three recruited participants not moti-
vated to quit, and the remaining 15 recruited participants regard-
less of their motivation. There was substantial evidence of effect
modification (I2 = 88.8%, P = 0.0001; Analysis 3.6). In the subgroup
that recruited participants regardless of motivation, there was evi-
dence that MI interventions resulted in superior quit rates to other
smoking cessation interventions (RR 1.44, 95% CI 1.09 to 1.90; I2 =
33%; N = 3703), whereas the one study that recruited participants
motivated to quit (Ahluwalia 2006) found substantial evidence that
MI worsened outcomes (RR 0.51, 95% CI 0.34 to 0.76; I2 = n/a; N =
755). The comparator in Ahluwalia 2006 was termed 'health educa-
tion', and was described as the current best smoking cessation sup-
port, focussed on providing information and advice by reviewing
the addictive nature of nicotine, the health consequences of smok-
ing, the benefits of quitting, and providing strategies to develop a
quit plan and identify an alternative to smoking when meeting trig-
gers to smoke. In trials where participants were recruited who were
Motivational interviewing for smoking cessation (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
21
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
not motivated to quit smoking (Catley 2016; Cook 2016; Davis 2011)
the confidence intervals provided evidence of substantial impreci-
sion, and for potential harm and benefit of MI (RR 0.81, 95% CI 0.36
to 1.85; I2 = 0%; N = 734).
Counselling modality
We also planned to assess whether the effect of MI might depend
on whether face-to-face sessions or remote sessions were provided
but all interventions incorporated at least one face-to-face session.
Mental health and QoL outcomes
No studies relevant to this comparison measured mental health or
QoL at any follow-up, by study group.
Intensity of the MI intervention (comparison 4)
Smoking cessation outcome
Five included studies examined whether the intensity of MI affect-
ed smoking cessation rates. When pooled, these studies resulted in
an RR of 1.23 (95% CI 1.11 to 1.37; adjusted N = 5620; I2 = 0%; Analy-
sis 4.1) favouring more intensive over less intensive intervention.
As described above, Vidrine 2019 randomised neighbourhood sites
rather than individual participants and conducted adjusted analy-
ses. This allowed us to calculate an ICC of 0.06 and adjust for this
in our analysis. We carried out three sensitivity analyses to test the
robustness of the effect of high versus low intensity MI: 1) we re-
moved Sherman 2016 as the two MI interventions differed not only
in intensity but also provider (RR 1.22, 95% CI 1.07 to 1.40; I2 = 0%;
adjusted N = 4002) (in the higher intensity arm, participants were
treated by the study team, whereas in the lower intensity arm they
were referred to a state quit-line); 2) we removed Vidrine 2019 as
both relevant intervention groups were based on CBT as well as MI
(RR 1.23, 95% CI 1.09 to 1.37; I2 = 0%; adjusted N = 5361); and 3) we
removed Hollis 2007; Sherman 2016 and Vidrine 2019 together, as
they were all judged to be at high risk of bias. The former two analy-
ses did not meaningfully change the estimate of higher versus low-
er intensity; however, removing the three studies at higher risk of
bias reduced the estimate to 1.00 (95% CI 0.65 to 1.54; I2 = n/a; N =
482), with CIs incorporating both a substantial benefit and harm of
increased intensity MI interventions. Although there were two stud-
ies included in this analysis that were judged to be at low or unclear
risk of bias (Ellerbeck 2009; Rohsenow 2014), the latter RR and CIs
were calculated from Ellerbeck 2009 only as no participants quit in
Rohsenow 2014, making it impossible to calculate a point estimate
for that individual study.
Counselling modality
We grouped studies into those where the intervention was deliv-
ered either wholly or partially face-to-face and those where none
of the intervention was delivered face-to-face (Analysis 4.2). One
study involved face-to-face contact (Rohsenow 2014) and four stud-
ies involved no face-to-face contact (interventions were delivered
either solely by telephone or via telephone and text message). How-
ever, this subgroup analysis had no effect (I2 = 0%, P = 0.80), as no
participants quit in either group in Rohsenow 2014.
MI fidelity monitoring
Four of the five studies included in this comparison reported MI fi-
delity monitoring. There was no evidence of a difference between
the four that did report monitoring and the single study that did not
(I2 = 0%, P = 0.78; Analysis 4.3). We had planned to assess the sensi-
tivity of the results to studies where fidelity was poor, but only one
of the four studies that monitored fidelity reported the results, and
that study found adequate fidelity.
Baseline participant motivation
Two studies in this comparison recruited participants who were al-
ready motivated to quit smoking at baseline, and the remaining
three recruited participants regardless of their motivation to quit.
Again, there was no evidence of a difference between these sub-
groups and both groups showed evidence of a benefit of higher in-
tensity MI versus lower intensity MI for smoking cessation (I2 = 0%,
P = 0.81; Analysis 4.4).
Age of participants
We also planned to carry out subgroup analyses investigating
whether providing higher intensity MI in adolescents versus adults
had any affect on smoking cessation; however, this was not possi-
ble, as all of the studies recruited adults.
Intervention provider
We also planned to carry out subgroup analyses investigating
whether the effect varied dependent on intervention provider.
However, this was not possible as all of the studies were delivered
by counsellors.
Mental health and QoL outcomes
None of the studies in this comparison measured mental health or
QoL at any follow-up, by study group.
Additional study
We included one additional study, which was relevant to more than
one comparison, that we were unable to include in any meta-analy-
ses (Matuszewski 2018). Matuszewski 2018 (N = 237) investigated
two MI interventions delivered in addition to brief smoking cessa-
tion support (referral to a patient resource centre that provided de-
tails of a smoking quit-line and a quit-line brochure). The MI inter-
ventions both consisted of a single session of MI counselling (10
minutes); however the second MI group also received a brief fol-
low-up session (5 minutes). Thus, this study investigated the inten-
sity of MI counselling as well as MI in addition to another type of
smoking cessation intervention. Analysis of study data was com-
pleted at the end of 2018 and has not yet been published. Howev-
er, results were presented at a conference in 2018. The conference
abstract stated that at six months, 35% of the comparison group
had quit, and 21% and 30% of the lower intensity and higher inten-
sity MI groups had quit respectively, with no evidence of differences
between these groups. The abstract did not state whether analy-
sis was carried out on an intention-to-treat or complete case basis;
however, the data presented suggests that this was probably not an
intention-to-treat analysis and it was not possible to conduct one
using data provided in the abstract alone.
D I S C U S S I O N
Summary of main results
This review included 37 trials. Five of these trials compared MI
to no smoking cessation intervention, 12 provided MI in addition
to another smoking cessation intervention and compared this to
the same intervention without MI, and 19 compared MI to another
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smoking cessation intervention. Five studies compared a more in-
tensive MI intervention to a lower intensity one. One study could
not be included in meta-analyses.
Pooling all available studies comparing MI to no smoking cessation
treatment resulted in substantial heterogeneity between studies
caused by one study carried out in incarcerated men. As this study
differed considerably from the other included studies, we excluded
this study from the analysis and pooled the remaining studies car-
ried out in adults and adolescents representing the general popula-
tion. This resulted in a pooled RR of 0.84 (95% CI 0.63 to 1.12; I2 = 0%;
adjusted N = 684). The pooled estimate was in favour of no treat-
ment; however the CIs incorporated the possibility of both bene-
fit and harm. This estimate was judged to be of low certainty as it
was imprecise, and all studies were judged to be at high or unclear
risk of bias. When studies at high risk of bias were removed, the
point estimate changed to be in favour of MI; however, the CIs were
still imprecise and spanned one; suggesting the possibility of both
harm and benefit. The comparison between MI plus another smok-
ing cessation intervention and that smoking cessation intervention
alone (RR 1.07, 95% CI 0.85 to 1.36; I2 = 47%; adjusted N = 4167),
and the comparison between MI and another smoking cessation in-
tervention (RR 1.24, 95% CI 0.91 to 1.69; I2 = 54%; N = 5192) also
produced CIs incorporating both benefit and harm. Concerns about
unexplained inconsistency and imprecision resulted in low certain-
ty relating to both of these estimates. We investigated the impact of
studies at high risk of bias, the impact of face-to-face contact, fideli-
ty monitoring, and participant motivation to quit. Across these sen-
sitivity and subgroup analyses, there were some differences split-
ting by subgroup, but no consistent pattern emerged across the
body of evidence.
Five trials examined the effectiveness of more intensive compared
with less intensive MI smoking cessation interventions and pro-
duced an RR of 1.23 (95% CI 1.11 to 1.37; adjusted N = 5620; I2 =
0%) in favour of more intensive MI. However, this analysis includ-
ed three studies at high risk of bias and removing these produced
an RR of 1.00 (95% CI 0.65 to 1.54; I2 = n/a; N = 482). We judged the
overall summary estimate as having low certainty because of this.
Only one study investigated the effect of an MI smoking cessa-
tion intervention on the well-being of participants (Battaglia 2016).
Battaglia 2016 studied participants with PTSD, and found modest
benefits of MI on PTSD and depression scores at final follow-up,
compared with a usual smoking cessation care group. However,
due to the paucity of evidence, no conclusions can be drawn on
whether MI smoking cessation interventions can improve the well-
being of people attempting to quit smoking.
Overall completeness and applicability of evidence
The studies identified for this review were mainly conducted in
the USA; most others took place in other high-income countries,
though some were conducted in middle-income countries. In ad-
dition, the majority of studies were carried out in specific popula-
tions rather than recruitment being carried out in the general pop-
ulation. The diversity of populations studied may have contributed
to the moderate to substantial heterogeneity observed across all
comparisons. We did not plan to, and therefore did not look for
evidence that population characteristics (other than participants'
baseline motivation to quit) modified the effectiveness of MI. Typi-
cally, the specialist populations studied represented what may be
referred to as 'hard to reach' groups (people with substance use
disorders, adolescents, offenders, hospital inpatients and outpa-
tients) and this should be considered when interpreting results;
however, where the characteristics of a population have led to low
quit rates in the intervention arm, this is also likely to have affected
quit rates in the comparator arm, and this may not have affected
the relative effectiveness of MI.
The significant heterogeneity detected within analyses is likely to
also have been influenced by considerable variation across the
characteristics of both the intervention and comparator arms. De-
spite dividing studies into separate comparisons for this update
and conducting preplanned subgroup analyses in an attempt to re-
duce and explain some of this variation, key differences remained
in the components of the MI and more general smoking cessation
support provided. Studies typically provided only limited explana-
tion of the content of the MI interventions; most specifying sim-
ply that MI techniques were adhered to, but giving sparse descrip-
tion of the counselling overall. This made it hard to differentiate
between studies based on the nature of the MI support provided,
which could have given further insight into why heterogeneity ex-
isted between studies. There was substantial variation in the inten-
sity of the support in both intervention and comparator groups,
which we did attempt to control for. However, it would have been
impossible to control for all possible sources of variation across
studies and this means that although we can hypothesise about the
causes of this heterogeneity, this remains largely unexplained.
MI can be a difficult technique to learn and enact and therefore
monitoring the fidelity of the intervention can give assurance that
MI was delivered as intended and was consonant with Miller and
Rollnick's key principles (Miller 2002; Miller 2013). Jelsma 2015 gave
guidance on why this is important and how trialists can ensure
that they satisfy this suggested requirement. Scales have been de-
veloped, such as the motivational interviewing treatment integri-
ty (MITI) code (Pierson 2007), in order to measure adherence to MI
consistently. However, most of the studies in this review did not at-
tempt to monitor and/or improve the fidelity of MI interventions;
and when monitoring was reported, they often did not report the
results of that monitoring. The inconsistency of monitoring tech-
niques and standards to define acceptable fidelity across studies
means it was impossible to report overall fidelity of implementa-
tion. This, in turn, makes it difficult to determine whether the mini-
mal beneficial effects detected in this review were due to a genuine
lack of MI efficacy, or whether the included studies were not deliv-
ering MI as intended.
Finally, MI is an intervention designed to help people change their
behaviour by increasing motivation to quit; however, only a minor-
ity of the included studies specifically recruited smokers who were
not motivated to quit (Catley 2016; Cook 2016; Davis 2011). Five
studies specifically recruited smokers motivated to quit and the re-
mainder did not specify that they had recruited based on motiva-
tion at baseline and, thus, we assume these were populations of
mixed motivation. That said, it is likely that only people somewhat
motivated to quit would join a study about smoking cessation and
it is likely that most studies in this review presented themselves to
potential participants in this manner. It is plausible that, if MI is ef-
fective, it would be more helpful for people with low motivation.
However, there was no evidence of this in this review as too few
studies have recruited this population.
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Certainty of the evidence
Of the 37 studies included in this review, we judged four to be at
low risk of bias for all domains, and 11 to be at high risk in one or
more domains. In many cases, we had to rate studies at an unclear
risk, because they did not report key information. In these cases, it
is impossible to know whether these studies were at any risk of bias
or whether the information was simply not reported. To investigate
the potential impact of studies that we judged to be at high risk of
bias on results, we removed studies judged to be at high risk of bias
in sensitivity analyses. In most cases, this did not materially change
the estimates of effect. However, removing the three studies judged
to be at high risk of bias from the analysis of higher versus lower
intensity MI did affect the results, changing the summary estimate
from clear evidence of modest benefit to no evidence of benefit.
We assessed the certainty of the evidence by creating 'Summary
of findings' tables for all four comparisons and carrying out GRADE
ratings for the smoking cessation outcome for each (Summary of
findings for the main comparison; Summary of findings 2; Sum-
mary of findings 3; Summary of findings 4). For the MI versus no
treatment comparison, we judged the certainty of the cessation ev-
idence to be low. We downgraded the evidence as all of the includ-
ed studies were at high or unclear risk of bias and the pooled esti-
mate was imprecise, as the upper and lower limits of the CIs includ-
ed both meaningful benefit and harm. We also judged the cessation
evidence to be of low certainty for all of the remaining comparisons.
When investigating MI in addition to another type of smoking ces-
sation treatment or versus another type of smoking cessation inter-
vention, this was due to imprecision, but also unexplained variation
in effect size between studies. We judged the evidence contribut-
ing to the 'intensity of MI' comparison as low certainty because of
the 'Risk of bias' assessment, where three of the five studies were
at high risk of bias. As previously discussed, removing these studies
in a sensitivity analysis changed the interpretation of the effect, so
that the confidence intervals encompassed both appreciable bene-
fit and harm of higher intensity motivational interviewing for smok-
ing cessation.
We generated funnel plots for the two comparisons that included
over ten studies ('MI in addition to another form of smoking cessa-
tion treatment' or 'MI versus another non-MI smoking cessation in-
tervention') in an attempt to identify any differential reporting of
studies finding negative effects of MI. In neither case did these plots
provide evidence of publication bias (Figure 3; Figure 4).
 
Figure 3.   Funnel plot of comparison: 2 MI in addition to other smoking cessation treatment, outcome: 2.1 cessation.
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Figure 4.   Funnel plot of comparison: 3 MI versus other SC intervention, outcome: 3.1 cessation.
 
Potential biases in the review process
We consider the review process used to be robust, and are un-
aware of any introduced bias. For outcome assessment, we fol-
lowed the standard methods used for Cochrane Tobacco Addic-
tion Review Group cessation reviews. Our search strategy includ-
ed the Cochrane Tobacco Addiction Group Specialised Register and
we also searched trial registries in an attempt to capture unpub-
lished and ongoing studies. There may be unpublished data that
our searches did not uncover; however funnel plots suggested that
this is unlikely to bias results for the two relevant comparisons. For
this update of the review, we modified the inclusion criteria and
therefore conducted a full search of the literature (rather than just
updating the searches run previously). As a result, we included 16
new studies and excluded ten previously included studies and two
ongoing studies. We introduced an exclusion criterion to exclude
studies that incorporated additional non-MI components in the MI
intervention arm but not the comparison arm (nine previously in-
cluded/ongoing studies have been now excluded for this reason).
It is plausible that the apparent effect of MI seen in the previous re-
view may have been partly because the interventions incorporated
these other active elements. We excluded quasi-randomised stud-
ies at this update as non-randomised studies are of lower quality
and the larger body of randomised trials allowed us to draw con-
clusions on the best quality evidence (we excluded one previously
included study for this reason). We also excluded one previously in-
cluded study that tested an MI intervention to encourage people to
participate in the trial rather than to aid them to quit smoking, and
another study that was based primarily on the stages of change the-
ory. We believe that these changes have reduced biases that previ-
ously existed in the review.
Agreements and disagreements with other studies or
reviews
Two previous reviews of MI for smoking cessation (Heckman 2010;
Hettema 2010) provided evidence of a very modest effect of MI at
long-term follow-up (six months or more). Our own effect estimates
are compatible when comparing MI (on its own or in addition to
other smoking cessation care) to another form of smoking cessa-
tion treatment, with point estimates suggesting very modest ben-
efit but, unlike the previous reviews, our summary estimate CIs in-
corporated potential harm of MI as well as benefit. A key differ-
ence is that these other reviews pooled together all comparisons
whereas we separated ours into four based on the type and inten-
sity of the comparator groups. Our findings reflect the findings of
the MI literature more generally, across a variety of health behav-
iours (Cheng 2015; Cowlishaw 2012; Foxcroft 2016; Gates 2016; Kli-
mas 2018; Mbuagbaw 2012; Morton 2015; Smedslund 2011). These
systematic reviews typically found modest effects of MI that were
not sustained at long-term follow-up. As in this review, these re-
views often detected moderate unexplained heterogeneity, possi-
bly relating to substantial differences between the intervention and
comparator, other than the presence or absence of MI across the
included studies.
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Hettema 2010 found evidence that the baseline motivation of par-
ticipants recruited moderated the effect of MI. The studies included
in their meta-analysis that recruited participants with low motiva-
tion to quit found a significant moderate effect of MI on quit rates at
both short- and long-term follow-up, whereas those which recruit-
ed highly-motivated participants resulted in a very small, non-sig-
nificant overall effect of MI on smoking cessation.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
• There is insufficient evidence to assess whether MI to promote
smoking cessation increases cessation compared with no inter-
vention, and further evidence may change our estimate of the
effect.
• MI may modestly increase the likelihood of long-term smoking
cessation when used in addition to other smoking cessation in-
tervention components or when compared with non-MI smok-
ing cessation interventions; however, there is also the possibil-
ity that MI may reduce quit rates relative to other smoking ces-
sation interventions. Further evidence is likely to strengthen or
weaken this effect.
• There is no clear evidence to suggest that the effect of MI is mod-
erated by the intervention provider, age of participant, partic-
ipants' motivation to quit at baseline, whether MI is delivered
face-to-face or whether MI fidelity monitoring takes place.
• Higher intensity MI may increase smoking cessation rates rela-
tive to lower intensity MI, however, due to risks of bias in the ex-
isting studies, further research could strengthen or weaken this
effect.
Implications for research
• Greater clarity and consistency of study methods, components
and counselling techniques would improve comparability be-
tween trials.
• Trials should aim to reduce confounding by minimising the
number of co-interventions when testing MI, and where co-in-
terventions are used, match these in the comparator arm.
• Future studies of MI should aim to maximise the fidelity to MI,
consider independent monitoring of the fidelity of intervention
delivery, and report these data. Standardising methods used to
monitor fidelity would allow easier comparisons across studies.
• Future research should attempt to identify which core compo-
nents of the motivational interviewing approach successfully
help people to quit smoking, and whether modifying them en-
hances or reduces the likelihood of quitting.
• Future studies should monitor the well-being of participants
throughout the study and at follow-up, reporting results by trial
arm, to investigate whether MI for smoking cessation improves
the well-being of smokers attempting to quit.
• Trialists should consider testing the effects of baseline motiva-
tion to quit when investigating MI interventions and recruiting
participants where motivation could benefit from improvement.
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mailing of referral letters from physicians
Participants Defining eligibility criteria?: African-American or black adults who smoked 10 or fewer cigarettes a day
for at least 6 months prior to enrolment (light smokers)
Participant characteristics: 755 adult smokers; 505/755 (66.9%) female; mean age: 45; mean cpd: 7.5;
nicotine dependence: mean Fagerstrom test for nicotine dependence (FTND) = 4.3
Ahluwalia 2006 
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Motivation to quit?: motivated
Interventions Control 1: Health Education plus 2 mg nicotine gum (HE + NG): HE was a standard counselling ap-
proach, based on the current US Department of Health & Human Services treatment guidelines that fo-
cused on providing information and advice. Participants received the counselling over six 20-minute
sessions (three in-person visits and three telephone calls). During HE sessions, trained counsellors used
the ‘KIS II Quit Smoking Guide’ (a 36-page booklet developed for African-American light smokers) and
semi-structured scripts to review the addictive nature of nicotine, health consequences of smoking and
benefits of quitting, and provided concrete strategies on developing a quit plan and identifying alterna-
tives against triggers to smoke. Participants were provided with an eight-week supply of 2 mg nicotine
gum.
Control 2: Health Education plus placebo gum (HE + PG): As control 1, however participants received
placebo gum rather than 2 mg nicotine gum.
Intervention 1: Motivational Interviewing plus 2 mg nicotine gum (MI + NG): MI counselling was provid-
ed by trained counsellors over six 20-minute sessions (three in-person visits and three telephone calls).
Counsellors followed semi-structured scripts that explored the pros and cons of smoking/quitting, and
motivation and confidence to quit. A values clarification strategy based on the work of Miller & Rollnick
was used. Participants also received the 36-page ‘KIS II Quit Smoking Guide’.
Intervention 2: Motivational Interviewing plus placebo gum (MI + PG): As intervention 1, however par-
ticipants received placebo gum rather than 2 mg nicotine gum.
Provider: trained counsellors (counsellors participated in two days of in-service training). All counsel-
lors participated in weekly group supervision to ensure the integrity of the respective counselling pro-
tocols.
Intensity: counselling took place during six 20-minute sessions (3 face-to-face and 3 telephone) over 16
weeks in all study arms.
Was MI fidelity monitored?: Yes. Each session was tape-recorded to maintain fidelity and consistency
throughout the study. A subset of audiotapes were rated by investigators for adherence to MI principles
using a modified version of the Motivational Interviewing Skills Code (results not reported). MI counsel-
lors and supervisors reviewed audiotapes and discussed current issues at their weekly meetings.
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 26 weeks
Validation: saliva cotinine-verified. A salivary cotinine cut-oC of ≤ 20 ng/mL was used.
Was mental health and/or well-being measured at follow-up?: No
Was quality of life measured at follow-up?: No
Funding source National Cancer Institute at the National Institutes of Health (R01CA091912). Glaxo-SmithKline provid-
ed study medication but played no role in the design, conduct of the study or interpretation and analy-
sis of the data.
Author conflicts of interest None
Notes For purposes of analysis, the two HE groups and the two MI groups were merged to create one HE
group and one MI group. This was acceptable as there was no interaction detected between study fac-
tors.
Risk of bias
Bias Authors' judgement Support for judgement
Ahluwalia 2006  (Continued)
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Random sequence genera-
tion (selection bias)
Low risk Quote: "a computer-generated random-numbers table was used to randomize
patients".
Allocation concealment
(selection bias)
Unclear risk Quote: "a sealed envelope with pre-assigned randomization numbers was
drawn to determine which form of counseling the participant would receive".
Did not state that envelope was opaque.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Smoking outcome was biochemically verified.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 18.8% lost to follow-up in MI groups; 12.5% lost to follow-up in HE groups.
Therefore, less than 50% overall and similar loss to follow-up between inter-
vention groups of interest.
Ahluwalia 2006  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: children's hospitals
Recruitment: through flyers and brochures advertising the study, available at the participating medical
sites. Participants were also referred by their physicians.
Participants Defining eligibility criteria?: adolescents aged 14 to 18 years
Participant characteristics: 355 adolescent smokers; 195/355 (54.9%) female; mean age: 17.02; mean
cpd: 9.8; nicotine dependence: mean modified Fagerstrom Tolerance Questionnaire (MFTQ)= 4.26
Motivation to quit?: not selected on motivation
Interventions Control: structured brief advice (SBA): based on clinical practice guidelines for treating nicotine depen-
dence - the “5 A’s” for those interested in quitting, and the “5 R’s” for participants not interested in quit-
ting smoking. In each session, the 5 A’s/R’s were followed by a review of self-help materials (smoking
cessation print materials, list of resources), and a brief check-in to see if the adolescent needed help in
gaining access to services (e.g. appointment with their physician for pharmacotherapy).
Intervention: motivational interviewing (MI), based on motivational enhancement therapy (MET), an
adaptation of motivational interviewing. MET adds personalised feedback about assessment results
(e.g. adolescent's tobacco use at baseline and during treatment) and collaborative development of a
formal change plan to the standard principles and techniques of MI.
Provider: counsellor
Intensity: the MI intervention consisted of three 45-minute office sessions and two 30-minute office or
telephone sessions over 12 weeks.
Was MI fidelity monitored?: "To promote treatment integrity, all treatment sessions were audio record-
ed and reviewed weekly by the treatment supervisor, who used an adherence checklist. MI and SBA
counselors received extensive training on the treatment protocol and received weekly individual or
group supervision."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 24 weeks
Validation: Saliva cotinine (<= 15 ng/mL classified as abstinent)
Audrain-McGovern 2011 
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Was mental health and/or well-being measured at follow-up?: yes, however results were not reported
by group at follow-up.
Was quality of life measured at follow-up?: no
Funding source "This study was supported by grant SAP 4100027295 from the Commonwealth of Pennsylvania, Penn-
sylvania Department of Health".
Author conflicts of interest "The authors have indicated they have no financial relationships relevant to this article to disclose."
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk At this initial assessment, participants were randomly assigned (stratified by
precontemplation stage of quitting smoking).
Allocation concealment
(selection bias)
Unclear risk No information
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Assessment of smoking outcome was blinded and cessation was biochemical-
ly verified.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Loss to follow-up low and similar across study arms 14/177 (8%) in MI group;
4/178 (2%) in control group.
Audrain-McGovern 2011  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: telephone support
Recruitment: lung cancer patients identified relatives and friends who smoked through four clinical
sites. A letter was written to the friend/relative explaining the study and asking them to call a toll-free
number if they wanted to decline participation. Those who did not decline were called by the study
team seven days later to assess eligibility.
Participants Defining eligibility criteria?: in social network/family of someone diagnosed with lung cancer
Participant characteristics: 496 adult smokers, randomised to intervention (245) control (251). 58% fe-
male. Mean age 47, mean cpd 19.5.
Motivation to quit?: not selected on motivation
Interventions Control: self-directed materials: letter from an oncologist encouraging participants to give up smoking,
quit kit (including an ALA cessation guide, straws, candy, cards, and a notepad), and an individually-tai-
lored information booklet. Mailing of 2-week nicotine patch starter kit and advised to call for a further
2-week supply as needed
Intervention: As control, plus 6 weekly telephone calls over the 12-week intervention period - standard
smoking cessation counselling using MI techniques and adaptive coping skills training
Provider: counsellors
Bastian 2013 
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Intensity: 1 x 30-minute session a week for 6 weeks
Was MI fidelity monitored?: not reported
Outcomes Definition of cessation used: 7-day PPA
Length of longest follow-up: 12 months
Validation: none
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?:no
Funding source Supported by the National Cancer Institute grant 5U01-CA-92622, also in part by the Intramural Pro-
gram of the National Human Genome Research Institute, National Institutes of Health
Author conflicts of interest Not reported
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Randomization was blocked by patient, with entire social network
units stratified by site and size of social network enrolled (one vs. two or more)
assigned to the same condition." No further information given
Allocation concealment
(selection bias)
Unclear risk Quote: "Randomization was blocked by patient, with entire social network
units stratified by site and size of social network enrolled (one vs. two or more)
assigned to the same condition." No further information given
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Quote: "We attempted to verify self-report cessation at 2 weeks, 6 months and
12 months postintervention with saliva cotinine analysis, but were unable to
do so because return rates (via mail) for saliva samples were low". Therefore,
quit rates were not validated and the amount of support differed between
arms.
Incomplete outcome data
(attrition bias) 
All outcomes
High risk 136/245 lost to follow-up in intervention arm; 132/251 lost to follow-up in con-
trol arm. Therefore, loss to follow-up was high (more than 50%).
Bastian 2013  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: over the telephone within the VHA healthcare system
Recruitment: recruited using informational flyers, provider referrals, and outreach letters
Participants Defining eligibility criteria?: veteran smokers with post traumatic stress disorder (PTSD) - Diagnostic
and Statistical Manual of Mental Disorders IV criteria for diagnosis code 309.81 PTSD documented in
their medical record
Participant characteristics: 175 adult smokers; 24/175 (13.7%) female; mean age: 55.6; mean cpd: not
provided; nicotine dependence: FTND: intervention arm: mean 5.4 (SD = 2.0); control arm: mean 5.1 (SD
= 2.3)
Battaglia 2016 
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Motivation to quit?: not selected on motivation
Interventions Control: usual PTSD Health Buddy Care: PTSD home telehealth care management program (Health
Buddy) and nurse care management alongside usually offered smoking cessation treatments. The
Health Buddy (BoschHealthcare, Palo Alto,CA) is designed to help individuals with PTSD self-monitor
and self-manage. This computer-like device is 12 × 8 × 4 inches with an LCD screen, on which partici-
pants read information, and four large buttons for responding to questions. A typical session is com-
pleted in approximately 2 minutes. Participants given access to nicotine replacement therapy (patch,
lozenge, gum, and inhaler), bupropion or varenicline
Intervention: enhanced PTSD Health Buddy and Motivational Interviewing: as control, plus MI-based
written smoking cessation curricula on home telehealth and weekly telephone MI smoking cessation
counselling with a nurse
Provider: nurses
Intensity: weekly (average duration 16.7 minutes)
Was MI fidelity monitored?: "To ensure fidelity, random calls made by the intervention research nurse
are observed throughout the study. Additionally, the research nurse will participate in ongoing MI train-
ing and workshops throughout the study to diminish “driJ” away from the principles of MI."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 9 months post-baseline
Validation: exhaled CO ≤ 10 ppm
Was mental health and/or well-being measured at follow-up?: PTSD symptoms assessed using the
PTSD Checklist. The 15-item Geriatric Depression Scale-Short Form was used to monitor depression.
Suicidal thoughts were assessed every 30 sessions during the intervention period with a question on
the Health Buddy.
Was quality of life measured at follow-up?: no
Funding source "Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development,
Health Services Research and Development"
Author conflicts of interest "The authors declare that they have no competing interests".
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk A research pharmacist who was unaffiliated with the study performed ran-
domisation using a blocked randomisation process. Did not specify how the
sequence was generated
Allocation concealment
(selection bias)
Unclear risk Study personnel were blinded to the randomisation process. Was not clear
how this took place
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Smoking/quitting was reported by participants via a handheld computer and
not directly to study personnel. Quitting was validated at end of treatment
and final follow-up using exhaled CO verification (CO verified rates obtained
through communication with author).
Incomplete outcome data
(attrition bias) 
Low risk Overall loss to follow-up 31% and was evenly matched between trial arms.
Battaglia 2016  (Continued)
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All outcomes
Battaglia 2016  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: observation unit of a hospital emergency department
Recruitment: admission records used to identify participants
Participants Defining eligibility criteria?: admitted to emergency department of hospital with chest pain
Participant characteristics: 543 adult smokers, randomised to intervention (271) usual care (272).
69.1% female; mean age 47.7. Mean cpd 18.9
Motivation to quit?: not selected on motivation
Interventions Control: referral sheet to local SC resources (usual care)
Intervention: Single 30-min MI session, including use of decision-balance tool, summation of reasons
to quit versus continuing to smoke etc. If trying to quit, given ALA manual, 2 brief (< 15 min) follow-up
telephone calls at 2 and 4 weeks after counselling session
All participants offered NRT if decided to quit, and received brief call on quit day and a week later
Provider: counsellors
Intensity: 1 x 30-minute session followed by 2 further 15-minute sessions
Was MI fidelity monitored?: "A subsample of 10% of all counseling sessions was audio-taped. Tapes
were audited by the study investigators for quality control and treatment fidelity. Counselors used a
decisional balance review tool and intervention component checklists to enhance treatment fidelity
and to document delivery of the intervention components and the amount of time spent on each com-
ponent."
Outcomes Definition of cessation used: continuous
Length of longest follow-up: 6 months
Validation: continuous abstinence defined as self-reported abstinent at all time points
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source A National Institutes of Health, National Heart, Lung and Blood Institute grant (1 R01HL60986)
Author conflicts of interest "The authors report no competing interests".
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "After providing informed consent, participants were randomly as-
signed…" No further information given
Bock 2008 
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Allocation concealment
(selection bias)
Unclear risk QUOTE: "After providing informed consent, participants were randomly as-
signed…" No further information given
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Continous cessation rates were not biochemically validated and contact dif-
fered between trial arms
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 133/271 (49%) of the intervention group and 118/272 (43%) of the control
group were lost to follow-up. Therefore overall there was less than 50% loss to
follow-up and rates were similar between groups.
Bock 2008  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: 3 hospital-based primary care clinics located in separate inner-city hospitals
Recruitment: during routine healthcare visits at primary care clinics. Patients invited to participate in a
study of smoking patterns and cessation
Participants Defining eligibility criteria?: all attending routine primary care appointments for variety of reasons
Participant characteristics: 846 adult smokers randomised to intervention (406) and control (440),
68.8% female; mean age 39.6. cpd of at least 10
Motivation to quit?: not selected on motivation
Interventions Control: smoking cessation assistance following guidelines for best practice, using the 5As. Participants
asked about smoking status, assessed for nicotine dependence, advised to quit smoking and offered
assistance with quitting (nicotine patches, self-help pamphlets and/or referral to the state quit-line)
Intervention: As control, plus 45-min individual counselling session with Health Educators, using MI
techniques. Participants ready to quit received behavioural skills training. Those who decided to quit
during this baseline visit were given 2 follow-up telephone counselling calls (on quit day and 2 weeks
later). Those choosing not to quit were called 2 and 4 weeks later.
All participants received 8 weeks of nicotine patches.
Provider: counsellor
Intensity: 1 x 45-minute face-to-face session followed by 2 telephone calls at 2 and 4 weeks
Was MI fidelity monitored?: "ME interventionists were trained and supervised by licensed clinical psy-
chologists. Ongoing fidelity was monitored through selected session observation and weekly clinical
supervision. All counselling sessions were tape recorded, and 20% of tapes were selected at random
for review by the study intervention coordinator, a PhD psychologist who was certified in MI. Regular,
weekly meetings were conducted to review the intervention procedures and results of counselling tape
audits to enhance treatment fidelity."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 12 months
Validation: Exhaled CO ≤ 5 ppm
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Bock 2014 
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Funding source A National Institutes of Health,National Institute on Drug Abuse grant (R01DA010860)
Author conflicts of interest "Authors declare no conflicts".
Notes Outcome data not clearly provided for ITT unadjusted analysis in the paper; therefore we obtained da-
ta directly from the author for meta-analyses.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk QUOTE: "the computer used a random number program to assign participants
at random to one of two treatment conditions".
Allocation concealment
(selection bias)
Low risk QUOTE: "the computer used a random number program to assign participants
at random to one of two treatment conditions".
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk QUOTE: " reports of tobacco abstinence were confirmed using expired carbon
monoxide testing with a Bedfont MicroSmokerlyzer™ machine with ≥ 5 ppm as
the cutoff indicating a positive smoking result".
Incomplete outcome data
(attrition bias) 
All outcomes
High risk 238/406 (59%) in the intervention arm and 232/440 (53%) in the control arm
lost to follow-up. Therefore, more than 50% dropout overall.
Bock 2014  (Continued)
 
 
Methods Study design: RCT
Location: Wales, UK
Setting: general practices 
Recruitment: GPs asked to recruit 1st smoker coming to each surgery
Participants Defining eligibility criteria?: all participants were consulting within primary care for various reasons.
Participant characteristics: 536 adult smokers, randomised to MI (270) or brief advice (266). 29% M.
Mean age 41. Mean cpd 25.5
Motivation to quit?: not selected on motivation
Interventions 1. Control: standardised brief advice (2 mins)
2. Intervention: structural motivational counselling for 1 session (mean 10 mins)
Provider: physicians
Intensity: 1 x 10-minute session
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: point prevalence
Length of longest follow-up: 6 months
Validation: attempted, but abandoned
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Butler 1999 
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Funding source The Welsh Office of Research and Development for Health and Social Care
Author conflicts of interest Not reported
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "Clinicians then opened sealed envelopes assigning patients to an in-
tervention group. These numbered envelopes were filed in a study pack and
clinicians were instructed to open them in order. Sequential blocks of six en-
velopes contained three allocations to each group, but the order varied." No
further information given. Therefore, the methods for generating the alloca-
tion sequence are unclear.
Allocation concealment
(selection bias)
Unclear risk QUOTE: "Clinicians then opened sealed envelopes assigning patients to an in-
tervention group. These numbered envelopes were filed in a study pack and
clinicians were instructed to open them in order. Sequential blocks of six en-
velopes contained three allocations to each group, but the order varied." Un-
clear if envelopes were opaque
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk QUOTE: "Biochemical validation of quitting was attempted, but uptake was
low and results did not alter conclusions from self-report data". Cessation was
measured by self-report only, however the amount of contact was similar be-
tween arms. This means the risk of misreporting was likely to be similar across
study arms.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 64/270 (24%) in the motivational arm and 54/266 (20%) in the brief advice arm
lost to follow-up at 6 months
Butler 1999  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: university
Recruitment: through word of mouth, newspaper ads, flyers, billboards, Internet advertising, and
physician referral using printed cards
Participants Defining eligibility criteria?: adult community resident smokers reporting low motivation and readiness
to quit
Participant characteristics: 255 adult smokers; 110/255 (43%) female; mean age: MI = 45.0, HE = 46.7,
BA = 45.5; mean cpd: MI = 16.2, HE = 16.9, BA = 18.0; nicotine dependence: Severity of Dependence Scale
(five-item dependence scale, with a score ranging from 0 to 15): MI = 6.6, HE = 6.9, BA = 5.7
Motivation to quit?: not motivated
Interventions Control 1: brief smoking cessation advice
Control 2: Health Education (HE) (intensity-matched comparison): the four-session HE intervention was
based on the relevant risks of smoking, rewards of quitting and roadblocks to cessation of the US Clin-
Catley 2016 
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ical Practice Guideline but excluded elements characteristic of MI. To ensure HE was distinct from MI,
counsellors followed a script and presented information via a computer during in-person visits.
Intervention 1: Motivational Interviewing (MI): "The MI sessions were unscripted and counselors used
the style (e.g. empathic, collaborative, and autonomy-supportive) and methods (e.g. open-ended ques-
tions, affirmations, and reflections) of MI. Counselors encouraged patient engagement in the conversa-
tion by exploring patient ambivalence regarding smoking cessation; developing discrepancy between
the client’s goals/values (e.g. health) and current behaviors (i.e. smoking); and increasing “change talk”
while avoiding arguing or disputing “sustain talk.” Provision of information was minimized and of-
fered only when judged necessary. For participants who expressed an interest in quitting, the MI coun-
selor worked to strengthen the commitment for change and used an MI style to complete the guide-
line-based quit plan and follow-up sessions as described above."
All participants who expressed any interest in quitting were offered a self-help guide and, for those who
set a quit date, free pharmacotherapy (varenicline and NRT offered)
Provider: counsellors
Intensity: four sessions over a 6-month period
Was MI fidelity monitored?: "Each counselor delivered all three treatments. This avoided confounding
counselor and treatment effects. To prevent treatment contamination, the HE and BA arms were script-
ed and stringent measures were implemented to ensure fidelity. Training, practice, and supervision for
each of the interventions continued until counselors met fidelity criteria for three consecutive sessions
(training hours per counselor were 96 for MI and 28.5 for HE). Counselors then began counseling en-
rolled participants and received regular group supervision of a randomly selected recent audio record-
ing from separate expert clinicians for each of the interventions (weekly for MI, every other week for HE,
and monthly for BA). Study-specific rating scales were completed to verify fidelity. To verify treatment
integrity, the duration of sessions was assessed and randomly selected 10% of regular sessions (i.e.
excluding quit plans and follow-ups) for evaluation (38 MI and 37 HE), using the MI Treatment Integri-
ty Code by an independent expert coding group blind to group assignment. The Code yields ratings of
counselor adherence to MI, including overall ratings of the session (e.g. expression of empathy) and be-
havior counts (e.g. frequency of open-ended questions)."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: saliva cotinine
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "This study was supported by a grant (R01 CA133068) from NIH, National Cancer Institute. Pfizer provid-
ed varenicline (Chantix) through Investigator- Initiated Research Support (No. WS759405)".
Author conflicts of interest "Delwyn Catley reports grants from NIH, Patient-Centered Outcomes Research Institute (PCORI), and
the National Multiple Sclerosis (MS) Foundation and non-financial support from Pfizer during the con-
duct of the study; Delwyn Catley occasionally received fees for providing Motivational Interviewing
training. Kathy Goggin reports grants from NIH, PCORI, and the National MS Foundation and consultant
fees for providing Motivational Interviewing training. Karen Williams reports personal fees from Proc-
tor and Gamble (P&G) and from P&G Global Advisory Committee, during the conduct of the study but
outside of the submitted work. Ken Resnicow occasionally conducts Motivational Interviewing training
and reports personal fees from University of Missouri, Kansas City during the conduct of the study. Ed-
ward Ellerbeck reports grants from NIH. James Grobe reports research consulting fees from the Univer-
sity of Texas, Southwestern & Texas Women’s University unrelated to the study. No other financial dis-
closures were reported by the authors of this paper."
Notes Control groups merged for all analyses apart from the intensity subgroup analysis, where the interven-
tion group was split and compared with the two separate control groups in the appropriate subgroups.
Catley 2016  (Continued)
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk QUOTE: "A predetermined computer-generated randomization sequence was
prepared by the study statistician".
Allocation concealment
(selection bias)
Low risk QUOTE: "A predetermined computer-generated randomization sequence was
prepared by the study statistician and provided in sealed opaque envelopes.
After research assistants enrolled participants and baseline measures were
collected, research assistants opened envelopes to allocate participants to
treatment group."
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Abstinence was biochemically verified. QUOTE: "self-report 7-day point-preva-
lence smoking abstinence was collected at 3 and 6 months, and verified bio-
chemically at 6 months using saliva cotinine."
"Although participants can differentiate whether they are in the BA versus MI
or
HE because of the different number of sessions, they are not informed in any
way regarding the names, the nature, or distinctions between HE and MI and
therefore will be blind to which of these two treatments they receive."
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk QUOTE: "Logistic regression analyses revealed no significant differences in at-
trition rates between the groups (Figure 1), with overall completion rates of
89.4% (n = 228) at Month 6. 12/102 of MI group, 7/51 of BA group and 8/102 of
the HE group were lost to follow-up, therefore attrition did not differ greatly
across groups".
Catley 2016  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: hospital outpatient clinic or Emergency Department (ED), then over the phone
Recruitment: in an eating disorder and an adolescent outpatient clinic at an urban hospital in the
Northeast
Participants Defining eligibility criteria?: adolescents (12 to 19 years of age)
Participant characteristics: 85 adolescents; 60/85 (71%) female; mean age: 16.3; mean cpd: 10.5; nico-
tine dependence: mean FTND = 5.9
Motivation to quit?: not selected on motivation
Interventions Control: Brief Advice; pamphlet on quitting smoking and list of local treatment referrals
Intervention: Motivational interview (MI). As control, plus feedback sheet, goal sheet, and information
about strategies for quitting and coping with withdrawal. Interventionists contacted participants by
telephone 1 week after baseline.
Provider: counsellors
Intensity: one 15 to 20-minute face-to-face session, plus one telephone call the following week
Was MI fidelity monitored?: "Interventionists participated in weekly group supervision. Patients and in-
terventionists rated each session as a compliance check. Rapport, counselor empathy, and self-effica-
cy enhancement were rated on scales from 1 (strongly disagree) to 4 (strongly agree). The delivery of 15
Colby 2005 
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essential elements of the protocol were rated as either 0 (topic not introduced), 1 (not at all useful), 2
(somewhat useful), or 3 (very useful)."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: CO validated (> 8 ppm) or cotinine validated (>= 15 ng/mL)
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "This study was supported by grant number 030330 from the Robert Wood Johnson Foundation. Addi-
tional support was provided by grant #DA11204 from the National Institute on Drug Abuse, and by two
Department of Veterans Affairs Career Research Scientist Awards to Dr. Monti and Dr. Rohsenow."
Author conflicts of interest None stated
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not specified - only specified that allocation was random
Allocation concealment
(selection bias)
Unclear risk Not specified - only specified that allocation was random
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Research assistants were blind to treatment condition and assured confiden-
tiality at each assessment. Biochemically verified
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Follow-up rates were 80% at 1 and 6 months and 86% at 3 months, and did not
differ by group.
Colby 2005  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: "in a private setting", conducted face-to-face and via telephone
Recruitment: from various sites: emergency department, hospital-based adolescent outpatient clin-
ic, paediatrician's office, high schools. In medical settings, flyers advertising the study were posted
and research staC proactively screened and recruited patients waiting for appointments/treatment. In
schools, classroom presentations were made and table displays in school cafeterias provided study in-
formation during lunch. Adolescents in the general community who heard about the study through fly-
ers, radio ads, and word of mouth called the research office and were screened for eligibility.
Participants Defining eligibility criteria?: adolescent smokers aged 14 to 18 years
Participant characteristics: 162 adolescents; 77/162 (47.5%) female; mean age: 16.2; mean cpd: inter-
vention: 11.3; control: 9.2; nicotine dependence: mean Stanford Dependence Index: intervention:14.1;
control: 13.5
Colby 2012 
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Motivation to quit?: not selected on motivation
Interventions Control: brief advice (BA) followed by a 5-minute telephone booster. Participants who reported quit at-
tempts were praised; those who reported continued smoking were strongly encouraged to try to quit
as soon as possible. Baseline parent assessment by telephone. Handouts on quitting smoking mailed
to adolescents and parents.
Intervention: motivational interviewing: "Interventionists' therapeutic style followed MI principles
(Miller 2002). The MI manual included the following sections: 1) establishing rapport; 2) exploring pros
and cons of smoking and quitting; 3) delivery of computer-generated personalized assessment feed-
back; 4) imagining the future with and without smoking; 5) reviewing a menu of change options and
developing a change plan; and 6) enhancing self-efficacy for change." MI participants were provided
with the same handouts as in BA, and also received an assessment feedback sheet and change plan.
The length of the baseline session was 45 min, with a 15 to 20-min telephone booster one week lat-
er, designed to reinforce progress toward goals. The interventionist assisted in problem-solving, dis-
cussed coping skills, promoted self-efficacy for change, and updated change plans if appropriate. Re-
vised change plans were mailed to participants afterwards. This group also received a parent interven-
tion: parents of MI participants took part in a 15 to 20-min discussion. This intervention was also de-
signed to be consistent with MI principles, emphasised the adolescent's responsibility for making de-
cisions/changes related to smoking, and focussed on increasing parent support for the adolescent's
goals for changing smoking, increasing clear communication, and establishing home smoking rules.
Interventionists used open-ended questions to elicit information about the parent's attitudes and be-
haviour relevant to these topics and, based on parent interest, introduced strategies for enhancing
communication, enforcing household smoking restrictions, and reinforcing adolescent efforts toward
change goals.
Provider: counsellors
Intensity: 1 x 45-minute session and 1 x 15 to 20-minute booster call
Was MI fidelity monitored?: "Interventionists participated in weekly group supervision. Post-MI and BA,
interventionists and adolescent participants completed session ratings."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: expired air CO (< 9 ppm); saliva cotinine (< 14 ng/mL)
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "Funded by NIDA grant # 1R01 DA11204. Preparation of the manuscript was also supported by NIAAA
grant # 1R01 AA016000 and NIDA grant # 1T32 DA016184. NIDA and NIAAA had no further role in study
design; in the collection, analysis and interpretation of data; in the writing of the report; or in the deci-
sion to submit the paper for publication."
Author conflicts of interest "All authors declare that they have no conflicts of interest".
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk QUOTE: "A computer-generated random number sequence allocated partici-
pants to treatment groups prior to enrollment".
Allocation concealment
(selection bias)
Unclear risk QUOTE: "assignments were sealed in envelopes which were filed in a series
of sequentially numbered folders. Interventionists used folders in order and
Colby 2012  (Continued)
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completed baseline assessment before opening the envelope." However, it
was not stated whether envelopes were opaque, hence unclear rating.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk QUOTE: "Two biochemical markers were used to validate self-reported absti-
nence at follow up"; QUOTE: "all interviewers were blind to condition assign-
ment during assessments".
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk QUOTE: "There were no significant group differences on booster or follow-up
completion rates". Follow-up rates at 6 months: MI (n = 61; 77.2%); BA (n = 71;
85.5%)
Colby 2012  (Continued)
 
 
Methods Study design: factorial RCT (4 factors, 16 trial arms)
Location: USA
Setting: primary care clinics
Recruitment: smokers were invited during primary care clinic visits to participate in a research program
to help them to reduce their smoking. Those interested were referred electronically to the research of-
fice.
Participants Defining eligibility criteria?: adult smokers with no interest in quitting in the next 30 days but willing to
cut down
Participant characteristics: 517 adult smokers; 328/517 (63.4%) female; mean age: 47; mean cpd: 17.5;
nicotine dependence: mean FTND = 4.8
Motivation to quit?: not motivated to quit
Interventions Intervention factors:
1. Motivational interviewing: initial 20-minute in-person counselling session followed by three biweek-
ly, 10-minute counselling calls over the 6-week intervention period. Based on Miller & Rollnick (Miller
2002), the counselling sessions included motivation-building exercises to reinforce intrinsic motivation
and to help participants overcome ambivalence about quitting. Case managers engaged participants
in a series of motivation building exercises such as reviewing feelings and thoughts about the pros and
cons of quitting and smoking, reinforcing the positives of quitting, helping to dispel myths and con-
cerns about the negatives of quitting, and posing questions about the "good" aspects of smoking.
2. Behavioural smoking reduction counselling: initial 20-minute in-person counselling session followed
by six weekly 10-minute counselling calls. During these sessions, participants set smoking reduction
goals and developed reduction strategies (e.g. delaying smoking, eliminating smoking in specific situa-
tions). Participants were also instructed to record daily smoking, which case managers used to identify
successes and challenges.
3. Nicotine gum: participants were instructed to use 2 mg gum for the 6-week intervention period (≥
nine per day, one piece per 1–2 hours) in place of smoking.
4. Nicotine patch: participants were instructed to use 14 mg patches daily for the 6-week intervention
period.
Where all intervention factors were OFF, this resulted in a 'no treatment' condition.
Provider: counsellors
Intensity: 1 x 20 minutes face-to-face session, followed by fortnightly 10-minute phone calls
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 7-day point prevalence
Cook 2016 
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Length of longest follow-up: 26 weeks
Validation: none
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "This research was supported by grants 9P50CA143188 and 1K05CA139871 from the National Cancer
Institute to the University of Wisconsin Center for Tobacco Research and Intervention and by the Wis-
consin Partnership Program. This work was carried out in part while T.R.S. was a Primary Care Research
Fellow supported by a National Research Service Award (T32HP10010) from the Health Resources and
Services Administration to the University of Wisconsin Department of Family Medicine. W.-Y.L. is also
supported by NSF grant DMS-1305725. L.M.C. is also supported by NIH grants P50DA10075 and R01D-
K097364. J.W.C. is supported by Merit Review Award 101CX00056 from the US Department of Veterans
Affairs."
Author conflicts of interest "The authors have received no direct or indirect funding from, nor do they have a connection with,
the tobacco, alcohol, pharmaceutical or gaming industries or anybody funded substantially by one of
these organizations. W.-Y.L. is supported partially by a grant from Eli Lilly and Company for research
that is unrelated to smoking or tobacco dependence treatment."
Notes In-line with guidance in the Cochrane Handbook, we looked for potential interactions between the fac-
tors in this factorial trial. An interaction between the MI and nicotine gum factor was reported by the
authors. Rather than exclude data from this trial from analyses, which we believe would introduce bias
we accounted for the risk of bias potentially introduced by this interaction in our 'Risk of bias assess-
ment' below and carried out sensitivity analyses removing it from analyses alongside other studies
judged to be at high risk of bias.
For the MI versus no treatment analyses, we compared the one study arm with MI and no other smok-
ing cessation treatment (behavioural reduction, gum and patch) to the one study arm with no MI and
no other smoking cessation treatment. For the analyses comparing MI plus other SC treatment to other
treatment alone, we compared any study arms receiving MI plus reduction and/or nicotine gum, and/
or nicotine patch to study arms receiving reduction, and/or nicotine gum, and/or nicotine patch with
no MI. For the analyses comparing MI to another form of smoking cessation treatment, we compared
the one study arm receiving MI and no other smoking cessation treatment (behavioural reduction, gum
and patch) to all study arms receiving reduction and/or nicotine gum, and/or nicotine patch.
Where relevant (analyses 2 and 3), we have ensured that study arms that received nicotine gum have
been entered into analyses separately to study arms that did not receive nicotine gum.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants were randomised to treatment conditions using stratified permut-
ed, computer-generated block randomisation; stratified by gender and clinic
with a fixed block size of 16 based on the 16 unique possible combinations of
intervention components (in random order within each block).
Allocation concealment
(selection bias)
Unclear risk No information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Self-report (no biochemical validation). The lack of MI meant that participants
had less face-to-face contact and less intensive support in some of the com-
parison trial arms.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk There were no significant differences in missing data across the contrasting
levels of each intervention factor. 46/253 (18%) were lost to follow-up in the MI
groups and 37/264 (14%) in the non-MI groups.
Cook 2016  (Continued)
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Other bias High risk This is a factorial trial and an interaction was found between motivational in-
terviewing and nicotine gum. This was not an a priori hypothesised interac-
tion, and challenged the assumption that the factors studied were indepen-
dent.
Cook 2016  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: laboratory
Recruitment: precontemplative and contemplative smokers were recruited from the community
through advertisements and direct recruitment (no further explanation). Participants were offered USD
25 for participation.
Participants Defining eligibility criteria?: unmotivated adult smokers
Participant characteristics: 218 adult smokers randomised to intervention (109) and control (109), 45%
female; mean age 37.6. cpd: 25.4
Motivation to quit?: not motivated
Interventions Control: Prescriptive 15-min interview regarding smoking. Described as the current dominant approach
(i.e. usual care), which maintains a firm and authoritative approach
Intervention: 15-min motivational interview regarding smoking. Motivational interviewing described as
seeking to establish supportive and empathic alliance
Provider: nurses
Intensity: 1 x 15-minute session
Was MI fidelity monitored?: "All tapes were reviewed for adherence to the protocol and weekly meet-
ings were held with the study nurses. Sessions not reaching criterion were removed from the analyses".
Outcomes Definition of cessation used: point prevalence
Length of longest follow-up: 6 months
Validation: urinary cotinine
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source A grant from The Arizona Disease Control Research Commission
Author conflicts of interest Not reported
Notes The outcome used for meta-analysis was point prevalence reported at both 1 m and 6 m (i.e. cross be-
tween point prevalence and prolonged abstinence). This outcome was used as for all others, the man-
ner of reporting made it impossible to tell which time point numbers referred to (i.e. abstinent at 1 m or
6 m).
Risk of bias
Bias Authors' judgement Support for judgement
Davis 2011 
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Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "participants completed informed consent, baseline assessments,
and were randomized to receive either a 15-min motivational or prescriptive
interview". No further information given
Allocation concealment
(selection bias)
Unclear risk QUOTE: "participants completed informed consent, baseline assessments,
and were randomized to receive either a 15-min motivational or prescriptive
interview". No further information given
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Cessation was verified through urinary cotinine levels.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 47/116 (41%) in the motivational arm and 61/114 (54%) in the prescriptive arm
were lost to follow-up at 6 months. Overall less than 50% loss to follow-up -
similar rates between arms
Davis 2011  (Continued)
 
 
Methods Study design: RCT
Location: Brazil
Setting: public university hospital
Recruitment: patients admitted to a public university hospital approached by research team to take
part - screening interview took place at patients’ bedside within 72 hours of admission
Participants Defining eligibility criteria?: hospital inpatients for variety of reasons
Participant characteristics: 273 adult smokers randomised to intervention (141) and control (132),
63.6% M; mean age 47; cpd (range = 11 to 20)
Motivation to quit?: not selected on motivation
Interventions 1. Control: 15-min session of individual counselling where participants were advised to stop smoking.
Counsellor reviewed the dangers of smoking and benefits of quitting. The counsellor suggested that,
after discharge, the participant should seek help to stop smoking.
2. Intervention: 30-min session of individual counselling consisting of a motivational interview, after
hospital discharge. Participants were given 7 follow-up telephone calls over 6 m (at 1, 2 and 3 weeks,
and at 1, 2, 3 and 4 m). Each call lasted 10 mins. It was an opportunity to reinforce motivation for stop-
ping smoking (or maintaining abstinence). Style of interview was in line with MI performed during hos-
pitalisation.
Intervention provider: smoking cessation advisor
Intensity: 1 x 30-minute session with 7 x 15-minute follow-up calls over 4 months
Was MI fidelity monitored?: "Counselors and main researchers met fortnightly along the study period
for clarification of any doubt that might have arisen."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: none
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
De Azevedo 2010 
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Funding source A grant from the Research Foundation of the State of São Paulo (grant no. 06/61885-6)
Author conflicts of interest Not reported
Notes There were 3 arms in the study; however, the usual-care arm was not randomised, so was not eligible
for the review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk QUOTE: "An allocation sequence based on a random-number table was used
to randomly assign all enrolled subjects to either LII or HII."
Allocation concealment
(selection bias)
Low risk QUOTE: "The allocation was maintained in a serially numbered, opaque enve-
lope, which was opened at the Phase 2 interview to prevent counselor bias."
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Abstinence was obtained via self-report and the amount of researcher-partici-
pant contact varied between trial arms.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 34/141 (24%) participants in the MI intervention group and 24/132 (18%) in the
control group were lost to follow-up. Less than 50% lost overall and similar be-
tween groups
De Azevedo 2010  (Continued)
 
 
Methods Study design: cluster RCT
Location: Brazil
Setting: primary care smoking cessation clinics
Recruitment: from smoking groups performed by the primary care teams of the Conceição Hospitalar
Group, Porto Alegre, Brasil
Participants Defining eligibility criteria?: adult smokers motivated to quit
Participant characteristics: 329 adult smokers; gender not provided; mean age: not provided; mean
cpd: not provided; nicotine dependence: not provided
Motivation to quit?: motivated (already attending smoking group)
Interventions Control: traditional CBT, as advocated by the Brazilian Ministry of Health's smoking programme
Intervention: motivational interviewing: "The professionals who coordinated the smoking groups were
trained to use Motivational Interviewing as an additional resource to the motivation and cognitive-be-
havioral approach usually performed in the groups."
Provider: Smoking cessation advisors
Intensity: not reported
Was MI fidelity monitored?: none reported
Outcomes Definition of cessation used: 30-day point prevalence
Length of longest follow-up: 11 months
Validation: none
Demétrio Faustino-Silva 2018 
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Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source Not reported
Author conflicts of interest Not reported
Notes Information from conference abstract. Limited information available on how clustering dealt with. We
entered data as presented in abstract and carried out sensitivity analysis applying the ICC of another
similar study (Vidrine 2019).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomised; no further information given
Allocation concealment
(selection bias)
Unclear risk No information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Did not look as though any biochemical validation took place and it was un-
clear whether the amount of contact with investigators was the same across
study arms
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk The numbers lost to follow-up were less than 50% overall and similar between
groups (34.8% in MI group; 42.4% in control group).
Demétrio Faustino-Silva 2018  (Continued)
 
 
Methods Study design: randomised controlled trial
Location: Kansas, USA
Setting: rural primary care practices
Recruitment: from 50 rural primary care practices in the Kansas Physicians Engaged in Prevention Re-
search network. Trained medical students systematically screened patients, identified smokers, and re-
cruited them for the study, obtaining consent. Participants’ contact information was forwarded to re-
search staC who contacted them via telephone, verified eligibility, and conducted the baseline survey.
Participants Defining eligibility criteria?: primary care patients
Participant characteristics: 726 adult smokers randomised to intervention (482) and control (244),
58.5% female; mean age 47.2; cpd 23.7
Motivation to quit?: general population (not selected on motivation)
Interventions Intervention: high intensity: educational support, telephone counselling, periodic progress reports
with counselling suggestions faxed to their physician, and a 6-monthly personalised KanQuit newslet-
ter with tips on quitting smoking. Offered up to 6 counselling calls every 6 months to either promote
quitting or prevent relapse. Counsellors used MI techniques and followed a semi-structured protocol.
Control: moderate-intensity MI: as intervention, however were only offered up to 2 telephone-based
counselling sessions every 6 months (1 session to promote a quit attempt and 1 additional follow-up
session for those who made a quit attempt).
Provider: counsellors
Ellerbeck 2009 
Motivational interviewing for smoking cessation (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
58
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Intensity: twice every 6 months in moderate intensity arm; 6 times every 6 months in high intensity arm
Was MI fidelity monitored?: "After each session, counsellors were asked to complete a checklist ask-
ing about several of the key concepts of MI that served as process markers of appropriate MI delivery
(e.g. rolling with resistance, making appropriate reflective statements, encouraging change talk) and a
checklist asking about specific content that should have been covered per the MI protocol guiding the
sessions (e.g. pros/cons of quitting, developing behavioural action plan). Counsellors rated themselves
and during supervision they were also rated using motivational interview markers."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 24 months
Validation: salivary cotinine level < 15 ng/mL in a mailed saliva sample. Because of resistance by par-
ticipants to providing salivary samples at month 12, validation by proxy report from a significant oth-
er at month 24 was used for quitters who did not return a salivary sample. The validated quit rate at 24
months was a mixture of the 2 approaches.
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source A grant from the National Cancer Institute (R01-101963). Study medication provided by GlaxoSmithK-
line
Author conflicts of interest Authors reported no conflicts.
Notes We compared the high intensity MI group and the moderate intensity MI group in this review and in
our analyses investigating the intensity of MI counselling support. The study also included a 'pharma-
cotherapy alone' condition; however this was not relevant to this review as it included non-MI interven-
tion components that were not received by the two MI intervention groups.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk QUOTE: "A computer-generated random-number table was used to gener-
ate allocation cards in blocks of 24, with allocation equally distributed across
treatment groups."
Allocation concealment
(selection bias)
Low risk QUOTE: "To conceal allocation, we placed these [allocation] cards in sequen-
tially numbered, opaque, sealed envelopes. After research assistants verified
participant eligibility and completed the baseline assessment, the project di-
rector opened the next sequential sealed envelope and determined the partici-
pant’s treatment allocation."
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk QUOTE: "Abstinence validated by salivary cotinine measurement (15 ng/mL)
or a significant other."
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 50/249 (20%) in the moderate intensity disease management group and
47/251 (19%) in the high intensity disease management were lost to follow-up
at the final follow-up (month 24).
Ellerbeck 2009  (Continued)
 
 
Methods Study design: cluster RCT
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Location: USA
Setting: university
Recruitment: proactive recruitment at fraternity and sorority chapter meetings at 1 large Midwestern
university at the start of 3 academic years (2006 - 2008)
Participants Defining eligibility criteria?: university students (sorority or fraternity members)
Participant characteristics: 452 adult smokers (college students) randomised to intervention (245) and
control (207), 54.4% M; mean age 19.5; cpd 3.5
Motivation to quit?: general population (not selected on motivation)
Interventions 1. Control: no smoking cessation treatment - up to 4 sessions of MI focussed on increasing consump-
tion of fruits and vegetables to at least 5 servings a day. The first 3 sessions occurred approximate-
ly every other week following baseline assessment and the fourth session occurred approximately 4
weeks after session 3. Sessions were typically 20 to 30 mins. A self-help guide on the benefits and meth-
ods for eating fruit and vegetables was given to participants.
2. Intervention: up to 4 sessions of MI focussed on motivating and assisting participants to quit ciga-
rette smoking. The first 3 sessions occurred approximately every other week following baseline and the
fourth approximately 4 weeks after session 3. Sessions were typically 20 to 30 mins. For students who
became motivated to change during the sessions, counsellors used a MI style to follow the outline of
a 'plan module' in which cognitive–behavioural principles were used to develop a change plan. A self-
help guide on quitting was also given to participants.
All students who smoked at a high level were encouraged to use pharmacotherapy obtainable through
the university and other resources.
Provider: clinical or counselling psychology students (counsellors)
Intensity: 4 x 20 to 30-min sessions over 7 weeks
Was MI fidelity monitored?: "We assessed fidelity to MI using supervisors' rating of counselors' in-ses-
sion proficiency on 18 items, including reflective listening, asking permission, and MI spirit, used in pri-
or studies".
Outcomes Definition of cessation used: 30-day point prevalence
Length of longest follow-up: 6 months
Validation: saliva cotinine ≤ 15 ng/mL
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source A grant from the National Cancer Institute (R01CA107191)
Author conflicts of interest "The authors declare that there are no conflicts of interest".
Notes An ICC of 0.003 is reported, which implied (30 clusters, n = 452) a design effect of 1 + (452/30 − 1) × 0.003
= 1.0422. We applied this design effect to account for clustering in our analysis.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "For each cohort, after all students completed the baseline survey,
fraternities and sororities were randomized to either treatment (smoking) or
comparison (fruits/vegetables) conditions without blocking". No further infor-
mation given
Harris 2010  (Continued)
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Allocation concealment
(selection bias)
Unclear risk QUOTE: "For each cohort, after all students completed the baseline survey,
fraternities and sororities were randomized to either treatment (smoking) or
comparison (fruits/vegetables) conditions without blocking". No further infor-
mation given
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Cessation was verified using cotinine and amount of contact matched be-
tween trial arms.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 25/245 (10%) in the MI for smoking cessation group and 23/207 (11%) in the
MI for fruits and vegetables group were lost to follow-up. Therefore, loss to fol-
low-up was low and similar between groups.
Harris 2010  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: community
Recruitment: "Participants identified from larger longitudinal study of problem drinking in adoles-
cents. Eligible adolescents were located through telephone calls to randomly generated telephone
numbers."
Participants Defining eligibility criteria?: adolescent offenders who had been arrested or given notice to appear in
court
Participant characteristics: 81 adolescent smokers; 34/81 (42%) female; mean age: 16; mean cpd: inter-
vention: 11.22; control: 9.56; nicotine dependence: not reported
Motivation to quit?: not selected on motivation
Interventions Control: tobacco education: an information session based on a pamphlet about tobacco use by the
American Cancer Society
Intervention: motivational enhancement therapy (MET): MET sessions began with individualised feed-
back about participants' smoking based on information from the baseline assessment. Then, partici-
pants' likes/dislikes, beliefs, and pattern of tobacco use were discussed and participants were assisted
in identifying goals for behaviour change and addressing their ambivalence about their smoking. For
participants ready to make changes, cessation strategies were provided, goals were defined, and a be-
haviour change plan was developed.
Provider: not specified
Intensity: one session - duration not specified
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 28-day point prevalence
Length of longest follow-up: 6 months
Validation: salivary cotinine (<= 15 ng/mL)
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source Research supported by "a grant from the National Institute on Drug Abuse awarded to the first author
(DA13182-02)"
Helstrom 2007 
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Author conflicts of interest Not reported
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No methods specified beyond reporting that participants were randomly allo-
cated
Allocation concealment
(selection bias)
Unclear risk No methods specified beyond reporting that participants were randomly allo-
cated
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Cessation was verified using salivary cotinine.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Fewer than 50% of participants dropped out overall; there was a difference
in dropout rates between groups (6.7% in the MET arm and 25% in the edu-
cation control arm), however this did not meet the threshold advised by the
Cochrane Tobacco Addiction Group (difference of 20% or more in follow-up
between arms) to signal a 'high' risk of bias.
Helstrom 2007  (Continued)
 
 
Methods Study design: factorial RCT (3 x 2)
Location: Oregon USA
Setting: community-based telephone quit-line programme
Recruitment: callers to quit-line invited to participate
Participants Defining eligibility criteria?: quit-line callers
Participant characteristics: 4614 smokers randomised to: brief counselling (872, no NRT; 868, with
NRT), moderate counselling (718, no NRT; 715, with NRT), or intensive counselling (720, no NRT; 721,
with NRT). 60% female, mean age 41. Mean cpd 21.
Motivation to quit?: as participants were callers to a telephone quit-line, they were assumed to be fully
or partly motivated to quit.
Interventions Two factors: intensity of MI counselling and NRT versus no NRT. The three levels of the intensity factor
were as follows:
1. Single brief (15-min) negotiation based on MI (usual care), 15-min call + referral material + tailored
self-help materials
2. Moderate counselling (40-min) based on MI + 1 brief call to encourage use of community services, tai-
lored self-help materials
3. Intensive counselling (as moderate counselling, plus offer of ≤ 4 additional telephone calls). Each call
incorporated MI techniques, stage assessment and relapse prevention as needed.
NRT offered free to the 'with NRT' groups
Provider: smoking cessation advisors
Intensity: brief: one oC; moderate: 1-2 weekly; intensive: 4 calls over 3 months
Hollis 2007 
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Was MI fidelity monitored?: "We taped calls for quality assurance monitoring and rated counsellors reg-
ularly on adherence to key elements of each protocol."
Outcomes Definition of cessation used: 30-day point prevalence
Length of longest follow-up: 12 months
Validation: none
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source A grant from the National Cancer Institute (R01 CA86242). Nicotine patches supplied by GlaxoSmithK-
line
Author conflicts of interest "JFH, JLF and KR have no competing interests. TAMcA and SMZ are with Free & Clear, Inc, which is a for-
profit company providing telephone counselling services."
Notes We compared the brief intensity MI to the high intensity MI in our analyses. NRT versus no NRT groups
were combined as no interaction effects were detected.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk QUOTE: "a computer algorithm randomly assigned participants".
Allocation concealment
(selection bias)
Low risk QUOTE: "a computer algorithm randomly assigned participants".
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk No validation of cessation and amount of contact varied between arms
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 550/1740 (32%) of the brief groups; 448/1433 (31%) of the moderate groups
and 497/1441 (35%) of the intensive groups were lost to follow-up at the 12-
month follow-up. Therefore, loss to follow-up overall was less than 50% and
similar between arms.
Hollis 2007  (Continued)
 
 
Methods Study design: RCT
Location: Australia
Setting: community
Recruitment: high school students caught smoking were recruited. "Participants were included if the
drug of concern was tobacco and if parent/guardian active informed consent was obtained."
Participants Defining eligibility criteria?: high school student smokers aged 14 to 16 years
Participant characteristics: 56 adolescent smokers; 19/56 (34%) female; mean age: 15; mean cpd: 7.4;
nicotine dependence: mean nicotine dependence (MTFQ): 3.6
Motivation to quit?: not selected on motivation
Kelly 2006 
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Interventions Control: standard care: included an education about the broad effects of smoking regardless of the par-
ticipant's experience. Built on a widely used psychoeducation model, where knowledge dissemina-
tion/attainment was assumed to result in change. This involved reviewing reading materials on the ef-
fects of smoking (and other drugs) and a 'Quit kit' on smoking.
Intervention: MI: explored the meaning of smoking in participants' lives, the positives and negatives of
smoking/quitting, the impact of smoking on self-concept, health goals, and identification of obstacles
to goal attainment. The intervention included information only where relevant to the participant's di-
rect experiences (e.g. effects of smoking on respiration if breathlessness in sport was reported).
All participants provided with reading materials
Provider: "The two interventions were delivered by the second author (KL), a PhD candidate and regis-
tered psychologist, with 4 years experience in adolescent psychotherapy." (counsellor/psychologist)
Intensity: single 1-hour session
Was MI fidelity monitored?: "The therapy manual documented a number of behavioral indices that
would normally characterize close adherence to the two interventions. Relative to the SC condition,
the MI intervention would normally be characterized by: more talking by the participant than the ther-
apist, open probes, summary statements aimed to develop discrepancy, asking permission of the stu-
dent to extend/expand the content focus, and reflexive delivery of intervention components. The ther-
apist regularly completed a behavioral checklist for each session to reduce content driJ/contamination
and promote discussion during supervision."
Outcomes Definition of cessation used: 30-day point prevalence abstinence
Length of longest follow-up: 6 months
Validation: none
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "The manuscript was completed during an NHMRC Career Development Award to the first author. The
study was funded by NHMRC Project 189414 awarded to the first author."
Author conflicts of interest Not reported
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "Students were randomly assigned to either the MI or SC conditions."
No further information provided
Allocation concealment
(selection bias)
Unclear risk QUOTE: "Students were randomly assigned to either the MI or SC conditions."
No further information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Smoking status measured by self-report; MI was one hour but length of SC not
stated. SC appeared to include less contact with therapist.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Attrition was less than 50% overall and similar between groups according to
the standard practice of the Cochrane Tobacco Addiction Group (6/30; 20% in
MI group; 8/26; 31% in standard care group).
Kelly 2006  (Continued)
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Methods Study design: RCT
Location: USA
Setting: hospital and over telephone
Recruitment: from inpatients admitted to the University of Wisconsin Hospital and clinics who ex-
pressed an interest in quitting smoking
Participants Defining eligibility criteria?: hospital inpatient smokers interested in quitting
Participant characteristics: 185 adult smokers; 85/185 (46.0%) female; mean age: control: 43, interven-
tion: 44.7; mean cpd: control: 22.5, intervention: 24.9; nicotine dependence: mean FTND = control: 6.6,
intervention: 6.9
Motivation to quit?: motivated
Interventions Control: minimal care: brief (2–3 min) motivational message to quit smoking and a copy of the National
Cancer Institute’s Clearing the Air self-help smoking cessation pamphlet
Intervention: counselling and placebo patch: as control, plus a placebo nicotine replacement patch,
and a study nurse provided brief (10 to 15 minute) phone counselling at 1, 3, 6, and 24 weeks after the
initiation of patch treatment. Phone counselling incorporated basic techniques of cognitive-behaviour-
al therapy and motivational interviewing. The nurse also frequently reminded participants of the Clear-
ing the Air pamphlets and encouraged them to look over the pamphlet between sessions.
Provider: nurse
Intensity: five 10 to 15-minute sessions over 24 weeks
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 24 weeks
Validation: expired carbon monoxide <= 10 ppm
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "This research was supported by a research grant provided by the Elan Pharmaceutical Research Cor-
poration, Gainsville, Georgia, and Athlone, Ireland."
Author conflicts of interest Not specified
Notes This study also included an additional intervention arm, which was the same as the intervention arm
reported above but included active rather than placebo nicotine patch. This study arm was not eligible
for this review and was not included in analyses as the use of pharmacotherapy was not matched to the
control arm.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "The patient was randomized to either the MC condition or a patch con-
dition using a predetermined computer-generated randomization code."
Allocation concealment
(selection bias)
Unclear risk Quote: "The patient was randomized to either the MC condition or a patch con-
dition using a predetermined computer-generated randomization code."
Lewis 1998 
Motivational interviewing for smoking cessation (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
65
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Cessation was biochemically verified.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Dropout rates not reported
Lewis 1998  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: immunology clinics (6 outpatient HIV clinics and 2 primary care medical offices)
Recruitment: patients who smoked, were deemed eligible to participate by their physician, and were
willing to speak with a health educator (HE) were referred to the study.
Participants Defining eligibility criteria?: HIV-positive
Participant characteristics: 444 HIV-positive, adult smokers, randomised to intervention (232) and con-
trol (212); 56.7% female; mean age 42.0; cpd 18.3
Motivation to quit?: not selected on motivation
Interventions 1. Control: NRT + brief standard care intervention (SC). 2 brief sessions, including brief assessment of
quitting plans. Participants returned to the clinic biweekly for distribution of additional patches, al-
lowing the counsellors to briefly (5 mins) reinforce quit efforts, check on patch side effects and an-
swer questions. HEs were instructed to provide praise of participant’s efforts and answer any questions
asked, but not to initiate additional discussion of the quit effort. Participants unwilling to set a quit
date were instructed to contact the counsellor when ready. This reflects the minimum standard of care
recommended by the Agency for Health Research and Quality (AHRQ).
2. Intervention: NRT + intensive motivationally enhanced counselling intervention (ME). Participants re-
ceived 4 30-min intervention sessions, as well as a quit-day counselling call. Quit dates determined by
individual participants in consultation with counsellors. MI elements delivered throughout all contacts.
Participants not willing to set a quit date were engaged in discussion of ‘quitting as a process’ and bar-
riers to quitting.
Provider: counsellors
Intensity: 4 biweekly medication contacts plus 5 counselling contacts
Was MI fidelity monitored?: "We monitored the delivery of both intervention conditions by: (i) au-
dio-taped supervision on a random subsample of counseling sessions; (ii) patient exit interviews (con-
ducted by the intervention-blinded research assistant); and (iii) documentation of time spent in each
intervention. To examine fidelity to each intervention protocol, two independent raters reviewed au-
dio tapes of 20% of all sessions and rated (i) the degree to which intervention providers of the ME inter-
vention adhered faithfully to the spirit of motivational interviewing (i.e. establish rapport, express em-
pathy, reflective listening, explore ambivalence); and (ii) the degree to which there was contamination
across conditions."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: exhaled CO (< 10 ppm)
Was mental health and/or well-being measured at follow-up?: no
Lloyd-Richardson 2009 
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Was quality of life measured at follow-up?: no
Funding source Grants from the National Institute of Drug Abuse (R01-DA12344-06), the National Heart, Lung and Blood
Institute (K23-HL069987), the National Cancer Institute (K07-CA95623), the NIH-funded Transdiscipli-
nary Tobacco Use Research Center (P50 CA084719), NIH-funded Lifespan/TuJs/Brown Center for AIDS
Research (P30 AI42853), and by the Robert Wood Johnson Foundation
Author conflicts of interest Paper stated that authors had no declarations of conflicts of interests.
Notes Different Ns and different loss to follow-up allocated to intervention and control arms in the results
section in comparison to the participant flow chart. Table 1 seemed consistent with text. Data inferred
based on this assumption as there was no response to a data request from authors
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "Patients were then randomized (using block randomization) to en-
sure stratification by gender and level of motivation to quit smoking". No fur-
ther information provided
Allocation concealment
(selection bias)
Unclear risk QUOTE: "Patients were then randomized (using block randomization) to en-
sure stratification by gender and level of motivation to quit smoking". No fur-
ther information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Cessation validated using exhaled carbon monoxide measures
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 60/212 (28%) in the intervention (ME) group, and 66/232 (28%) in the control
(SC) group were lost to follow-up at 6 months. Therefore, rates were similar be-
tween groups.
Lloyd-Richardson 2009  (Continued)
 
 
Methods Study design: RCT
Location: South Africa
Setting: tuberculosis (TB) clinics
Recruitment: newly diagnosed adult patients initiating TB treatment were approached to participate.
Participants Defining eligibility criteria?: TB patients initiating TB treatment
Participant characteristics: 409 adult smokers newly diagnosed with TB randomised to intervention
(205) and control (204); 10% female; mean age 41.3; cpd 10.0
Motivation to quit?: not selected on motivation
Interventions Control (brief smoking cessation advice): the following short standardised smoking cessation message
from the TB nurse: "Tobacco use is extremely harmful for your health. If you stop smoking now, your TB
will heal better and you will have a lower risk of getting TB again in the future. You will also reduce your
risk of heart disease and cancer and protect your children against TB. As a professional nurse, I advise
you to stop using tobacco in the interests of your health", plus a smoking cessation booklet supplied by
the National Council against Smoking of South Africa
2. Intervention (brief motivational interviewing): as control, plus a brief motivational interviewing ses-
sion (15 to 20 mins) consisting of a quick assessment, the participant identifying problems and solu-
Louwagie 2014 
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tions and the setting of targets. Participants already highly motivated to quit were helped to design a
quit plan.
Provider: lay healthcare workers
Intensity: single 15 to 20-minute session
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: only occurred in small subset of participants and so has not been used; however outcomes
were the same with validation. As participants did not know whether the monitor was allocated to their
clinics at specific time points, this approach introduced a 'bogus pipeline' procedure, thus increasing
the likelihood of truthful answers.
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source Grants from the KNCV Tuberculosis Foundation (12.402.2/MvdW/U.10.0696/cal), and the National Re-
search Foundation of South Africa (80843), and by the Global Bridges Health Care Alliance for Tobacco
Dependence Treatment
Author conflicts of interest "K.O. received Pfizer funding for an FDA-approved research project (unrelated to this project) involving
the use of nicotine patch, bupropion and varenicline. O.A.A.-Y. is a sub-awardee of an unrestricted Pfiz-
er Education grant to Mayo Clinic for the Global Bridges Health Alliance project and received an hono-
rarium as a speaker at the 2012 congress of the South African Dental Association for a session on treat-
ment funded by Pfizer".
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "The randomization sequence was generated by an independent epi-
demiologist who was not otherwise involved in the research project, with a 1:1
allocation and random block sizes of 2, 4, 6, 8 and 10." No further information
given therefore method of sequence generation unclear
Allocation concealment
(selection bias)
Low risk QUOTE: "Current smokers were then allocated by the LHCWs to either the
intervention or the control arm by means of sequentially numbered sealed
opaque envelopes, thus ensuring allocation concealment".
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Validation occurred in a small subset of participants and has not been applied
to data; however, outcomes were the same with validation. As participants did
not know whether the monitor was allocated to their clinics at specific time
points, this approach introduced a 'bogus pipeline' procedure, thus increasing
the likelihood of truthful answer.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 53/205 (26%) in the intervention arm and 43/204 (21%) in the control arm were
lost to follow-up at 6 months. Therefore rates were similar between arms.
Louwagie 2014  (Continued)
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Methods Study design: RCT
Location: Australia
Setting: outpatient clinic
Recruitment: "Smokers in the Queensland Lung Cancer Screening Study were invited to enrol in the
sub-study by letter prior to each scheduled CT screening scan".
Participants Defining eligibility criteria?: attending lung cancer screening (age 60 to 74 years; ≥ 30 pack year smok-
ing)
Participant characteristics: 55 older smokers; 20/55 (36.4%) female; mean age: control = 63.0, interven-
tion = 63.0; mean cpd: control = 25.0, intervention = 25.0; nicotine dependence: mean FTND = control =
6.0, intervention = 6.0
Motivation to quit?: not selected on motivation
Interventions Control: non-tailored printed materials, quit-line details
Intervention: MI counselling: single face-to-face counselling session on the day of attendance for lung
cancer screening plus audio cessation advice (on mp3 player), plus written quit materials
Provider: physician
Intensity: one-oC session lasting an average of 26.5 minutes
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 12 months
Validation: exhaled carbon monoxide >= 10 parts per million "However CO not always obtainable at the
12-month time point because the CT protocol allowed scans to take place between 11 and 15 months
after the previous scan (one intervention group and three control group quitters had exhaled CO < 10
ppm, the remainder were not tested)."
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "Queensland Health, Smart State Research Grant (388600); National Health and Medical Research
Council (NHMRC) National Research Centre for Asbestos-Related Diseases (NRCARD) (440812); The
Prince Charles Hospital Foundation (FRC0207-24)."
Author conflicts of interest "None to declare"
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Group allocation sequence was generated at randomisation using a random
number generator.
Allocation concealment
(selection bias)
Unclear risk QUOTE: "Group allocation was concealed at randomization". No further detail
given
Marshall 2016 
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Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Although biochemical verification was planned, the investigators could not at-
tempt it in all participants due to the timing of hospital appointments. There-
fore, we have not been able to use verified rates. Amount and intensity of con-
tact differed between study groups.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 3/28 (10.7%) intervention group participants and 2/27 (7.4%) control group
participants did not return 12-month questionnaires and were assumed to be
smokers.
Marshall 2016  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: hospital
Recruitment: inpatients with an operative fracture were enrolled from hospital
Participants Defining eligibility criteria?: hospital inpatients with an operative fracture
Participant characteristics: 237 smokers; sex: not reported; mean age: not reported; mean cpd: not re-
ported; nicotine dependence: not reported
Motivation to quit?: not selected on motivation
Interventions Control: standard care: informational materials about smoking cessation, referred to the patient re-
source centre and provided with a quit-line brochure
Intervention 1: standard care + brief counselling + extended follow-up: as control, plus 10 to 30 minutes
of guided discussion about the risks and benefits of smoking for the healing of their traumatic injuries,
plus smoking educator checked in with participants' progress for approximately 5 minutes at follow-up
appointments
Intervention 2: standard care + brief counselling: as control, plus 10 to 30 minutes of guided discussion
about the risks and benefits of smoking for the healing of their traumatic injuries. No additional 'check-
in' at follow-up
Provider: smoking cessation advisors
Intensity: single 20 to 30-minute face-to-face session. Intervention 1 also received 5-minute check-ins at
2 weeks, 6 weeks, 3 months and 6 months.
Was MI fidelity monitored?: unclear
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: exhaled carbon monoxide (8 ppm)
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source Not reported
Author conflicts of interest Not reported
Notes Completed trial, not published yet. Has been presented at 2018 Annual Meeting of the Orthopaedic
Trauma Association in Kissimmee (Orlando), Florida, October 17-20 2018. Unable to calculate numbers
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quit from abstract, contacted authors for quit rates, however did not receive all the information need-
ed. Study discussed narratively
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Allocation: randomised. No further information
Allocation concealment
(selection bias)
Unclear risk Allocation: randomised. No further information
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Cessation was CO validated.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Dropout at 6 months not reported in conference abstract. Paper not yet pub-
lished
Matuszewski 2018  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: Group Health Co-operative, a staC-model integrated health care organisation
Recruitment: women smokers with an abnormal pap smear or colposcopy were invited to participate.
Participants Defining eligibility criteria?: women with abnormal pap smear or a colposcopy within the preceding 2
months (i.e. elevated risk for cervical cancer)
Participant characteristics: 275 women, randomised to intervention (138) or control (137). Mean age 33,
Mean cpd 14
Motivation to quit?: not selected on motivation
Interventions 1. Control: usual care: a letter explaining the association between cervical cancer and smoking, self-
help booklet, contact information for a phone-based smoking cessation treatment programme. En-
couraged to use NRT or bupropion
2. Intervention: as control, plus ME telephone counselling (4 x 15-min proactive calls), focussed on mo-
tivation building and strengthening, action plans for quitting or relapse prevention strategies, depend-
ing on readiness to quit
Provider: counsellors
Intensity: one oC mailing plus four 15-minute calls over 6 months
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 12 months
Validation: CO < 10 ppm or salivary cotinine, at 12 months only
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
McClure 2005 
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Funding source Grants from the National Cancer Institute (CA84603; CA74517), and the National Institute on Drug
Abuse (DA11194)
Author conflicts of interest Not reported
Notes For this update, cessation rates were changed to 12-month verified rates (taking into account data in
table 2). The ones previously used were 6 m and 12 m combined self-report (from table 3).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "Participants were randomly assigned to usual care (UC) or motiva-
tionally enhanced counseling (MEC)." No further information provided
Allocation concealment
(selection bias)
Unclear risk QUOTE: "Participants were randomly assigned to usual care (UC) or motiva-
tionally enhanced counseling (MEC)." No further information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk QUOTE: "biochemical confirmation of abstinence was obtained only at the 12-
month follow-up from nonsmokers. Women were given the option of providing
a breath sample in person or returning a salivary cotinine test strip by mail".
12-month validated rates were used in our analyses as the amount of contact
differed between groups.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Loss to follow-up not reported
McClure 2005  (Continued)
 
 
Methods Study design: RCT
Location: India
Setting: prison
Recruitment: random sampling of male prisoners at Central jail in Bangalore City
Participants Defining eligibility criteria?: incarcerated males
Participant characteristics: 600 adult smokers; 0/600 (0%) female; mode age: 21 to 30 years; mean cpd:
21 to 30 in intervention group, control not reported; nicotine dependence: not reported
Motivation to quit?: not selected on motivation
Interventions Control: waiting-list control
Intervention: motivational interviewing: the topics for the intervention included: introduction to tobac-
co, prevalence of tobacco use, effects of tobacco use on general health and dental health, psychosocial
factors influencing tobacco use, healthy diet and behavioural intervention for prevention of tobacco
use.
Provider: not specified
Intensity: not specified
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: unclear - "stopped smoking"
Naik 2014 
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Length of longest follow-up: 6 months
Validation: Unclear - CO was measured but didn't specify if used for validation.
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no, quality of life was measured in the intervention group
only, not allowing comparison to the control group.
Funding source "Nil"
Author conflicts of interest "None declared"
Notes Contacted authors to confirm that the control group received no smoking cessation treatment as this
was unclear in the study report.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "Among 600 prisoners, 300 were selected for each group (study and control) by
simple random sampling". No further information provided
Allocation concealment
(selection bias)
Unclear risk "Among 600 prisoners, 300 were selected for each group (study and control) by
simple random sampling". No further information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Unclear whether investigators were blind to treatment condition. Although
carbon monoxide was measured, it was unclear whether these were used to
validate cessation rates.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk No information on dropouts provided
Other bias Unclear risk As reported in the publication, the content of the control group was unclear,
therefore we contacted the authors. The authors replied as follows: "Control
group received 3 month smoking cessation motivational intervention after fin-
ishing the study group intervention", suggesting that the control group were
a waiting-list control. Based on the extra information provided, it was unclear
whether the control group received the intervention immediately after the
study group, within the 6-month follow-up. We sought additional clarification
on this from the authors but did not receive a response; however, the much
higher result in the MI group suggested the control group did not receive the
intervention before follow-up.
Naik 2014  (Continued)
 
 
Methods Study design: RCT
Location: China
Setting: primary care
Recruitment: via general practice
Participants Defining eligibility criteria?: adult smokers
Participant characteristics: 210 adult smokers; 12/210 (5.7%) female; mean age: 45.3; mean cpd: not re-
ported; nicotine dependence: mean FTND = 4
NCT02645838 
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Motivation to quit?: not selected on motivation
Interventions Control: brief smoking cessation advice
Intervention: motivational interviewing: 20-minute discussion with physician, determining stage of
change in smoking cessation and using motivational interviewing skills
Provider: physicians
Intensity: single 20-minute face-to-face session, plus up to six follow-up calls
Was MI fidelity monitored?: not stated
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: exhaled CO (< 10 ppm)
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source Not reported
Author conflicts of interest Not reported
Notes Contacted authors and received extensive additional data and information, beyond what was reported
in trial registry.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk SAS 9.4 was used to generate random numbers, random grouping was used to
perform random grouping, and random grouping schemes were sequentially
saved into opaque sealed envelopes with sequential numbers.
Allocation concealment
(selection bias)
Low risk After the patient consented to take part in the study, the researcher opened
the sealed opaque envelopes according to the envelope number sequence,
and assigned the included smoking patients to the intervention group or the
control according to the assignment in the envelope.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Smoking cessation was biochemically validated.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 19/105 participants in the MI group were lost to follow-up and 18/105 in the BA
group. Therefore, loss to follow-up was less than 20% and was similar between
arms.
NCT02645838  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: emergency homeless shelters and transitional housing units
Okuyemi 2013 
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Recruitment: through health fairs, staC informational sessions, fliers at homeless shelters and word of
mouth
Participants Defining eligibility criteria?: homeless people
Participant characteristics: 430 homeless adult smokers randomised to intervention (216) and control
(214); 74.7% M; mean age 44.4; cpd 19.3
Motivation to quit?: not selected on motivation
Interventions 1. Control: single session of brief advice to quit smoking lasting approximately 10 to 15 mins. Includ-
ed topics of smoking history, current smoking, direct advice about the health risks of smoking and the
health benefits of quitting, affirmation of the participant’s decision to quit, an assessment of prepared-
ness to quit and addressing strategies for coping with smoking cues
2. Intervention: six individual MI counselling sessions, each lasting 15 to 20 minutes, which occurred at
baseline and follow-up at weeks 1, 2, 4, 6 and 8. The focus of sessions was to encourage cessation and
NRT adherence.
Pharmacotherapy: At baseline, participants in both groups received a 2-week supply of 21-mg nicotine
patches, and every 2 weeks they received an additional 2-week supply of 21 mg nicotine patches, over
the 8 week treatment period.
All participants received health educational resource called The Power to Quit: A Quit Smoking Guide,
developed by the project investigators, and a 2-week supply of 21-mg nicotine patches. Every 2 weeks,
they received an additional 2-week supply of 21 mg nicotine patches, over the 8-week treatment peri-
od.
Provider: counsellors
Intensity: six 15 to 20-minute sessions over 8 weeks
Was MI fidelity monitored?: "Sessions were audio recorded and reviewed during weekly supervision".
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: expired carbon monoxide (≤ 10 ppm). Salivary cotinine testing was performed if the expired
CO was greater than 10 ppm. for those who self-reported cessation. A cut-oC of ≤ 20 ng/mL for salivary
cotinine was used to verify abstinence.
Was mental health and/or well-being measured at follow-up?: no, change in depression was measured
but not reported by intervention group.
Was quality of life measured at follow-up?: no
Funding source A grant from the National Heart Lung and Blood Institute (R01HL081522)
Author conflicts of interest Paper stated that there were no conflicts.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "pre-assigned randomization numbers prepared by the study statisti-
cian determined into which study arm the participant would be enrolled". No
further information provided
Okuyemi 2013  (Continued)
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Allocation concealment
(selection bias)
Unclear risk QUOTE: "pre-assigned randomization numbers prepared by the study statisti-
cian determined into which study arm the participant would be enrolled". No
further information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk A cessation was biochemically verified using exhaled CO and cotinine.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 47/216 (22%) in MI intervention group and 59/214 (28%) in control group lost
to follow-up. Therefore, rates were similar between groups.
Okuyemi 2013  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: state-funded inner-city residential substance abuse treatment programme with state-wide
catchment
Recruitment: residents of the abstinence-oriented programme were told the study would provide infor-
mational sessions about smoking without requiring cessation, and asked if they would like to take part.
Participants Defining eligibility criteria?: alcohol-dependent smokers
Participant characteristics: 165 adult smokers meeting current alcohol dependence criteria, ran-
domised to intervention (80) and control (85); 32.4% female; mean age 33.8; cpd 21.2
Motivation to quit?: not selected on motivation
Interventions 1. Control: brief advice used AHRQ-recommended methods. At the Initial session (15 mins), therapists
assessed smoking rate and interest in quitting, directly advised participants to stop smoking now dur-
ing substance use treatment for their health, and given advice about useful methods. 43 participants
were randomised to receive booster sessions (5 to 15 mins each), 7 and 30 days after the initial session.
The remaining 42 participants did not receive boosters.
2. Intervention: used motivational therapist style with assessment feedback, based on motivational in-
terviewing. Initial session (45 mins) involved discussing pros and cons of smoking, interpreting health
risks, costs of smoking, smoking rate, relationship of smoking to ongoing alcohol use, and barriers to
change, with corrective information. 40 participants were randomised to booster sessions (5 to 15 mins
each), 7 and 30 days after the initial session. The remaining 40 participants did not receive boosters.
All participants informed of free access to smoking cessation pamphlets, smoking cessation skills
groups, hard candy, and free access to NRT (transdermal nicotine or nicotine gum) if medically eligible
and willing to cease smoking while using it.
Provider: counsellors
Intensity: single 45-minute initial session, with two 5- to 15-minute booster sessions (in booster group
only)
Was MI fidelity monitored?: "Treatment session audiotapes (24% of initial sessions, 19% of booster ses-
sions) were reviewed in weekly group supervision with Dr. Rohsenow and a treatment coordinator, and
rated for MI style and adherence to the manual (see 2.4.4), with immediate feedback to therapists to
prevent driJ. Treatment sessions were rated by the treatment coordinator (primary rater) or the first
author on 1 (not at all) to 5 (extensively) scales for five motivational style measures (arguing, demon-
strating empathy, reflective listening, supporting self-efficacy, emphasizing personal responsibility for
change), and supervisors endorsed adequacy of six MI adherence items (discuss ambivalence (pros and
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cons, goal discrepancies), discuss feedback about smoking effects, explore barriers to change, provide
summaries, discuss various goals, discuss methods)."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 12 months
Validation: exhaled CO ≤ 10 ppm
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source A grant from the National Institute of Alcohol Abuse and Alcoholism (1 RO1 AA11318) and two Senior
Research Career Scientist Awards from the United States Department of Veterans Affairs
Author conflicts of interest Not reported
Notes The study was made up of 4 trial arms: MI with and without booster sessions and brief advice with and
without booster sessions. For the purpose of MI versus other smoking cessation support analyses, we
combined these into 2 groups: 1. MI and 2. brief advice. However, we also compared the two MI groups
in our intensity analysis.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk QUOTE: "Randomization to MI or BA and to booster sessions versus no boost-
ers within each gender occurred in the first week of the program using a ran-
dom numbers table".
Allocation concealment
(selection bias)
Unclear risk QUOTE: "Assignment was placed in a sealed envelope opened just before the
first treatment session." Did not state whether envelopes were opaque.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Abstinence was validated by exhaled carbon monoxide.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 27/80 (34%) in the MI intervention group and 25/85 (29%) in the BA control
group were lost to 12-month follow-up. Therefore, dropout rate was similar be-
tween arms.
Rohsenow 2014  (Continued)
 
 
Methods Study design: factorial RCT (2 x 2)
Location: USA
Setting: residential substance abuse treatment programme
Recruitment: from the substance abuse treatment programme (no further information given)
Participants Defining eligibility criteria?: drug use disorder and in residential substance abuse treatment
Participant characteristics: 184 adult smokers; 102/184 (55.4%) female; mean age: 34.5; mean cpd:
22.3; nicotine dependence: mean FTND = 5.28
Motivation to quit?: not selected on motivation
Rohsenow 2015 
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Interventions Control 1: brief advice with non-contingent vouchers: participants received a session (15 minutes) of
brief advice to promote motivation to quit used AHRQ-recommended methods, adapted for substance
use disorder recovery issues. Counsellors assessed smoking rate and interest in quitting, directly ad-
vised participants to stop smoking now for their health, assisted by giving advice about useful meth-
ods, and asked them to set a quit-date within the next 2 weeks. If participants expressed concern about
effects on sobriety, they were given corrective information. Additional sessions were provided at 7, 14
and 19 days after the first session (10 to 15 minutes each) where progress toward smoking cessation
was checked, participants were engaged in problem-solving around barriers to quitting, successes in
accomplishing goals were noted, repeated direct advice to quit was given, and reminders of methods
available were given. Participants could earn payments per day for 19 days, simply for providing breath
samples as scheduled (not contingent on abstinence). In the last session there was discussion address-
ing the transition away from the contingency payments provided in the study.
Control 2: brief advice with contingency vouchers: as control 1, however the payments participants
could earn were awarded for providing reduced CO breath samples rather than just for providing sam-
ples.
Intervention 1: motivational interviewing with non contingent vouchers: As control 1, however partici-
pants received motivational interviewing rather than the brief advice intervention. “The initial session
(45 minutes) involved discussing pros and cons of smoking, the health risks associated with their car-
bon monoxide (CO) level, the costs of smoking relative to their income, their smoking rate compared to
state and national norms, the relationship of smoking to alcohol use and to sobriety, and their barriers
to change with corrective information (since more barriers are associated with lower motivation). Pa-
tients chose goals and methods from a menu of suggestions, and were provided with their choice of a
variety of smoking cessation pamphlets. At additional sessions at 7, 14 and 19 days after the first ses-
sion (15–30 minutes each), patients were asked about progress toward their own stated goals, barriers
and ways to overcome barriers, successes (focussing on self-efficacy), and revised goal preferences.”
Intervention 2: motivational interviewing with contingency vouchers: as control 2, however partici-
pants received motivational interviewing rather than the brief advice intervention.
All participants received free access to NRT (patch or gum), smoking cessation pamphlets and hard
candy.
Provider: counsellors
Intensity: single 45-minute face-to-face session plus three 15- to 30-minute sessions
Was MI fidelity monitored?: "Treatment session audiotapes (15% of initial sessions, 10% of addition-
al sessions) were reviewed in weekly group supervision with the treatment coordinator and a psychol-
ogist trained in MI, and rated for MI style and adherence to the manual, with immediate feedback to
therapists to prevent driJ."
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 12 months
Validation: CO level ≤ 4 ppm and salivary cotinine level ≤ 15 ng/mL
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "Supported by 1 RO1 DA13616 from the National Institute on Drug Abuse; two Senior Career Research
Scientist Awards from the Department of Veterans Affairs (DJR and PMM); and K05AA019681 from the
National Institute on Alcohol Abuse and Alcoholism."
Author conflicts of interest "No authors declare conflicts".
Notes Two MI groups and 2 brief advice (BA) groups merged into one MI and one BA group to contribute to 'MI
versus other smoking cessation treatment' comparison as no interaction effects were detected.
Rohsenow 2015  (Continued)
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Used stratified random assignment, using urn randomisation. No further detail
given
Allocation concealment
(selection bias)
Unclear risk No information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Research interviewers blind to treatment condition conducted all assess-
ments. Cessation was biochemically verified.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 45/184 (24.5%) lost to follow-up, with no significant differences by condition
Rohsenow 2015  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: hospital
Recruitment: "Using the electronic medical record, a daily list was generated of inpatients documented
as current smokers on admission screening. Research assistants (RAs) reviewed the list twice daily and
went to the bedside of every patient on the list. In addition to the inpatient units, RAs approached ad-
mitted patients who remained in the emergency department and patients in the intensive care units."
Participants Defining eligibility criteria?: admitted to hospital for various healthcare problems
Participant characteristics: 1619 adult smokers; 346/1619 (21.4%) female; mean age: control: 48, in-
tervention: 49; mean cpd: control: 12.5, intervention: 12.3; nicotine dependence: level of nicotine ad-
diction, first cigarette within: 5 minutes: 685/1619 (42.3%), 6 to 30 minutes: 321/1619 (19.8%), 31 to 60
minutes: 180/1619 (11.1%), > 60 minutes: 422/1619 (26.1%).
Motivation to quit?: not selected on motivation
Interventions Control: referral to quit-line based on MI: participants referred to a quit-line and offered NRT. Partici-
pants received one 15 to 20-minute counselling session with a follow-up call to assess quit status and
assure any requested NRT was received. Most participants were referred to the New York state quit-line
where the counsellors are trained in MI.
Intervention: MI intensive counselling plus 8 weeks of NRT if they had not received an NRT prescription
at discharge. "The structured counselling protocol was based on Motivational Interviewing and Prob-
lem Solving Therapy".
Provider: counsellors
Intensity: single 15 to 20-minute initial call, followed by six 10 to 15-minute calls over 42 weeks
Was MI fidelity monitored?: "The program staC members use a structured protocol to maintain a record
of each of the counselling calls for internal quality assurance. To ensure intervention standardization
and fidelity after study implementation, a random sample of the counsellors' phone calls will be audio
taped and reviewed by a clinical psychologist and the study’s counsellor supervisor".
Outcomes Definition of cessation used: 30-day point prevalence
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Length of longest follow-up: 6 months
Validation: "Where possible salivary cotinine was used: several sites (including New York) made exhaus-
tive efforts to obtain saliva from a consecutive subsample of participants reporting abstinence and no
NRT or e-cigarette use in the past 7 days at 6-month follow-up."
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "This work was supported by a grant from the National Heart, Lung and Blood Institute (NHLBI) of NIH
(#1U01HL105229) and a Hurricane Sandy Supplement (#3U01HL105229-04S1), and also in part by the
New York University CTSA grant UL1TR000038 from the National Center for Advancing Translational
Sciences, NIH."
Author conflicts of interest "None of the authors have any conflicts of interest to report".
Notes Both intervention groups received counselling based on MI albeit from different providers. This study
was included in our comparison investigating the intensity of MI; however, it was removed in a sensitiv-
ity analysis due to the difference in providers between arms, which made it different to other studies in-
cluded in the same comparison.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk The study database generated random assignments. QUOTE: "The randomi-
sation scheme, designed by the biostatistician, employed a computerized ran-
dom number generator and stratified participants on hospital site."
Allocation concealment
(selection bias)
Low risk The study database generated random assignments. QUOTE: "The randomi-
sation scheme, designed by the biostatistician, employed a computerized ran-
dom number generator and stratified participants on hospital site."
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Biochemical verification did not occur in full sample and intervention contact
was not matched across study arms.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 247/804 (30.7%) lost to follow-up in the hospital intervention arm, and 278/814
(34.2%) lost to follow-up in the quit-line arm. Less than 50% overall and similar
rates between groups
Sherman 2016  (Continued)
 
 
Methods Study design: RCT
Location: Spain
Setting: family health centres
Recruitment: smokers making routine GP visits
Participants Defining eligibility criteria?: patients attending primary care for variety of reasons
Participant characteristics: 200 smokers, randomised to intervention (114) or control (86). 53% female,
mean age 38. Mean cpd 18
Motivation to quit?: not selected on motivation
Interventions Control: brief (3 mins) anti-smoking advice
Soria 2006 
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Intervention: three 20-min MI-based interviews, at intervals to suit doctor and participant
Pharmacotherapy: bupropion offered to highly nicotine-dependent members of both groups
Provider: physicians
Intensity: three 20-minute sessions
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: point prevalence
Length of longest follow-up: 12 months
Validation: expired CO < 6 ppm
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source Grant from the Department of Health, Health Science Institute of the Government of the Autonomous
Communities of Castille - La Mancha (Spain)
Author conflicts of interest "The authors have stated that there are none".
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk QUOTE: "The patients were randomly assigned to either one of the actions
groups by means of a non-block table of random numbers", "patient randomi-
sation was achieved by applying a non-block table of random numbers as op-
posed to a block table, resulting in unbalanced group sizes".
Allocation concealment
(selection bias)
Low risk QUOTE: "Two hundred non-transparent sealed envelopes containing the inter-
ventions (either brief advice or MI) were prepared. Before the start of daily con-
sultations, the GPs conducting the interventions would extract one of the en-
velopes, not knowing the type of action it contained. The first smoker patient
who attended the consultation would be offered the possibility of taking part
in the study. If they accepted and signed the informed consent form, the enve-
lope
would be opened, upon which the GP would learn of the patient’s group as-
signment."
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Cessation was validated using exhaled carbon monoxide measures.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 17/114 (14.9%) of the MI intervention group and 9/86 (10.5%) of the brief ad-
vice control group were lost to follow-up at the 12-month follow-up.
Soria 2006  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: methadone maintenance treatment programme centres
Stein 2006 
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Recruitment: offered to smokers routinely attending maintenance clinic
Participants Defining eligibility criteria?: opiate-dependent people on methadone maintenance treatment for 3
months or more
Participant characteristics: 383 methadone-maintained adult smokers, randomised to maximal (191)
or minimal (192) SC programmes. 48% female, mean age 40, mean cpd 27
Motivation to quit?: not selected on motivation
Interventions Control: up to 2 visits, i.e. baseline and quit-date (if set). Brief advice using National Cancer Institute's
4As model (< 3 mins), plus self-help materials
Intervention: up to 3 visits from study counsellor, i.e. one 30-min MI-based tailored interview, plus 15 to
30-min quit-date session + follow-up relapse prevention session. Those not ready to quit only received
2 sessions.
All participants willing to make quit attempt offered NRT patches.
Provider: counsellors
Intensity: single 30-minute session, followed by two follow-up sessions within 30 days
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: Expired CO < 8 ppm
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source A grant from the National Cancer Institute (R01CA84392). Transdermal nicotine therapy provided by
GlaxoSmithKline
Author conflicts of interest "The authors have no conflicts of interest, financial or otherwise, to report for this article or this re-
search."
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "At this point, randomization and group assignment occurred." No fur-
ther information provided
Allocation concealment
(selection bias)
Unclear risk QUOTE: "At this point, randomization and group assignment occurred." No fur-
ther information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Cessation was validated using exhaled carbon monoxide measurements.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk QUOTE: "A total of 383 participants were assessed at baseline; 312 (81.5%)
were successfully located and assessed at 6 months". However, rates of fol-
low-up were not reported by study arm.
Stein 2006  (Continued)
Motivational interviewing for smoking cessation (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
82
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
 
 
Methods Study design: RCT
Location: USA
Setting: colleges and universities
Recruitment: advertisements posted in campuses, in campus newspapers, and on the Internet (e.g.
Craigslist)
Participants Defining eligibility criteria?: young people 18-24 years
Participant characteristics: 110 adult (18 to 24 years), student, daily smokers verified by a CO > 10 ppm,
randomised to intervention (55) and control (55); 0.1% female; mean age 19.8; cpd 12.3
Motivation to quit?: not selected on motivation
Interventions Control 1: progressive muscle relaxation (REL) with non-contingent payments: i.e. non-smoking cessa-
tion support, matched to the intervention for contact time. Therapists followed a standardised manual
for implementation. In session 1, therapists guided the participant through progressive muscle REL ex-
ercises. Muscle REL techniques were then practiced during sessions 2 and 3. Participants received pay-
ments for providing breath samples, regardless of CO level across 3 weeks. Payments were provided to
promote session attendance and to minimise differences in attendance between groups.
Control 2: progressive muscle relaxation (REL) with contingency payments: as control 1 however, as
well as receiving the non-contingent payments participants received contingent reinforcement for CO
reductions of 25% or greater from their baseline levels.
Intervention 1: MET with non-contingent payments: as control 1, however rather than REL therapy, par-
ticipants received three sessions of motivational enhancement therapy (MET), incorporating central
principles of MI. The first session (60 mins) focussed on enhancing motivation to cut down and quit
smoking. Students received information about smoking effects, coping with withdrawal symptoms,
and strategies for quitting.The therapist and student developed an action plan for behaviour change.
Sessions 2 and 3 (each 30 mins) used MET principles, focussed on progress made and planning for the
future.
Intervention 2: MET with contingency payments: as control 2, however, rather than REL therapy, partic-
ipants received three sessions of motivational enhancement therapy (MET), incorporating central prin-
ciples of MI. The first session (60 mins) focussed on enhancing motivation to cut down and quit smok-
ing. Students received information about smoking effects, coping with withdrawal symptoms, and
strategies for quitting.The therapist and student developed an action plan for behaviour change. Ses-
sions 2 and 3 (each 30 mins) used MET principles, focussed on progress made and planning for the fu-
ture.
Intervention provider: counsellors
Intensity: single 60-minute session, followed by two 30-minute sessions over the following two weeks
Was MI fidelity monitored?: "Students and therapists separately rated which of 19 possible session ele-
ments (15 MET elements and 4 REL elements) had been completed at posttreatment".
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: salivary cotinine < 15 ng/mL or CO ≤ 8 ppm
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Tevyaw 2009 
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Funding source A grant from the National Institute on Drug Abuse (DA011204), and a Senior Career Research Scientist
Award from the Department of Veterans Affairs
Author conflicts of interest "None declared"
Notes The study was made up of 4 trial arms: MET with and without contingency reinforcement, and REL with
and without contingency reinforcement. We compared the two non-contingent groups for our MI ver-
sus no smoking cessation treatment comparison, and compared the two contingent groups for our MI
as an adjunct comparison. The authors kindly provided the quit data for individual study arms in re-
sponse to an information request.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "Participants were randomly assigned to one of four conditions". No
further information provided
Allocation concealment
(selection bias)
Unclear risk QUOTE: "Participants were randomly assigned to one of four conditions". No
further information provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Cessation was validated using saliva cotinine and exhaled carbon monoxide.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 3/55 (6%) in the MET intervention group and 3/55 (6%) in the relaxation con-
trol group were lost to follow-up at the 6-month follow-up. Therefore, dropout
rate was low and the same across study arms.
Tevyaw 2009  (Continued)
 
 
Methods Study design: cluster RCT
Location: USA
Setting: community (over telephone)
Recruitment: took place at churches, public housing sites, and community centres (no further informa-
tion given)
Participants Defining eligibility criteria?: adult smokers
Participant characteristics: 624 adult smokers; 316/624 (50.6%) female; mean age: 45.8; cpd: 1 to 10:
188/624 (30.1%), 11 to 20: 285/624 (45.7 %), >= 21: 151/624 (24.2%); nicotine dependence: mean FTND =
5.59
Motivation to quit?: motivated
Interventions Control: brief advice to quit smoking, self-help written materials, a quit-line referral, and a 10-week
supply of NRT patches
Intervention 1: as control, plus tailored text messaging. "Message delivery began several days before a
scheduled quit date and continued for a 12-week period. Frequency of messages was highest (i.e. 5 per
day) near the time of the quit date, but gradually reduced to 1 per day. Message content was informed
by cognitive behavioral and motivational enhancement principles and was designed to increase health
knowledge, quit motivation, use of coping skills, support, and self-efficacy. Messages were tailored
based on participants’ first name and current smoking status (proactively assessed weekly by mobile
phone), and on disease history, future disease concerns, and preferred coping skills (each assessed at
the baseline audio computer assisted self-interview)."
Vidrine 2019 
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Intervention 2: as intervention 1, plus proactive telephone counselling. As with text messaging, coun-
selling session content was primarily drawn from cognitive-behavioural and MI techniques.
Provider: counsellors
Intensity: 11 10- to 12-minute sessions over a 12-week period
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 30-day point prevalence
Length of longest follow-up: 6 months
Validation: saliva cotinine (< 20 ng/mL) via postal swab but only introduced in second year of recruit-
ment (N = 377; 60.4%)
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "This study was supported by grant R01 CA141628 from the National Cancer Institute (principal inves-
tigators [PIs]: Drs D. J. Vidrine and Prokhorov); grant P30 CA225520 from the Stephenson Cancer Cen-
ter (PI: Dr Robert S. Mannel, MD); grant P30 CA016672 from The University of Texas MD Anderson Cancer
Center (PI: Louis L. Pisters, MD); grant 092-016-0002l from the Oklahoma Tobacco Settlement Endow-
ment Trust (PI: Dr J. I. Vidrine); and grant U54GM104938 from the National Institute of General Medical
Sciences (PI: Judith A. James, MD, PhD)."
Author conflicts of interest "Authors reported no conflicts of interest."
Notes Intervention groups merged and compared with control for MI as an adjunct comparison. Intervention
groups compared with one another for intensity of MI comparison. The study randomised neighbour-
hood sites and conducted adjusted analyses, accounting for the type of site (church, housing complex
or community centre) and the individual site (46 sites). This allowed us to calculate an ICC of 0.06 and
adjust for this in our analyses.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk QUOTE: "Neighborhood sites were stratified based on type (i.e. church, com-
munity center, or public housing complex) and racial/ethnic composition, then
randomized to a treatment group using a random number list generated by a
staC statistician".
Allocation concealment
(selection bias)
Unclear risk QUOTE: "Research staC who recruited, consented, and administered the as-
sessments were blinded to the treatment group assignment." No further infor-
mation
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Research staC who recruited, consented, and administered the assessments
were blinded to the treatment group assignment. However, validation of absti-
nence only began at year 2 of recruitment so we have not used validated rates,
and the amount of contact with counsellors differed between groups.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk QUOTE: "The overall 6-month follow-up rate was 73.6%, and no significant
group differences (P > .57 for all) were observed".
Vidrine 2019  (Continued)
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Methods Study design: cluster RCT
Location: USA
Setting: high schools (via virtual environment)
Recruitment: from 14 local high school using classroom presentations, lunch-hour sign-up tables, fly-
ers, posters, school newspaper ads and articles, school-wide announcements, and school liaison refer-
rals
Participants Defining eligibility criteria?: high school students (adolescents)
Participant characteristics: 136 adolescent smokers; 63/136 (46%) female; mean age: 16; mean cpd: 2
to 5; nicotine dependence: latency to first cigarette of the day assessed on a scale ranging from 1 (im-
mediately after waking) to 6 (more than 2 hours after waking), mean: intervention; 4.44; control; 4.78
Motivation to quit?: not selected on motivation
Interventions Control: no treatment (measurement only)
Intervention: "The Breathing Room" virtual world incorporating motivational interviewing: participants
were represented by an avatar in the virtual world and received counselling in a group, delivered by a
counsellor, in a shopping mall setting. "The Breathing Room virtual world", used proprietary interactive
software known as ActiveWorlds that created a virtual mall environment with chat box communication.
Provider: counsellor
Intensity: single 45-minute session per week for 7 weeks
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 12 months
Validation: none
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source "This research was funded by California's Tobacco-related Disease Research Program (TRDRP), grant
number 11HT-3301".
Author conflicts of interest Not reported
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Randomization to condition was done by school to avoid contamina-
tion between intervention and control groups". No further information given
Allocation concealment
(selection bias)
High risk Clusters knew which condition they were in, and recruitment was tailored to
this. Participants recruited were different at each site due to recruitment ma-
terials associated with condition - this resulted in non-equivalent groups.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Smoking status measured by self-report and control group had no interaction
with study counsellor (compared with seven sessions of MI/chat room).
Woodru; 2007 
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Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Overall loss to follow-up was 27% for the 12-month follow-up survey. QUOTE:
"There was tendency for survey non-response to be higher among interven-
tion participants than among controls. For example, at the post-intervention
assessment, 15% of controls did not respond compared to 33% of intervention
participants." Exact numbers per group lost to follow-up not reported and 18%
difference between controls and intervention participants at post-intervention
assessment (no report of difference at 12-month follow-up).
Woodru; 2007  (Continued)
 
 
Methods Study design: RCT
Location: USA
Setting: Asian community health coalition’s member organisations. Community setting in New York
City
Recruitment: participants were recruited through the Asian Community Health Coalition’s Chinese
member organisations by bilingual staC from Temple University’s Center for Asian Health in coopera-
tion with trained community volunteers.
Participants Defining eligibility criteria?: self-identification as ethnic Chinese
Participant characteristics: 139 adult ethnic Chinese smokers, randomised to intervention (67) and
control (72); 12.3% female; mean age 44.4; cpd not stated
Motivation to quit?: not selected on motivation
Interventions Control: four 60-min 'health education' sessions and general self-help health information, covering nu-
trition, exercise, and harmful effects of tobacco. Quitting strategies were provided.
Intervention: four in-person 60-min sessions of MI counselling for smoking cessation and self-help
smoking cessation materials. The effects of tobacco use, secondhand smoke, and participants’ experi-
ences with smoking were discussed. Participants were counselled about the addictive nature of nico-
tine, encouraged to examine the pros and cons of smoking, and contemplate quitting behaviour.
All participants were provided with nicotine patches.
Provider: counsellors
Intensity: four in-person 60-minute sessions. Frequency unclear
Was MI fidelity monitored?: no
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: 6 months
Validation: expired CO was measured; however results by arm not reported and so non-validated data
used.
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Funding source A grant from the National Cancer Institute Community Network Program (U01CA114582-02S2)
Author conflicts of interest "None declared"
Notes  
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk QUOTE: "Eligible participants/smokers aged 18 years and older were random-
ly assigned to MI or to the general health – counseling program". No further in-
formation provided
Allocation concealment
(selection bias)
Unclear risk QUOTE: "Eligible participants/smokers aged 18 years and older were random-
ly assigned to MI or to the general health – counseling program". No further in-
formation provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk QUOTE: "All participants were measured by breath CO as cross validation of
their smoking status at two timepoints: baseline and 6-month follow-up".
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 7/67 (11%) in the MI intervention group, and 10/72 (14%) of the general health
control group were lost to follow-up at 6 months.
Wu 2009  (Continued)
5As: 'Ask, Advise, Assess, Assist, and Arrange'
5Rs: 'Relevance, Risks, Rewards, Roadblocks, Repetition'
AHRQ: Agency for Health care Research and Quality
ALA: American Lung Association
AMI: adapted motivational interviewing
BA: brief advice
CA: continuous abstinence
CBT: Cognitive Behavioural Therapy
CO: carbon monoxide
cpd: cigarettes per day
CT: computerised tomography
FTND: Fagerstrom Test for Nicotine Dependence
HE: health education
HII: high intensity intervention
HIV: Human Immunodeficiency Virus
ICC: intraclass correlation
ITT: intention to treat
LCD: liquid-crystal display
LHCW: lay health care workers
LII: low intensity intervention
M: male
m: month
MA: meta-analysis
ME: motivational enhancement
MEC: motivationally enhanced counselling
MET: motivational enhancement therapy
MFTQ: modified Fagerstrom Tolerance Questionnaire
MI: motivational interviewing
MISC: Motivational Interviewing Skill Code
mp3: Moving Picture Experts Group Layer-3 Audio (audio file format/extension)
N: number of participants
NG:nicotine gum
NRT: Nicotine replacement therapy
PA: prolonged abstinence
PG: placebo gum
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PPA: point prevalence abstinence
ppm: parts per million
PTSD: post-traumatic stress disorder
RCT: randomised controlled trial
REL: progressive muscle relaxation
RP: relapse prevention
SBA: structured brief advice
SC: smoking cessation
S-H: self help
SUD: substance use disorder
TB: tuberculosis
TQD: target quit date
UC: usual care
USD: United States dollars
VHA: Veterans Health Administration
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
ACTRN12609000627257 Non-MI intervention components not matched between arms
ACTRN12609001039279 Non-MI intervention components not matched between arms
ACTRN12612000016831 Was non-randomised or quasi-randomised
ACTRN12614000876695 Non-MI intervention components not matched between arms
ACTRN12614001147673 Was non-randomised or quasi-randomised
ACTRN12616000314426 Participants not current smokers
Aertsen Van Der Kuip 2006 Measured cessation at less than 6 m follow-up
Ahluwalia 1998 Did not test a behavioural motivational smoking cessation intervention
Auer 2016 Was non-randomised or quasi-randomised
Baker 2006 Non-MI intervention components not matched between arms
Bernstein 2018 Measured cessation at less than 6 m follow-up
Boccio 2017 Was non-randomised or quasi-randomised
Bolger 2010 Measured cessation at less than 6 m follow-up
Bonevski 2018 Non-MI intervention components not matched between arms
Borrelli 2002 Non-MI intervention components not matched between arms
Borrelli 2005 Non-MI intervention components not matched between arms
Borrelli 2016 Non-MI intervention components not matched between arms
Borrelli 2017 Non-MI intervention components not matched between arms
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Study Reason for exclusion
Boyle 2007 Tested a motivational intervention not based on M & R's MI
Breland 2014 Measured cessation at less than 6 m follow-up
Bronson 1989 Tested a motivational intervention not based on M & R's MI
Brooks 2017 Non-MI intervention components not matched between arms
Brown 2003 Non-MI intervention components not matched between arms
Caponnetto 2017 Intervention based on stages of change theory
Carpenter 2004 Tested a motivational intervention not based on M & R's MI
Cigrang 2002 Did not test a behavioural motivational smoking cessation intervention
Collicott 2001 Measured cessation at less than 6 m follow-up
Cornuz 2002 Tested a motivational intervention not based on M & R's MI
Curry 2003 Non-MI intervention components not matched between arms
Dornelas 2000 Intervention based on stages of change theory; only participants in precontemplative and contem-
plative stages received MI counselling, the rest received relapse prevention counselling only
Eakin 2014 Did not test a behavioural motivational smoking cessation intervention
Emmons 2001 Non-MI intervention components not matched between arms
Ershoff 1999 Participants were pregnant smokers
Gariti 2002 Non-MI intervention components not matched between arms
George 2000 Non-MI intervention components not matched between arms
Glasgow 2000 Non-MI intervention components not matched between arms
Ha 2012 Was non-randomised or quasi-randomised
Ha 2015 Was non-randomised or quasi-randomised
Haas 2015 Non-MI intervention components not matched between arms
Hennrikus 2002 Did not test a behavioural motivational smoking cessation intervention
Hennrikus 2005 Non-MI intervention components not matched between arms
Hokanson 2006 Non-MI intervention components not matched between arms
Horn 2007 Non-MI intervention components not matched between arms
Huang 2015 Non-MI intervention components not matched between arms
Hughes 2017 Participants not current smokers
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Study Reason for exclusion
Hutchinson 2017 Participants not current smokers
Hyman 2007 Did not test a behavioural motivational smoking cessation intervention
Idrisov 2013 Non-MI intervention components not matched between arms
Ingersoll 2005 Measured cessation at less than 6 m follow-up
IRCT2017080435257N1 Tested a motivational intervention not based on M & R's MI
ISRCTN11353250 Non-MI intervention components not matched between arms
ISRCTN50627997 Tested a motivational intervention not based on M & R's MI
Klemperer 2017 Tested a motivational intervention not based on M & R's MI
Krigel 2011 Measured cessation at less than 6 m follow-up
Lasser 2012 Did not test a behavioural motivational smoking cessation intervention
Lennox 1998 Intervention based on stages of change theory
Lindqvist 2013 Was non-randomised or quasi-randomised
Luna 2005 Measured cessation at less than 6 m follow-up
Ma 2005a Was non-randomised or quasi-randomised
Ma 2005b Was non-randomised or quasi-randomised
Mahajan 2017 Was non-randomised or quasi-randomised
Manfredi 1999 Measured cessation at less than 6 m follow-up
Manfredi 2004 Did not test a behavioural motivational smoking cessation intervention
Martin-Lujan 2011 Non-MI intervention components not matched between arms
Mazas 2007 Didn't measure smoking cessation
McCambridge 2005 Participants not current smokers
Menzie 2018 Measured cessation at less than 6 m follow-up
Metse 2017 Non-MI intervention components not matched between arms
Metz 2006a Non-MI intervention components not matched between arms. NRT only recommended to partici-
pants in one trial arm
Metz 2006b Tested a motivational intervention not based on M & R's MI
Meyer 2003 Tested a motivational intervention not based on M & R's MI
Mujcic 2018 Non-MI intervention components not matched between arms
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Study Reason for exclusion
NCT00169260 Tested a motivational intervention not based on M & R's MI
NCT00701896 Tested a motivational intervention not based on M & R's MI
NCT00907309 Did not test a behavioural motivational smoking cessation intervention
NCT01098955 Tested a motivational intervention not based on M & R's MI
NCT01846910 Non-MI intervention components not matched between arms
NCT01982617 Measured cessation at less than 6 m follow-up
NCT02086162 Tested a motivational intervention not based on M & R's MI
Nichter 2018 Tested a motivational intervention not based on M & R's MI
Pardavila-Belio 2015 Non-MI intervention components not matched between arms
Parker 2007 Participants were pregnant smokers
Persson 2006 Non-MI intervention components not matched between arms
Pineiro 2014 Was non-randomised or quasi-randomised
Polosa 2011 Intervention based on stages of change theory
Reitzel 2010 Participants were pregnant smokers
Rigotti 1997 Non-MI intervention components not matched between arms
Rigotti 2006 Participants were pregnant smokers
Rogers 2016 Was non-randomised or quasi-randomised
Schuck 2014 Non-MI intervention components not matched between arms
Severson 2009 Non-MI intervention components not matched between arms
Sherbot 2005 Intervention based on stages of change theory
Sims 2013 Tested a motivational intervention not based on M & R's MI
Skov-Ettrup 2016 Intervention based on stages of change theory
Smith 2001 Did not test a behavioural motivational smoking cessation intervention
Sobell 2017 Non-MI intervention components not matched between arms
Steinberg 2016 Measured cessation at less than 6 m follow-up
Stotts 2002 Participants were pregnant smokers
Stotts 2009 Participants were pregnant smokers
Tappin 2000 Participants were pregnant smokers
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Study Reason for exclusion
Tappin 2005 Participants were pregnant smokers
Thomsen 2010 Non-MI intervention components not matched between arms
Van Rossem 2015 Tested a motivational intervention not based on M & R's MI
Wakefield 2004 Non-MI intervention components not matched between arms
Weaver 2015 Measured cessation at less than 6 m follow-up
m: month
M & R: Miller & Rollnick
MI: Motivational Interviewing
NRT: Nicotine replacement therapy
 
Characteristics of studies awaiting assessment [ordered by study ID]
 
Methods Study design: unclear
Location: China
Setting: not specified
Recruitment: unclear
Participants N: 139
Defining eligibility criteria?: smokers with coronary heart disease
Motivation to quit?: unknown
Interventions Control: usual clinic care and health education
Intervention: motivational interviewing: "MI participants received six MI sessions over 3 months. In-
terviews include: (1) To help patients recognize that smoking and coronary heart disease are close-
ly related. (2) To help patients realize the dangers of smoking on cardiovascular health. (3) To help
patients recognize the potential benefits of quitting smoking. (4) Encourage the patients to face ob-
stacles and setbacks in the process of smoking cessation bravely, and provide a solution available
for the patients, enhancing patient confidence and motivation. (5) Encountering with the patients
do not want to try to change, repeat the above explanation optionally."
Provider: not specified
Intensity: 6 sessions over 3 months
Was MI fidelity monitored?: unclear
Outcomes Definition of cessation used: unclear (abstinence not reported in abstract)
Length of longest follow-up: unclear
Validation: unclear
Was mental health and/or well-being measured at follow-up?: unclear
Was quality of life measured at follow-up?: unclear
Zhou 2014 
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Funding source Not reported
Authors' declarations of inter-
est
Not reported
Notes Unclear whether smoking cessation was measured (although seems likely) and at what follow-up
points, making it impossible to ascertain whether the study met eligibility criteria. No cessation
rates were reported in the abstract. Tried to contact authors however was unable to identify any
contact details and an email to a generic university email address did not receive a response.
Zhou 2014  (Continued)
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Informed development of smoking cessation interventions for college students
Methods Study design: RCT
Location: not specified
Setting: not specified
Recruitment: not specified
Participants N: 136
Defining eligibility criteria?: college students
Motivation to quit?: not specified
Interventions Control: brief individualised smoking cessation treatment plus 8 weeks of NRT
Intervention: motivationally-enhanced group treatment plus NRT
Provider: not specified
Intensity: not specified
Was MI fidelity monitored?: not specified
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: six months
Validation: yes - details not stated
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Starting date Not reported
Contact information EE Lloyd-Richardson
Funding source Not reported
Authors' declarations of inter-
est
Not reported
Lloyd-Richardson 2003 
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Notes Whole sample had not been recruited when abstract was submitted, therefore six-month cessation
rates were not reported. Attempt made to contact the author with no response
Lloyd-Richardson 2003  (Continued)
 
 
Trial name or title Motivation and skills for detained teen smokers
Methods Study design: factorial RCT (2 x 2)
Location: USA
Setting: adolescent detention centre
Recruitment: adolescents who had been detained at the Rhode Island Training School (no further
details)
Participants N: 314
Defining eligibility criteria?: adolescents detained at the Rhode Island Training School
Motivation to quit?: not selected on motivation
Interventions Control 1: relaxation intervention (no smoking cessation treatment): "The Relaxation Therapy in-
tervention is a 60-90 minute individual session. The session encompasses several techniques, in-
cluding Progressive Muscle Relaxation and Visualization-Imagination, and as a whole is really a
meditation protocol. The Relaxation Therapy intervention encompasses several techniques, in-
cluding Progressive Muscle Relaxation and Visualization-Imagination, and meditation to reduce
stress."
Control 2: self-help programming: "Self Help intervention is administered during two 90 minute
group sessions. The intervention modules are based on the principles of Nicotine Anonymous
(NicA), to provide those who use nicotine but want a nicotine-free life, with a community of people
that have also experienced nicotine addiction and strive to be nicotine free. Elements incorporated
in this intervention include the 12 Steps and the NicA "tools" (i.e. meetings, phone list, literature,
sponsorship, and service) to facilitate and maintain abstinence from nicotine."
Control 3: cognitive behavioural therapy: "The Cognitive Behavioral Therapy (CBT) Intervention is
administered during two 90 minute group sessions. The focus is on the interrelationship between
thoughts, feelings, and behaviors. It is used to address specific deficits, such as improving problem
solving skills and developing social supports, and behaviors such as substance abuse and smok-
ing."
Intervention 1: motivational intervention: "Motivational Interviewing (MI) will be a 60-90 minutes
individual session. The focus is on establishing rapport and building motivation. The counselor ex-
plores youth's reasons for entering treatment, prior treatment experience, previous attempts to
change use, possible goals for treatment, substance effect expectancy, and perceptions of self-effi-
cacy. A personalized feedback report outlines assessment results, highlights any problems or con-
cerns related to cigarette use expressed by teen, and compares tobacco use levels with national
norms for same age and gender peers."
Provider: counsellor
Intensity: MI/RT: 60 to 90 minutes over one session; CBT/SHP: 60 to 75 minutes over two sessions
Was MI fidelity monitored?: not specified
Outcomes Definition of cessation used: 7-day point prevalence
Length of longest follow-up: six months (post-release)
NCT01387516 
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Validation: CO levels & saliva cotinine tests
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Starting date July 2007
Contact information Lynda Stein, University of Rhode Island
Funding source Not reported
Authors' declarations of inter-
est
Not reported
Notes Contacted author to ask about study status - author replied that the study was complete and that
they were about to start study write-up. No data were supplied.
NCT01387516  (Continued)
 
 
Trial name or title Strategies to promote cessation in smokers who are not ready to quit (PACE)
Methods Study design: factorial RCT
Location: USA
Setting: quit-line
Recruitment: not specified
Participants N: 828
Defining eligibility criteria?: not specified
Motivation to quit?: not motivated to quit
Interventions Control: brief advice: "Participants will receive brief advice to quit smoking, and be provided psy-
cho-education citing health consequences and the positive impact on mortality and morbidity".
Intervention 1: motivational Interviewing (MI): "Motivational interviewing (MI) is a collaborative
conversation style for strengthening a person's own motivation and commitment to change. MI at-
tempts to avoid a confrontational style and, instead, guides participants toward choosing to make
a change in their behavior."
Intervention 2: rate reduction (RR): "Participants will be informed of the strong medical evidence of
systematic reductions in smoking behavior can lead to long-term smoking cessation." This condi-
tion will receive Nicotine Replacement Therapy in the form of gum.
Intervention 3: motivation interviewing + rate reduction: participants will receive both intervention
1 and intervention 2 combined.
Provider: not specified
Intensity: 3 to 6 30-minute sessions + 3 booster sessions
Was MI fidelity monitored?: not specified
Outcomes Definition of cessation used: prolonged abstinence (defined as continuous abstinence with a two-
week grace period)
NCT02905656 
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Length of longest follow-up: 12 months
Validation: not specified
Was mental health and/or well-being measured at follow-up?: not specified
Was quality of life measured at follow-up?: not specified
Starting date September 2016
Contact information Karen Derefinko: kderefin@uthsc.edu
Sarah Hand: sarkbill@uthsc.edu
Funding source "Funded by the US NIH".
Authors' declarations of inter-
est
Not reported
Notes Trial registry record stated that the study is due to complete in 2020.
NCT02905656  (Continued)
 
 
Trial name or title STAND community college tobacco cessation trial
Methods Study design: RCT
Location: USA
Setting: community college
Recruitment: from Sacremento Community Colleges (no further information)
Participants N: 113
Defining eligibility criteria?: community college students
Motivation to quit?: motivated to quit
Interventions Control 1: usual care: "Students educated about and referred to student health for tobacco cessa-
tion resources and provided with campus "Quit Kits" ("Quit Kit" water bottle with small cessation
aids (e.g. sunflower seeds))"
Control 2: direct referral to quit-line: as control 1 plus "Students were directly referred to the state
quitline for follow-up counseling. Peer educator educates about state quitline services and gets
verbal consent to use quitline's direct referral web portal for quitline to contact participant in 1-2
business days about free counseling services to make a quit plan".
Intervention: brief motivational interviewing: as control 1, plus "students received brief motiva-
tional interviewing by a student peer educator about tobacco cessation and participant goals"
Provider: student peer educator
Intensity: one session
Was MI fidelity monitored?: not specified
Outcomes Definition of cessation used: point prevalence (period not defined)
Length of longest follow-up: 6 months
NCT03002883 
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Validation: saliva cotinine level
Was mental health and/or well-being measured at follow-up?: not specified
Was quality of life measured at follow-up?: not specified
Starting date September 2014
Contact information Elisa Tong, University of California, Davis
Funding source Not reported
Authors' declarations of inter-
est
Not reported
Notes Contacted author to ask about study status - author replied that the study was complete and that
they were currently writing up results. No data was supplied.
NCT03002883  (Continued)
 
 
Trial name or title Planning a change easily (PACE): a randomized controlled trial for smokers who are not ready to
quit
Methods Study design: RCT
Location: USA
Setting: nationwide quit-line
Recruitment: "Recruitment is multi-faceted, including local and regional strategies. Including tra-
ditional strategies, such as flyers, business cards, and medical referrals, and electronic strategies,
such as Facebook, Pandora Radio. A “refer-a-friend” program is also used, where participants re-
ceive an extra $20 giJ card for referring a person who is eligible and enrolls in the study."
Participants N: not specified
Defining eligibility criteria?: not specified
Motivation to quit?: not motivated to quit
Interventions Control 1: brief advice (BA):
Control 2: rate reduction (RR): participants encouraged to reduce the amount they smoke, and in-
structed on the benefits this will have to their health. 26 weeks' worth of 4 mg nicotine gum provid-
ed
Intervention 1: motivational interviewing (MI): "Basic MI principles will be used for each call with
the intention of eliciting language that indicates behavioral change (i.e. “change talk”) using open-
ended questions, affirmations, reflections, and summaries. First, each telephone call will include
an initial period of engagement. Then, motivation and confidence to change smoking behavior will
be assessed separately using scales from 1 (not at all motivated/confident) to 10 (extremely moti-
vated/confident). Next, the counsellor will focus the discussion using the “5Rs” to increase the par-
ticipants' motivation for change and eventual odds of cessation. The 5Rs will provide opportunities
to elicit information from participants. At the end of each session, a summary of the discussion will
be provided, and motivation and confidence to change smoking behavior will, again, be assessed.
Should the participant wish to quit at any point during the sessions, the interventionist may assist
in creating a participant-centred cessation plan, but no specific skills will be provided in this con-
dition (e.g. “it seems like distraction and exercise could help you quit”). At the end of each session,
the interventionist will ask the participant about their willingness to set a quit date using the elic-
Salgado Garcia 2018 
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it-provide-elicit approach, where the interventionist will elicit permission to provide information,
will provide the information (e.g. higher likelihood of quitting if setting a quit date), and will elicit
the participant's thoughts about setting a quit date."
Intervention 2: motivational interviewing and rate reduction (MI + RR): control 2 and intervention 1
combined
Provider: "The interventionists will be recruited based on educational background and past experi-
ence with counselling or delivering behavioral interventions. All interventionists will be required to
have at least master's degrees in diverse areas of study (e.g. social work, public health, counselling,
and psychology)."
Intensity: 3 sessions provided over 3 to 6 weeks (weekly or biweekly); 3 booster sessions provided
bimonthly; 30 minutes overall
Was MI fidelity monitored?: "Audio from all study sessions will be recorded, and approximately one
out of every ten sessions will be reviewed and scored for fidelity and MI adherence (when applica-
ble) by doctoral-level clinical supervisors. Interventionists will receive weekly clinical supervision
from doctoral level supervisors for feedback on scored sessions and further training when needed.
MI training by local and national experts will be provided periodically throughout the study peri-
od."
Outcomes Definition of cessation used: prolonged abstinence (length of time since the quit-date with a two-
week grace period)
Length of longest follow-up: 12 months
Validation: saliva cotinine
Was mental health and/or well-being measured at follow-up?: no
Was quality of life measured at follow-up?: no
Starting date Not specified
Contact information F.I. Salgado García: fsalgado@uthsc.edu
Funding source "National Institutes of Health [grant number 1R01CA193245-01A1]"
Authors' declarations of inter-
est
"All authors confirm that there are no known conflicts of interest".
Notes Contacted author to ask about study status - author replied that the study was still recruiting. Re-
cruitment was planned to end in summer 2019, with results expected autumn 2020.
Salgado Garcia 2018  (Continued)
BA: brief advice
CBT: Cognitive Behavioural Therapy
CO: carbon monoxide
MI: Motivational Interviewing
NicA: Nicotine Anonymous
NRT: nicotine replacement therapy
PACE: Planning a Change Easily
RR: rate reduction
RT: relaxation therapy
SHP:self-help programming
STAND: Sacramento Taking Action Against Tobacco Dependence
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Comparison 1.   MI versus no treatment
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All studies: cessation 5   Risk Ratio (M-H, Random, 95% CI) Totals not selected
2 All studies: cessation - Naik 2014 re-
moved
4 684 Risk Ratio (M-H, Random, 95% CI) 0.84 [0.63, 1.12]
 
 
Analysis 1.1.   Comparison 1 MI versus no treatment, Outcome 1 All studies: cessation.
Study or subgroup MI No treatment Risk Ratio Risk Ratio
  n/N n/N M-H, Random, 95% CI M-H, Random, 95% CI
Cook 2016 3/28 4/31 0.83[0.2,3.39]
Harris 2010 48/235 49/199 0.83[0.58,1.18]
Naik 2014 48/300 6/300 8[3.48,18.41]
Tevyaw 2009 3/27 0/28 7.25[0.39,134.07]
WoodruC 2007 19/77 18/59 0.81[0.47,1.4]
Favours no treatment 1000.01 100.1 1 Favours MI
 
 
Analysis 1.2.   Comparison 1 MI versus no treatment, Outcome 2 All studies: cessation - Naik 2014 removed.
Study or subgroup MI No treatment Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Cook 2016 3/28 4/31 4.18% 0.83[0.2,3.39]
Harris 2010 48/235 49/199 67.35% 0.83[0.58,1.18]
Tevyaw 2009 3/27 0/28 0.97% 7.25[0.39,134.07]
WoodruC 2007 19/77 18/59 27.51% 0.81[0.47,1.4]
   
Total (95% CI) 367 317 100% 0.84[0.63,1.12]
Total events: 73 (MI), 71 (No treatment)  
Heterogeneity: Tau2=0; Chi2=2.16, df=3(P=0.54); I2=0%  
Test for overall effect: Z=1.18(P=0.24)  
Favours no treatment 500.02 100.1 1 Favours MI
 
 
Comparison 2.   MI in addition to other SC treatment versus that SC treatment alone
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All studies: cessation 12 4167 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.85, 1.36]
2 Intensity subgroups: cessation 12 4167 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.85, 1.36]
2.1 Intervention higher intensity 11 3838 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.76, 1.35]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
2.2 Intensity matched 1 329 Risk Ratio (M-H, Random, 95% CI) 1.30 [1.06, 1.59]
3 Provider subgroups: cessation 12 4167 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.85, 1.36]
3.1 Physician 1 55 Risk Ratio (M-H, Random, 95% CI) 0.77 [0.23, 2.57]
3.2 Nurse 2 298 Risk Ratio (M-H, Random, 95% CI) 0.52 [0.09, 2.95]
3.3 Counsellor 8 3405 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.89, 1.32]
3.4 Lay healthcare worker 1 409 Risk Ratio (M-H, Random, 95% CI) 2.30 [1.40, 3.81]
4 Counselling modality subgroups: ces-
sation
12 4167 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.85, 1.36]
4.1 Some face-to-face 8 2818 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.87, 1.56]
4.2 No face-to-face 4 1349 Risk Ratio (M-H, Random, 95% CI) 0.86 [0.53, 1.42]
5 Fidelity subgroups: cessation 12 4167 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.85, 1.36]
5.1 Fidelity monitoring reported 5 2115 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.57, 1.41]
5.2 No fidelity monitoring reported 7 2052 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.93, 1.56]
6 Baseline motivation subgroups: cessa-
tion
12 4167 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.85, 1.36]
6.1 Motivated 3 855 Risk Ratio (M-H, Random, 95% CI) 1.30 [1.10, 1.54]
6.2 Not selected on motivation 8 2854 Risk Ratio (M-H, Random, 95% CI) 1.04 [0.69, 1.55]
6.3 Not motivated 1 458 Risk Ratio (M-H, Random, 95% CI) 0.70 [0.36, 1.37]
 
 
Analysis 2.1.   Comparison 2 MI in addition to other SC treatment
versus that SC treatment alone, Outcome 1 All studies: cessation.
Study or subgroup MI + oth-
er SC care
Other SC
care only
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Bastian 2013 29/245 35/251 10.5% 0.85[0.54,1.34]
Battaglia 2016 3/89 13/86 3.08% 0.22[0.07,0.76]
Bock 2008 24/271 15/272 7.87% 1.61[0.86,2.99]
Bock 2014 48/406 58/440 12.45% 0.9[0.63,1.28]
Cook 2016 0/33 3/33 0.63% 0.14[0.01,2.66]
Cook 2016 1/33 2/32 0.95% 0.48[0.05,5.09]
Cook 2016 6/35 7/32 4.36% 0.78[0.29,2.09]
Cook 2016 7/30 2/32 2.19% 3.73[0.84,16.57]
Cook 2016 2/30 4/37 1.88% 0.62[0.12,3.14]
Favours other care 500.02 100.1 1 Favours MI + other care
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Study or subgroup MI + oth-
er SC care
Other SC
care only
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Cook 2016 3/32 7/34 2.91% 0.46[0.13,1.61]
Cook 2016 1/32 4/33 1.14% 0.26[0.03,2.18]
Demétrio Faustino-Silva 2018 110/178 72/151 15.44% 1.3[1.06,1.59]
Lewis 1998 4/62 3/61 2.29% 1.31[0.31,5.62]
Louwagie 2014 44/205 19/204 9.75% 2.3[1.4,3.81]
Marshall 2016 4/28 5/27 3.15% 0.77[0.23,2.57]
McClure 2005 15/138 16/137 7.33% 0.93[0.48,1.81]
Tevyaw 2009 1/28 0/27 0.54% 2.9[0.12,68.15]
Vidrine 2019 97/259 41/144 13.55% 1.32[0.97,1.78]
   
Total (95% CI) 2134 2033 100% 1.07[0.85,1.36]
Total events: 399 (MI + other SC care), 306 (Other SC care only)  
Heterogeneity: Tau2=0.08; Chi2=32.36, df=17(P=0.01); I2=47.46%  
Test for overall effect: Z=0.57(P=0.57)  
Favours other care 500.02 100.1 1 Favours MI + other care
 
 
Analysis 2.2.   Comparison 2 MI in addition to other SC treatment versus
that SC treatment alone, Outcome 2 Intensity subgroups: cessation.
Study or subgroup MI + oth-
er SC care
Other
care alone
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
2.2.1 Intervention higher intensity  
Bastian 2013 29/245 35/251 10.5% 0.85[0.54,1.34]
Battaglia 2016 3/89 13/86 3.08% 0.22[0.07,0.76]
Bock 2008 24/271 15/272 7.87% 1.61[0.86,2.99]
Bock 2014 48/406 58/440 12.45% 0.9[0.63,1.28]
Cook 2016 1/33 2/32 0.95% 0.48[0.05,5.09]
Cook 2016 0/33 3/33 0.63% 0.14[0.01,2.66]
Cook 2016 2/30 4/37 1.88% 0.62[0.12,3.14]
Cook 2016 3/32 7/34 2.91% 0.46[0.13,1.61]
Cook 2016 1/32 4/33 1.14% 0.26[0.03,2.18]
Cook 2016 7/30 2/32 2.19% 3.73[0.84,16.57]
Cook 2016 6/35 7/32 4.36% 0.78[0.29,2.09]
Lewis 1998 4/62 3/61 2.29% 1.31[0.31,5.62]
Louwagie 2014 44/205 19/204 9.75% 2.3[1.4,3.81]
Marshall 2016 4/28 5/27 3.15% 0.77[0.23,2.57]
McClure 2005 15/138 16/137 7.33% 0.93[0.48,1.81]
Tevyaw 2009 1/28 0/27 0.54% 2.9[0.12,68.15]
Vidrine 2019 97/259 41/144 13.55% 1.32[0.97,1.78]
Subtotal (95% CI) 1956 1882 84.56% 1.01[0.76,1.35]
Total events: 289 (MI + other SC care), 234 (Other care alone)  
Heterogeneity: Tau2=0.12; Chi2=30.7, df=16(P=0.01); I2=47.89%  
Test for overall effect: Z=0.09(P=0.92)  
   
2.2.2 Intensity matched  
Demétrio Faustino-Silva 2018 110/178 72/151 15.44% 1.3[1.06,1.59]
Subtotal (95% CI) 178 151 15.44% 1.3[1.06,1.59]
Total events: 110 (MI + other SC care), 72 (Other care alone)  
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Study or subgroup MI + oth-
er SC care
Other
care alone
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Z=2.5(P=0.01)  
   
Total (95% CI) 2134 2033 100% 1.07[0.85,1.36]
Total events: 399 (MI + other SC care), 306 (Other care alone)  
Heterogeneity: Tau2=0.08; Chi2=32.36, df=17(P=0.01); I2=47.46%  
Test for overall effect: Z=0.57(P=0.57)  
Test for subgroup differences: Chi2=1.9, df=1 (P=0.17), I2=47.29%  
Favours other care 500.02 100.1 1 Favours MI + other care
 
 
Analysis 2.3.   Comparison 2 MI in addition to other SC treatment versus
that SC treatment alone, Outcome 3 Provider subgroups: cessation.
Study or subgroup MI + oth-
er SC care
Other SC
care alone
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
2.3.1 Physician  
Marshall 2016 4/28 5/27 3.15% 0.77[0.23,2.57]
Subtotal (95% CI) 28 27 3.15% 0.77[0.23,2.57]
Total events: 4 (MI + other SC care), 5 (Other SC care alone)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.42(P=0.67)  
   
2.3.2 Nurse  
Battaglia 2016 3/89 13/86 3.08% 0.22[0.07,0.76]
Lewis 1998 4/62 3/61 2.29% 1.31[0.31,5.62]
Subtotal (95% CI) 151 147 5.37% 0.52[0.09,2.95]
Total events: 7 (MI + other SC care), 16 (Other SC care alone)  
Heterogeneity: Tau2=1.12; Chi2=3.38, df=1(P=0.07); I2=70.4%  
Test for overall effect: Z=0.74(P=0.46)  
   
2.3.3 Counsellor  
Bastian 2013 29/245 35/251 10.5% 0.85[0.54,1.34]
Bock 2008 24/271 15/272 7.87% 1.61[0.86,2.99]
Bock 2014 48/406 58/440 12.45% 0.9[0.63,1.28]
Cook 2016 1/32 4/33 1.14% 0.26[0.03,2.18]
Cook 2016 6/35 7/32 4.36% 0.78[0.29,2.09]
Cook 2016 2/30 4/37 1.88% 0.62[0.12,3.14]
Cook 2016 3/32 7/34 2.91% 0.46[0.13,1.61]
Cook 2016 0/33 3/33 0.63% 0.14[0.01,2.66]
Cook 2016 7/30 2/32 2.19% 3.73[0.84,16.57]
Cook 2016 1/33 2/32 0.95% 0.48[0.05,5.09]
Demétrio Faustino-Silva 2018 110/178 72/151 15.44% 1.3[1.06,1.59]
McClure 2005 15/138 16/137 7.33% 0.93[0.48,1.81]
Tevyaw 2009 1/28 0/27 0.54% 2.9[0.12,68.15]
Vidrine 2019 97/259 41/144 13.55% 1.32[0.97,1.78]
Subtotal (95% CI) 1750 1655 81.73% 1.08[0.89,1.32]
Total events: 344 (MI + other SC care), 266 (Other SC care alone)  
Heterogeneity: Tau2=0.03; Chi2=17.78, df=13(P=0.17); I2=26.87%  
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Study or subgroup MI + oth-
er SC care
Other SC
care alone
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Test for overall effect: Z=0.78(P=0.43)  
   
2.3.4 Lay healthcare worker  
Louwagie 2014 44/205 19/204 9.75% 2.3[1.4,3.81]
Subtotal (95% CI) 205 204 9.75% 2.3[1.4,3.81]
Total events: 44 (MI + other SC care), 19 (Other SC care alone)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.26(P=0)  
   
Total (95% CI) 2134 2033 100% 1.07[0.85,1.36]
Total events: 399 (MI + other SC care), 306 (Other SC care alone)  
Heterogeneity: Tau2=0.08; Chi2=32.36, df=17(P=0.01); I2=47.46%  
Test for overall effect: Z=0.57(P=0.57)  
Test for subgroup differences: Chi2=8.88, df=1 (P=0.03), I2=66.21%  
Favours other care 2000.005 100.1 1 Favours MI + other care
 
 
Analysis 2.4.   Comparison 2 MI in addition to other SC treatment versus that
SC treatment alone, Outcome 4 Counselling modality subgroups: cessation.
Study or subgroup MI + oth-
er SC care
Other SC
care alone
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
2.4.1 Some face-to-face  
Bock 2008 24/271 15/272 7.87% 1.61[0.86,2.99]
Bock 2014 48/406 58/440 12.45% 0.9[0.63,1.28]
Cook 2016 3/32 7/34 2.91% 0.46[0.13,1.61]
Cook 2016 0/33 3/33 0.63% 0.14[0.01,2.66]
Cook 2016 7/30 2/32 2.19% 3.73[0.84,16.57]
Cook 2016 2/30 4/37 1.88% 0.62[0.12,3.14]
Cook 2016 1/32 4/33 1.14% 0.26[0.03,2.18]
Cook 2016 1/33 2/32 0.95% 0.48[0.05,5.09]
Cook 2016 6/35 7/32 4.36% 0.78[0.29,2.09]
Demétrio Faustino-Silva 2018 110/178 72/151 15.44% 1.3[1.06,1.59]
Lewis 1998 4/62 3/61 2.29% 1.31[0.31,5.62]
Louwagie 2014 44/205 19/204 9.75% 2.3[1.4,3.81]
Marshall 2016 4/28 5/27 3.15% 0.77[0.23,2.57]
Tevyaw 2009 1/28 0/27 0.54% 2.9[0.12,68.15]
Subtotal (95% CI) 1403 1415 65.54% 1.17[0.87,1.56]
Total events: 255 (MI + other SC care), 201 (Other SC care alone)  
Heterogeneity: Tau2=0.08; Chi2=21.63, df=13(P=0.06); I2=39.9%  
Test for overall effect: Z=1.04(P=0.3)  
   
2.4.2 No face-to-face  
Bastian 2013 29/245 35/251 10.5% 0.85[0.54,1.34]
Battaglia 2016 3/89 13/86 3.08% 0.22[0.07,0.76]
McClure 2005 15/138 16/137 7.33% 0.93[0.48,1.81]
Vidrine 2019 97/259 41/144 13.55% 1.32[0.97,1.78]
Subtotal (95% CI) 731 618 34.46% 0.86[0.53,1.42]
Total events: 144 (MI + other SC care), 105 (Other SC care alone)  
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Study or subgroup MI + oth-
er SC care
Other SC
care alone
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Heterogeneity: Tau2=0.16; Chi2=9.49, df=3(P=0.02); I2=68.39%  
Test for overall effect: Z=0.58(P=0.57)  
   
Total (95% CI) 2134 2033 100% 1.07[0.85,1.36]
Total events: 399 (MI + other SC care), 306 (Other SC care alone)  
Heterogeneity: Tau2=0.08; Chi2=32.36, df=17(P=0.01); I2=47.46%  
Test for overall effect: Z=0.57(P=0.57)  
Test for subgroup differences: Chi2=1.04, df=1 (P=0.31), I2=4.07%  
Favours other care 500.02 100.1 1 Favours MI + other care
 
 
Analysis 2.5.   Comparison 2 MI in addition to other SC treatment versus
that SC treatment alone, Outcome 5 Fidelity subgroups: cessation.
Study or subgroup MI + oth-
er SC care
Other SC
care alone
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
2.5.1 Fidelity monitoring reported  
Bastian 2013 29/245 35/251 10.5% 0.85[0.54,1.34]
Battaglia 2016 3/89 13/86 3.08% 0.22[0.07,0.76]
Bock 2008 24/271 15/272 7.87% 1.61[0.86,2.99]
Bock 2014 48/406 58/440 12.45% 0.9[0.63,1.28]
Tevyaw 2009 1/28 0/27 0.54% 2.9[0.12,68.15]
Subtotal (95% CI) 1039 1076 34.44% 0.9[0.57,1.41]
Total events: 105 (MI + other SC care), 121 (Other SC care alone)  
Heterogeneity: Tau2=0.13; Chi2=8.92, df=4(P=0.06); I2=55.15%  
Test for overall effect: Z=0.47(P=0.64)  
   
2.5.2 No fidelity monitoring reported  
Cook 2016 3/32 7/34 2.91% 0.46[0.13,1.61]
Cook 2016 0/33 3/33 0.63% 0.14[0.01,2.66]
Cook 2016 6/35 7/32 4.36% 0.78[0.29,2.09]
Cook 2016 1/32 4/33 1.14% 0.26[0.03,2.18]
Cook 2016 1/33 2/32 0.95% 0.48[0.05,5.09]
Cook 2016 2/30 4/37 1.88% 0.62[0.12,3.14]
Cook 2016 7/30 2/32 2.19% 3.73[0.84,16.57]
Demétrio Faustino-Silva 2018 110/178 72/151 15.44% 1.3[1.06,1.59]
Lewis 1998 4/62 3/61 2.29% 1.31[0.31,5.62]
Louwagie 2014 44/205 19/204 9.75% 2.3[1.4,3.81]
Marshall 2016 4/28 5/27 3.15% 0.77[0.23,2.57]
McClure 2005 15/138 16/137 7.33% 0.93[0.48,1.81]
Vidrine 2019 97/259 41/144 13.55% 1.32[0.97,1.78]
Subtotal (95% CI) 1095 957 65.56% 1.2[0.93,1.56]
Total events: 294 (MI + other SC care), 185 (Other SC care alone)  
Heterogeneity: Tau2=0.05; Chi2=18.17, df=12(P=0.11); I2=33.94%  
Test for overall effect: Z=1.38(P=0.17)  
   
Total (95% CI) 2134 2033 100% 1.07[0.85,1.36]
Total events: 399 (MI + other SC care), 306 (Other SC care alone)  
Heterogeneity: Tau2=0.08; Chi2=32.36, df=17(P=0.01); I2=47.46%  
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Study or subgroup MI + oth-
er SC care
Other SC
care alone
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Test for overall effect: Z=0.57(P=0.57)  
Test for subgroup differences: Chi2=1.2, df=1 (P=0.27), I2=16.86%  
Favours other care 500.02 100.1 1 Favours MI + other care
 
 
Analysis 2.6.   Comparison 2 MI in addition to other SC treatment versus that
SC treatment alone, Outcome 6 Baseline motivation subgroups: cessation.
Study or subgroup MI + oth-
er SC care
Other SC care Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
2.6.1 Motivated  
Demétrio Faustino-Silva 2018 110/178 72/151 15.44% 1.3[1.06,1.59]
Lewis 1998 4/62 3/61 2.29% 1.31[0.31,5.62]
Vidrine 2019 97/259 41/144 13.55% 1.32[0.97,1.78]
Subtotal (95% CI) 499 356 31.28% 1.3[1.1,1.54]
Total events: 211 (MI + other SC care), 116 (Other SC care)  
Heterogeneity: Tau2=0; Chi2=0.01, df=2(P=1); I2=0%  
Test for overall effect: Z=3.09(P=0)  
   
2.6.2 Not selected on motivation  
Bastian 2013 29/245 35/251 10.5% 0.85[0.54,1.34]
Battaglia 2016 3/89 13/86 3.08% 0.22[0.07,0.76]
Bock 2008 24/271 15/272 7.87% 1.61[0.86,2.99]
Bock 2014 48/406 58/440 12.45% 0.9[0.63,1.28]
Louwagie 2014 44/205 19/204 9.75% 2.3[1.4,3.81]
Marshall 2016 4/28 5/27 3.15% 0.77[0.23,2.57]
McClure 2005 15/138 16/137 7.33% 0.93[0.48,1.81]
Tevyaw 2009 1/28 0/27 0.54% 2.9[0.12,68.15]
Subtotal (95% CI) 1410 1444 54.67% 1.04[0.69,1.55]
Total events: 168 (MI + other SC care), 161 (Other SC care)  
Heterogeneity: Tau2=0.18; Chi2=19.7, df=7(P=0.01); I2=64.47%  
Test for overall effect: Z=0.18(P=0.86)  
   
2.6.3 Not motivated  
Cook 2016 1/32 4/33 1.14% 0.26[0.03,2.18]
Cook 2016 6/35 7/32 4.36% 0.78[0.29,2.09]
Cook 2016 0/33 3/33 0.63% 0.14[0.01,2.66]
Cook 2016 2/30 4/37 1.88% 0.62[0.12,3.14]
Cook 2016 3/32 7/34 2.91% 0.46[0.13,1.61]
Cook 2016 7/30 2/32 2.19% 3.73[0.84,16.57]
Cook 2016 1/33 2/32 0.95% 0.48[0.05,5.09]
Subtotal (95% CI) 225 233 14.05% 0.7[0.36,1.37]
Total events: 20 (MI + other SC care), 29 (Other SC care)  
Heterogeneity: Tau2=0.16; Chi2=7.42, df=6(P=0.28); I2=19.19%  
Test for overall effect: Z=1.04(P=0.3)  
   
Total (95% CI) 2134 2033 100% 1.07[0.85,1.36]
Total events: 399 (MI + other SC care), 306 (Other SC care)  
Heterogeneity: Tau2=0.08; Chi2=32.36, df=17(P=0.01); I2=47.46%  
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Study or subgroup MI + oth-
er SC care
Other SC care Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Test for overall effect: Z=0.57(P=0.57)  
Test for subgroup differences: Chi2=3.82, df=1 (P=0.15), I2=47.59%  
Favours other care 500.02 100.1 1 Favours MI + other care
 
 
Comparison 3.   MI versus other SC intervention
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All studies: cessation 19 5192 Risk Ratio (M-H, Random, 95% CI) 1.24 [0.91, 1.69]
2 Intensity subgroups: cessation 19 5192 Risk Ratio (M-H, Random, 95% CI) 1.25 [0.93, 1.68]
2.1 Intervention higher intensity 14 3641 Risk Ratio (M-H, Random, 95% CI) 1.21 [0.95, 1.55]
2.2 Intensity matched 6 1402 Risk Ratio (M-H, Random, 95% CI) 1.14 [0.49, 2.65]
2.3 Comparator higher intensity 1 149 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.19, 4.42]
3 Age subgroups: cessation 19 5192 Risk Ratio (M-H, Random, 95% CI) 1.24 [0.91, 1.69]
3.1 Adults 14 4453 Risk Ratio (M-H, Random, 95% CI) 1.21 [0.84, 1.74]
3.2 Adolescents 5 739 Risk Ratio (M-H, Random, 95% CI) 1.36 [0.77, 2.41]
4 Provider subgroups: cessation 18 5111 Risk Ratio (M-H, Random, 95% CI) 1.24 [0.90, 1.70]
4.1 Physician 3 946 Risk Ratio (M-H, Random, 95% CI) 2.24 [0.92, 5.45]
4.2 Nurse 1 218 Risk Ratio (M-H, Random, 95% CI) 3.0 [0.12, 72.84]
4.3 Counsellor/psychologist 14 3947 Risk Ratio (M-H, Random, 95% CI) 1.11 [0.79, 1.55]
5 Fidelity monitoring subgroups: cessa-
tion
19 5192 Risk Ratio (M-H, Random, 95% CI) 1.24 [0.91, 1.69]
5.1 Fidelity monitoring reported 12 3382 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.71, 1.37]
5.2 No fidelity monitoring reported 7 1810 Risk Ratio (M-H, Random, 95% CI) 1.83 [1.28, 2.60]
6 Baseline motivation subgroups: cessa-
tion
19 5192 Risk Ratio (M-H, Random, 95% CI) 1.24 [0.91, 1.69]
6.1 Motivated 1 755 Risk Ratio (M-H, Random, 95% CI) 0.51 [0.34, 0.76]
6.2 Not selected on motivation 15 3703 Risk Ratio (M-H, Random, 95% CI) 1.44 [1.09, 1.90]
6.3 Not motivated 3 734 Risk Ratio (M-H, Random, 95% CI) 0.81 [0.36, 1.85]
 
Motivational interviewing for smoking cessation (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
107
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
 
Analysis 3.1.   Comparison 3 MI versus other SC intervention, Outcome 1 All studies: cessation.
Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Ahluwalia 2006 32/378 63/377 10.29% 0.51[0.34,0.76]
Audrain-McGovern 2011 10/177 10/178 6.38% 1.01[0.43,2.36]
Butler 1999 8/270 4/266 4.36% 1.97[0.6,6.47]
Catley 2016 3/102 8/153 3.86% 0.56[0.15,2.07]
Colby 2005 4/43 1/42 1.76% 3.91[0.46,33.53]
Colby 2012 3/79 2/83 2.45% 1.58[0.27,9.18]
Cook 2016 2/14 18/137 3.66% 1.09[0.28,4.21]
Cook 2016 1/14 11/96 2.04% 0.62[0.09,4.46]
Davis 2011 1/109 0/109 0.87% 3[0.12,72.84]
De Azevedo 2010 48/141 45/132 10.9% 1[0.72,1.39]
Helstrom 2007 4/45 2/36 2.75% 1.6[0.31,8.25]
Kelly 2006 7/30 4/26 4.75% 1.52[0.5,4.6]
Lloyd-Richardson 2009 21/232 21/212 8.68% 0.91[0.51,1.62]
NCT02645838 7/105 6/105 5.05% 1.17[0.41,3.36]
Okuyemi 2013 20/216 12/214 7.66% 1.65[0.83,3.29]
Rohsenow 2014 0/80 3/85 1% 0.15[0.01,2.89]
Rohsenow 2015 6/98 2/86 2.93% 2.63[0.55,12.7]
Soria 2006 21/114 3/86 4.42% 5.28[1.63,17.13]
Stein 2006 10/191 9/192 6.19% 1.12[0.46,2.69]
Wu 2009 40/67 19/72 10% 2.26[1.47,3.49]
   
Total (95% CI) 2505 2687 100% 1.24[0.91,1.69]
Total events: 248 (MI), 243 (Other intervention)  
Heterogeneity: Tau2=0.2; Chi2=41.53, df=19(P=0); I2=54.25%  
Test for overall effect: Z=1.39(P=0.16)  
Favours other int 500.02 100.1 1 Favours MI
 
 
Analysis 3.2.   Comparison 3 MI versus other SC intervention, Outcome 2 Intensity subgroups: cessation.
Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
3.2.1 Intervention higher intensity  
Audrain-McGovern 2011 10/177 10/178 6.24% 1.01[0.43,2.36]
Butler 1999 8/270 4/266 4.18% 1.97[0.6,6.47]
Catley 2016 1/51 0/51 0.81% 3[0.13,71.96]
Colby 2005 4/43 1/42 1.65% 3.91[0.46,33.53]
Colby 2012 3/79 2/83 2.31% 1.58[0.27,9.18]
Cook 2016 1/7 7/32 1.98% 0.65[0.09,4.5]
Cook 2016 1/7 7/66 1.96% 1.35[0.19,9.42]
De Azevedo 2010 48/141 45/132 11.16% 1[0.72,1.39]
Lloyd-Richardson 2009 21/232 21/212 8.69% 0.91[0.51,1.62]
NCT02645838 7/105 6/105 4.88% 1.17[0.41,3.36]
Okuyemi 2013 20/216 12/214 7.59% 1.65[0.83,3.29]
Rohsenow 2014 0/80 3/85 0.93% 0.15[0.01,2.89]
Rohsenow 2015 6/98 2/86 2.77% 2.63[0.55,12.7]
Favours other int 500.02 100.1 1 Favours MI
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Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Soria 2006 21/114 3/86 4.24% 5.28[1.63,17.13]
Stein 2006 10/191 9/192 6.04% 1.12[0.46,2.69]
Subtotal (95% CI) 1811 1830 65.42% 1.21[0.95,1.55]
Total events: 161 (MI), 132 (Other intervention)  
Heterogeneity: Tau2=0.01; Chi2=14.92, df=14(P=0.38); I2=6.17%  
Test for overall effect: Z=1.56(P=0.12)  
   
3.2.2 Intensity matched  
Ahluwalia 2006 32/378 63/377 10.47% 0.51[0.34,0.76]
Catley 2016 2/51 8/102 2.95% 0.5[0.11,2.27]
Davis 2011 1/109 0/109 0.8% 3[0.12,72.84]
Helstrom 2007 4/45 2/36 2.59% 1.6[0.31,8.25]
Kelly 2006 7/30 4/26 4.58% 1.52[0.5,4.6]
Wu 2009 40/67 19/72 10.14% 2.26[1.47,3.49]
Subtotal (95% CI) 680 722 31.53% 1.14[0.49,2.65]
Total events: 86 (MI), 96 (Other intervention)  
Heterogeneity: Tau2=0.71; Chi2=27.29, df=5(P<0.0001); I2=81.68%  
Test for overall effect: Z=0.3(P=0.76)  
   
3.2.3 Comparator higher intensity  
Cook 2016 1/7 11/71 2.05% 0.92[0.14,6.13]
Cook 2016 0/7 4/64 1.01% 0.9[0.05,15.27]
Subtotal (95% CI) 14 135 3.05% 0.92[0.19,4.42]
Total events: 1 (MI), 15 (Other intervention)  
Heterogeneity: Tau2=0; Chi2=0, df=1(P=0.99); I2=0%  
Test for overall effect: Z=0.11(P=0.91)  
   
Total (95% CI) 2505 2687 100% 1.25[0.93,1.68]
Total events: 248 (MI), 243 (Other intervention)  
Heterogeneity: Tau2=0.18; Chi2=41.98, df=22(P=0.01); I2=47.59%  
Test for overall effect: Z=1.46(P=0.14)  
Test for subgroup differences: Chi2=0.14, df=1 (P=0.93), I2=0%  
Favours other int 500.02 100.1 1 Favours MI
 
 
Analysis 3.3.   Comparison 3 MI versus other SC intervention, Outcome 3 Age subgroups: cessation.
Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
3.3.1 Adults  
Ahluwalia 2006 32/378 63/377 10.29% 0.51[0.34,0.76]
Butler 1999 8/270 4/266 4.36% 1.97[0.6,6.47]
Catley 2016 3/102 8/153 3.86% 0.56[0.15,2.07]
Cook 2016 2/14 18/137 3.66% 1.09[0.28,4.21]
Cook 2016 1/14 11/96 2.04% 0.62[0.09,4.46]
Davis 2011 1/109 0/109 0.87% 3[0.12,72.84]
De Azevedo 2010 48/141 45/132 10.9% 1[0.72,1.39]
Lloyd-Richardson 2009 21/232 21/212 8.68% 0.91[0.51,1.62]
NCT02645838 7/105 6/105 5.05% 1.17[0.41,3.36]
Favours other int 500.02 100.1 1 Favours MI
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Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Okuyemi 2013 20/216 12/214 7.66% 1.65[0.83,3.29]
Rohsenow 2014 0/80 3/85 1% 0.15[0.01,2.89]
Rohsenow 2015 6/98 2/86 2.93% 2.63[0.55,12.7]
Soria 2006 21/114 3/86 4.42% 5.28[1.63,17.13]
Stein 2006 10/191 9/192 6.19% 1.12[0.46,2.69]
Wu 2009 40/67 19/72 10% 2.26[1.47,3.49]
Subtotal (95% CI) 2131 2322 81.9% 1.21[0.84,1.74]
Total events: 220 (MI), 224 (Other intervention)  
Heterogeneity: Tau2=0.25; Chi2=39.48, df=14(P=0); I2=64.54%  
Test for overall effect: Z=1.01(P=0.31)  
   
3.3.2 Adolescents  
Audrain-McGovern 2011 10/177 10/178 6.38% 1.01[0.43,2.36]
Colby 2005 4/43 1/42 1.76% 3.91[0.46,33.53]
Colby 2012 3/79 2/83 2.45% 1.58[0.27,9.18]
Helstrom 2007 4/45 2/36 2.75% 1.6[0.31,8.25]
Kelly 2006 7/30 4/26 4.75% 1.52[0.5,4.6]
Subtotal (95% CI) 374 365 18.1% 1.36[0.77,2.41]
Total events: 28 (MI), 19 (Other intervention)  
Heterogeneity: Tau2=0; Chi2=1.52, df=4(P=0.82); I2=0%  
Test for overall effect: Z=1.07(P=0.28)  
   
Total (95% CI) 2505 2687 100% 1.24[0.91,1.69]
Total events: 248 (MI), 243 (Other intervention)  
Heterogeneity: Tau2=0.2; Chi2=41.53, df=19(P=0); I2=54.25%  
Test for overall effect: Z=1.39(P=0.16)  
Test for subgroup differences: Chi2=0.12, df=1 (P=0.73), I2=0%  
Favours other int 500.02 100.1 1 Favours MI
 
 
Analysis 3.4.   Comparison 3 MI versus other SC intervention, Outcome 4 Provider subgroups: cessation.
Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
3.4.1 Physician  
Butler 1999 8/270 4/266 4.53% 1.97[0.6,6.47]
NCT02645838 7/105 6/105 5.23% 1.17[0.41,3.36]
Soria 2006 21/114 3/86 4.59% 5.28[1.63,17.13]
Subtotal (95% CI) 489 457 14.35% 2.24[0.92,5.45]
Total events: 36 (MI), 13 (Other intervention)  
Heterogeneity: Tau2=0.28; Chi2=3.66, df=2(P=0.16); I2=45.4%  
Test for overall effect: Z=1.78(P=0.08)  
   
3.4.2 Nurse  
Davis 2011 1/109 0/109 0.91% 3[0.12,72.84]
Subtotal (95% CI) 109 109 0.91% 3[0.12,72.84]
Total events: 1 (MI), 0 (Other intervention)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.5)  
Favours other int 1000.01 100.1 1 Favours MI
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Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
   
3.4.3 Counsellor/psychologist  
Ahluwalia 2006 32/378 63/377 10.44% 0.51[0.34,0.76]
Audrain-McGovern 2011 10/177 10/178 6.57% 1.01[0.43,2.36]
Catley 2016 3/102 8/153 4.01% 0.56[0.15,2.07]
Colby 2005 4/43 1/42 1.85% 3.91[0.46,33.53]
Colby 2012 3/79 2/83 2.57% 1.58[0.27,9.18]
Cook 2016 1/14 11/96 2.14% 0.62[0.09,4.46]
Cook 2016 2/14 18/137 3.81% 1.09[0.28,4.21]
De Azevedo 2010 48/141 45/132 11.03% 1[0.72,1.39]
Kelly 2006 7/30 4/26 4.93% 1.52[0.5,4.6]
Lloyd-Richardson 2009 21/232 21/212 8.86% 0.91[0.51,1.62]
Okuyemi 2013 20/216 12/214 7.86% 1.65[0.83,3.29]
Rohsenow 2014 0/80 3/85 1.06% 0.15[0.01,2.89]
Rohsenow 2015 6/98 2/86 3.06% 2.63[0.55,12.7]
Stein 2006 10/191 9/192 6.38% 1.12[0.46,2.69]
Wu 2009 40/67 19/72 10.15% 2.26[1.47,3.49]
Subtotal (95% CI) 1862 2085 84.73% 1.11[0.79,1.55]
Total events: 207 (MI), 228 (Other intervention)  
Heterogeneity: Tau2=0.19; Chi2=33.13, df=14(P=0); I2=57.74%  
Test for overall effect: Z=0.6(P=0.55)  
   
Total (95% CI) 2460 2651 100% 1.24[0.9,1.7]
Total events: 244 (MI), 241 (Other intervention)  
Heterogeneity: Tau2=0.21; Chi2=41.34, df=18(P=0); I2=56.45%  
Test for overall effect: Z=1.32(P=0.19)  
Test for subgroup differences: Chi2=2.42, df=1 (P=0.3), I2=17.21%  
Favours other int 1000.01 100.1 1 Favours MI
 
 
Analysis 3.5.   Comparison 3 MI versus other SC intervention, Outcome 5 Fidelity monitoring subgroups: cessation.
Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
3.5.1 Fidelity monitoring reported  
Ahluwalia 2006 32/378 63/377 10.29% 0.51[0.34,0.76]
Audrain-McGovern 2011 10/177 10/178 6.38% 1.01[0.43,2.36]
Catley 2016 3/102 8/153 3.86% 0.56[0.15,2.07]
Colby 2005 4/43 1/42 1.76% 3.91[0.46,33.53]
Colby 2012 3/79 2/83 2.45% 1.58[0.27,9.18]
Davis 2011 1/109 0/109 0.87% 3[0.12,72.84]
De Azevedo 2010 48/141 45/132 10.9% 1[0.72,1.39]
Kelly 2006 7/30 4/26 4.75% 1.52[0.5,4.6]
Lloyd-Richardson 2009 21/232 21/212 8.68% 0.91[0.51,1.62]
Okuyemi 2013 20/216 12/214 7.66% 1.65[0.83,3.29]
Rohsenow 2014 0/80 3/85 1% 0.15[0.01,2.89]
Rohsenow 2015 6/98 2/86 2.93% 2.63[0.55,12.7]
Subtotal (95% CI) 1685 1697 61.53% 0.98[0.71,1.37]
Total events: 155 (MI), 171 (Other intervention)  
Favours other int 500.02 100.1 1 Favours MI
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Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Heterogeneity: Tau2=0.11; Chi2=18.59, df=11(P=0.07); I2=40.82%  
Test for overall effect: Z=0.09(P=0.93)  
   
3.5.2 No fidelity monitoring reported  
Butler 1999 8/270 4/266 4.36% 1.97[0.6,6.47]
Cook 2016 1/14 11/96 2.04% 0.62[0.09,4.46]
Cook 2016 2/14 18/137 3.66% 1.09[0.28,4.21]
Helstrom 2007 4/45 2/36 2.75% 1.6[0.31,8.25]
NCT02645838 7/105 6/105 5.05% 1.17[0.41,3.36]
Soria 2006 21/114 3/86 4.42% 5.28[1.63,17.13]
Stein 2006 10/191 9/192 6.19% 1.12[0.46,2.69]
Wu 2009 40/67 19/72 10% 2.26[1.47,3.49]
Subtotal (95% CI) 820 990 38.47% 1.83[1.28,2.6]
Total events: 93 (MI), 72 (Other intervention)  
Heterogeneity: Tau2=0.03; Chi2=7.68, df=7(P=0.36); I2=8.84%  
Test for overall effect: Z=3.32(P=0)  
   
Total (95% CI) 2505 2687 100% 1.24[0.91,1.69]
Total events: 248 (MI), 243 (Other intervention)  
Heterogeneity: Tau2=0.2; Chi2=41.53, df=19(P=0); I2=54.25%  
Test for overall effect: Z=1.39(P=0.16)  
Test for subgroup differences: Chi2=6.23, df=1 (P=0.01), I2=83.96%  
Favours other int 500.02 100.1 1 Favours MI
 
 
Analysis 3.6.   Comparison 3 MI versus other SC intervention, Outcome 6 Baseline motivation subgroups: cessation.
Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
3.6.1 Motivated  
Ahluwalia 2006 32/378 63/377 10.29% 0.51[0.34,0.76]
Subtotal (95% CI) 378 377 10.29% 0.51[0.34,0.76]
Total events: 32 (MI), 63 (Other intervention)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.33(P=0)  
   
3.6.2 Not selected on motivation  
Audrain-McGovern 2011 10/177 10/178 6.38% 1.01[0.43,2.36]
Butler 1999 8/270 4/266 4.36% 1.97[0.6,6.47]
Colby 2005 4/43 1/42 1.76% 3.91[0.46,33.53]
Colby 2012 3/79 2/83 2.45% 1.58[0.27,9.18]
De Azevedo 2010 48/141 45/132 10.9% 1[0.72,1.39]
Helstrom 2007 4/45 2/36 2.75% 1.6[0.31,8.25]
Kelly 2006 7/30 4/26 4.75% 1.52[0.5,4.6]
Lloyd-Richardson 2009 21/232 21/212 8.68% 0.91[0.51,1.62]
NCT02645838 7/105 6/105 5.05% 1.17[0.41,3.36]
Okuyemi 2013 20/216 12/214 7.66% 1.65[0.83,3.29]
Rohsenow 2014 0/80 3/85 1% 0.15[0.01,2.89]
Rohsenow 2015 6/98 2/86 2.93% 2.63[0.55,12.7]
Favours other int 500.02 100.1 1 Favours MI
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Study or subgroup MI Other in-
tervention
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Soria 2006 21/114 3/86 4.42% 5.28[1.63,17.13]
Stein 2006 10/191 9/192 6.19% 1.12[0.46,2.69]
Wu 2009 40/67 19/72 10% 2.26[1.47,3.49]
Subtotal (95% CI) 1888 1815 79.29% 1.44[1.09,1.9]
Total events: 209 (MI), 143 (Other intervention)  
Heterogeneity: Tau2=0.08; Chi2=20.95, df=14(P=0.1); I2=33.17%  
Test for overall effect: Z=2.55(P=0.01)  
   
3.6.3 Not motivated  
Catley 2016 3/102 8/153 3.86% 0.56[0.15,2.07]
Cook 2016 2/14 18/137 3.66% 1.09[0.28,4.21]
Cook 2016 1/14 11/96 2.04% 0.62[0.09,4.46]
Davis 2011 1/109 0/109 0.87% 3[0.12,72.84]
Subtotal (95% CI) 239 495 10.42% 0.81[0.36,1.85]
Total events: 7 (MI), 37 (Other intervention)  
Heterogeneity: Tau2=0; Chi2=1.2, df=3(P=0.75); I2=0%  
Test for overall effect: Z=0.49(P=0.62)  
   
Total (95% CI) 2505 2687 100% 1.24[0.91,1.69]
Total events: 248 (MI), 243 (Other intervention)  
Heterogeneity: Tau2=0.2; Chi2=41.53, df=19(P=0); I2=54.25%  
Test for overall effect: Z=1.39(P=0.16)  
Test for subgroup differences: Chi2=17.82, df=1 (P=0), I2=88.77%  
Favours other int 500.02 100.1 1 Favours MI
 
 
Comparison 4.   Intensity of MI
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All studies: cessation 5 5620 Risk Ratio (M-H, Random, 95%
CI)
1.23 [1.11, 1.37]
2 Counsellor modality subgroups: cessation 5 5620 Risk Ratio (M-H, Random, 95%
CI)
1.23 [1.11, 1.37]
2.1 Some face-to-face 1 80 Risk Ratio (M-H, Random, 95%
CI)
0.0 [0.0, 0.0]
2.2 No face-to-face 4 5540 Risk Ratio (M-H, Random, 95%
CI)
1.23 [1.11, 1.37]
3 Fidelity monitoring subgroups: cessation 5 5620 Risk Ratio (M-H, Random, 95%
CI)
1.23 [1.11, 1.37]
3.1 Fidelity monitoring reported 4 5361 Risk Ratio (M-H, Random, 95%
CI)
1.23 [1.09, 1.37]
3.2 No fidelity monitoring reported 1 259 Risk Ratio (M-H, Random, 95%
CI)
1.28 [0.94, 1.76]
Motivational interviewing for smoking cessation (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
113
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
4 Baseline motivation subgroups: cessation 5 5620 Risk Ratio (M-H, Random, 95%
CI)
1.23 [1.11, 1.37]
4.1 Motivated 2 3440 Risk Ratio (M-H, Random, 95%
CI)
1.25 [1.08, 1.44]
4.2 Not selected on motivation 3 2180 Risk Ratio (M-H, Random, 95%
CI)
1.21 [1.03, 1.43]
 
 
Analysis 4.1.   Comparison 4 Intensity of MI, Outcome 1 All studies: cessation.
Study or subgroup Higher in-
tensity
Lower intensity Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Ellerbeck 2009 36/244 35/238 6.31% 1[0.65,1.54]
Hollis 2007 256/1441 250/1740 45.65% 1.24[1.05,1.45]
Rohsenow 2014 0/40 0/40   Not estimable
Sherman 2016 207/804 167/814 36.3% 1.25[1.05,1.5]
Vidrine 2019 51/120 46/139 11.74% 1.28[0.94,1.76]
   
Total (95% CI) 2649 2971 100% 1.23[1.11,1.37]
Total events: 550 (Higher intensity), 498 (Lower intensity)  
Heterogeneity: Tau2=0; Chi2=0.99, df=3(P=0.8); I2=0%  
Test for overall effect: Z=3.8(P=0)  
Favours lower intensity 50.2 20.5 1 Favours higher intensity
 
 
Analysis 4.2.   Comparison 4 Intensity of MI, Outcome 2 Counsellor modality subgroups: cessation.
Study or subgroup Higher in-
tensity
Lower intensity Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
4.2.1 Some face-to-face  
Rohsenow 2014 0/40 0/40   Not estimable
Subtotal (95% CI) 40 40 Not estimable
Total events: 0 (Higher intensity), 0 (Lower intensity)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
4.2.2 No face-to-face  
Ellerbeck 2009 36/244 35/238 6.31% 1[0.65,1.54]
Hollis 2007 256/1441 250/1740 45.65% 1.24[1.05,1.45]
Sherman 2016 207/804 167/814 36.3% 1.25[1.05,1.5]
Vidrine 2019 51/120 46/139 11.74% 1.28[0.94,1.76]
Subtotal (95% CI) 2609 2931 100% 1.23[1.11,1.37]
Total events: 550 (Higher intensity), 498 (Lower intensity)  
Heterogeneity: Tau2=0; Chi2=0.99, df=3(P=0.8); I2=0%  
Favours lower intensity 50.2 20.5 1 Favours higher intensity
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Study or subgroup Higher in-
tensity
Lower intensity Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Test for overall effect: Z=3.8(P=0)  
   
Total (95% CI) 2649 2971 100% 1.23[1.11,1.37]
Total events: 550 (Higher intensity), 498 (Lower intensity)  
Heterogeneity: Tau2=0; Chi2=0.99, df=3(P=0.8); I2=0%  
Test for overall effect: Z=3.8(P=0)  
Test for subgroup differences: Not applicable  
Favours lower intensity 50.2 20.5 1 Favours higher intensity
 
 
Analysis 4.3.   Comparison 4 Intensity of MI, Outcome 3 Fidelity monitoring subgroups: cessation.
Study or subgroup Higher in-
tensity
Lower intensity Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
4.3.1 Fidelity monitoring reported  
Ellerbeck 2009 36/244 35/238 6.31% 1[0.65,1.54]
Hollis 2007 256/1441 250/1740 45.65% 1.24[1.05,1.45]
Rohsenow 2014 0/40 0/40   Not estimable
Sherman 2016 207/804 167/814 36.3% 1.25[1.05,1.5]
Subtotal (95% CI) 2529 2832 88.26% 1.23[1.09,1.37]
Total events: 499 (Higher intensity), 452 (Lower intensity)  
Heterogeneity: Tau2=0; Chi2=0.91, df=2(P=0.63); I2=0%  
Test for overall effect: Z=3.47(P=0)  
   
4.3.2 No fidelity monitoring reported  
Vidrine 2019 51/120 46/139 11.74% 1.28[0.94,1.76]
Subtotal (95% CI) 120 139 11.74% 1.28[0.94,1.76]
Total events: 51 (Higher intensity), 46 (Lower intensity)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.56(P=0.12)  
   
Total (95% CI) 2649 2971 100% 1.23[1.11,1.37]
Total events: 550 (Higher intensity), 498 (Lower intensity)  
Heterogeneity: Tau2=0; Chi2=0.99, df=3(P=0.8); I2=0%  
Test for overall effect: Z=3.8(P=0)  
Test for subgroup differences: Chi2=0.07, df=1 (P=0.78), I2=0%  
Favours lower intensity 50.2 20.5 1 Favours higher intensity
 
 
Analysis 4.4.   Comparison 4 Intensity of MI, Outcome 4 Baseline motivation subgroups: cessation.
Study or subgroup Higher in-
tensity
Lower intensity Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
4.4.1 Motivated  
Hollis 2007 256/1441 250/1740 45.65% 1.24[1.05,1.45]
Vidrine 2019 51/120 46/139 11.74% 1.28[0.94,1.76]
Favours lower intensity 50.2 20.5 1 Favours higher intensity
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Study or subgroup Higher in-
tensity
Lower intensity Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Subtotal (95% CI) 1561 1879 57.39% 1.25[1.08,1.44]
Total events: 307 (Higher intensity), 296 (Lower intensity)  
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.83); I2=0%  
Test for overall effect: Z=3.03(P=0)  
   
4.4.2 Not selected on motivation  
Ellerbeck 2009 36/244 35/238 6.31% 1[0.65,1.54]
Rohsenow 2014 0/40 0/40   Not estimable
Sherman 2016 207/804 167/814 36.3% 1.25[1.05,1.5]
Subtotal (95% CI) 1088 1092 42.61% 1.21[1.03,1.43]
Total events: 243 (Higher intensity), 202 (Lower intensity)  
Heterogeneity: Tau2=0; Chi2=0.89, df=1(P=0.35); I2=0%  
Test for overall effect: Z=2.3(P=0.02)  
   
Total (95% CI) 2649 2971 100% 1.23[1.11,1.37]
Total events: 550 (Higher intensity), 498 (Lower intensity)  
Heterogeneity: Tau2=0; Chi2=0.99, df=3(P=0.8); I2=0%  
Test for overall effect: Z=3.8(P=0)  
Test for subgroup differences: Chi2=0.05, df=1 (P=0.81), I2=0%  
Favours lower intensity 50.2 20.5 1 Favours higher intensity
 
 
A D D I T I O N A L   T A B L E S
 
Study ID Details of monitoring Monitoring results Fidelity
achieved?
(defined by
individual
study para-
meters)
Ahluwalia
2006
Weekly supervision; subset of sessions rat-
ed using MISC
Not reported n/a
Audrain-Mc-
Govern 2011
Weekly supervision, subset of sessions rat-
ed using MITI code
Benchmarks for MI competency (>= 6) ap-
proached/achieved for 2 ratings of empathy (mean:
5.2; SD: 0.87) & spirit (mean: 5.9; SD: 0.81) using 7-
point Likert scale. Behavioural counts met bench-
marks for proficiency, including ratio of reflections to
questions (1.8), percentage of open questions (61%),
and MI adherence (96%). 28% of complex reflections
approached benchmark for beginning proficiency
(40%).
No, in some
cases marker
did not quite
meet the
benchmarks
set; however
were close
Bastian 2013 Each counsellors first 3 sessions monitored
& feedback provided; weekly supervision;
random sessions rated using MITI code
Not reported n/a
Battaglia
2016
Random calls observed; nurse participated
in ongoing MI training
Not reported n/a
Table 1.   Details of MI fidelity monitoring (studies that reported monitoring only) 
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Bock 2008 Subset of sessions audited using a deci-
sional balance review tool and interven-
tion component checklists
Not reported n/a
Bock 2014 Subset of sessions reviewed; weekly super-
vision
Not reported n/a
Catley 2016 Training continued until counsellors met
fidelity criteria for 3 consecutive sessions;
subset of sessions rated using MITI code
Mean (SD) global ratings (1–5): Empathy MI = 4.5 (0.6)
95% above criterion, HE = 2.3 (1.2) 24% above criteri-
on, MD = 2.3 (95% CI = 1.8, 2.8). Direction MI = 4.9 (0.4)
97% above criterion, HE = 4.7 (0.8) 95% above criteri-
on, MD = 0.3 (–0.2, 0.8), P = 0.17. Collaboration MI = 4.2
(0.9) 79% above criterion, HE = 2.1 (1.2) 14% above cri-
terion, MD = 2.1 (1.6, 2.5). Evocation MI = 4.4 (0.7) 92%
above criterion, HE = 2.3 (1.1) 19% above criterion, MD
= 2.2 (1.8, 2.7). Autonomy support MI = 4.3 (0.8) 87%
above criterion, HE 2.8 (1.2) 27% above criterion, MD =
1.5 (1.1, 2.0). Giving information (counts): MI = 3.9 (4.8)
n/a % above criterion, HE = 12.8 (9.5) n/a % above cri-
terion, MD = 1.2 (95% CI 0.7, 1.7). Reflections: ques-
tions (ratio of counts): MI = 3.1 (2.4) 92% above crite-
rion, HE = 0.2 (0.3) 5% above criterion, MD = 1.7 (95%
CI 1.2, 2.1). Open-ended questions (%): MI = 66.0 (27.6)
76% above criterion, HE = 10.5 (11.0) 3% above criteri-
on, MD = 2.6 (95% CI 2.2, 3.1). Complex reflections (%)
MI = 53.9 (16.3) 82% above criterion, HE = 19.6 (27.6)
24% above criterion, MD = 1.5 (95% 1.1, 2.0). MI ad-
herent (%) MI = 79.4 (37.9) 71% above criterion, HE =
30.3 (42.6) 22% above criterion, MD = 1.2 (95% CI 0.8,
1.7). MI adherent behaviour counts MI = 2.3 (1.7) n/a
% above criterion, HE = 0.8 (1.3) n/a % above criteri-
on, MD = 1.0 (95% 0.5, 1.5). MI non-adherent behav-
iour counts MI = 0.2 (0.7) n/a % above criterion, HE =
1.5 (3.0) n/a % above criterion, MD = 0.6 (95% CI 0.1,
1.1)
Yes
Colby 2005 Weekly group supervision; each session
rated on scales from 1 (strongly disagree)
to 4 (strongly agree) on rapport, counsellor
empathy & self-efficacy enhancement; de-
livery of 15 essential elements of the pro-
tocol were also rated as 0 (topic not intro-
duced), 1 (not at all useful), 2 (somewhat
useful), or 3 (very useful)
Participant ratings high for counsellor rapport (M =
3.8, SD = 0.6), empathy (M = 3.5, SD = 0.8), and self-effi-
cacy enhancement (M = 3.7, SD = 0.7). Participants re-
called 94% of essential elements; interventionists re-
ported discussing 98% of the elements. Utility judged
high by participants (M = 2.4, SD = 0.5) and interven-
tionists (M = 2.4, SD = 0.3)
Yes
Colby 2012 Weekly supervision; interventionists & ado-
lescent participants rated sessions
Interventionists & adolescents indicated that near-
ly all 16 MI session components were delivered (M =
15.6, SD = 0.80 and M = 15.4, SD = 1.39 respectively).
Interventionists indicated that they provided 10.7 of
12 (SD = 1.78) parent MI components.
Yes
Davis 2011 Sessions reviewed for protocol adherence
and discussed at weekly meetings
Two cases did not meet treatment standard. Cases
not reaching criterion were removed from the analy-
ses.
Yes
De Azevedo
2010
Fortnightly supervision n/a n/a
Table 1.   Details of MI fidelity monitoring (studies that reported monitoring only)  (Continued)
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Ellerbeck
2009
Each session rated on key concepts of MI
and specific content of MI protocol; coun-
sellors rated themselves and were rated
during supervision using MI markers.
Not reported n/a
Harris 2010 Counsellors had to demonstrate proficien-
cy in MI; weekly supervision; supervisors
rated counsellors' in-session proficiency
on 18 items, including reflective listening,
asking permission, and MI spirit; where fi-
delity scores dropped, additional supervi-
sion was provided until they increased or
the counsellor was dismissed
Fidelity scores remained high throughout (mean rat-
ing of 6.12 (0.87 SD) on the MI-spirit item)
Yes
Hollis 2007 Calls monitored and rated on adherence Not reported n/a
Kelly 2006 Supervision, including a review of each
session to reduce content driJ/contamina-
tion
Not reported n/a
Lloyd-
Richardson
2009
Supervision on sample of sessions; partic-
ipant exit interviews; documentation of
time spent in intervention; subset of ses-
sions rated on degree of adherence
Content delivered was appropriate, and exceeded SC
arm
Yes
Okuyemi
2013
Sessions reviewed during weekly supervi-
sion
Not reported n/a
Rohsenow
2014
Subset of sessions reviewed in weekly su-
pervision, rated for MI style & adherence
with feedback given. Rated from 1 (not at
all) to 5 (extensively) scale for 5 motiva-
tional style measures, and on adequacy of
six MI adherence items
Therapist style ratings did not differ across conditions
for arguing (on average not at all), but MI therapists
showed more empathy, used more reflective listen-
ing, supported self-efficacy more, and emphasised
personal responsibility more. MI therapists more like-
ly to discuss topics to increase ambivalence (100%
of MI, 4% of BA sessions), provide assessment feed-
back (100% of MI, 0% of BA sessions), explore barriers
(82.1% of MI, 0% of BA sessions), provide summaries
(100% of MI, 0% of BA sessions), and discuss possible
goals (100% of MI, 14.8% of BA sessions)
Yes
Rohsenow
2015
Subset of sessions reviewed in weekly su-
pervision, rated for MI style & adherence
& feedback given. Rated from 1 (not at all)
to 5 (extensively) scale for 5 motivational
style measures, and on adequacy of six MI
adherence items
MI more likely to discuss: ambivalence about smoking
(93% of MI, 4% of BA sessions), assessment feedback
(100% of MI, 0% of BA sessions), barriers to quitting
smoking (100% of MI, 17% of BA sessions), provide
summaries (100% of MI, 0% of BA sessions), methods
of quitting or preparing to quit (100% of MI, 58% of BA
sessions), and possible goals (100% of MI, 14.8% of
BA sessions). Therapist style ratings did not differ be-
tween conditions for arguing, empathy, or reflective
listening, but MI therapists more likely to support self-
efficacy & emphasise personal responsibility.
Yes
Sherman
2016
Subset of calls reviewed & feedback given
on MI techniques; weekly supervision
Not reported n/a
Tevyaw 2009 Participants & counsellors rated which of
15 MET elements and 4 REL elements were
completed
Therapists reported covering 14.9 (SD = 0.4) of 15 MET
components and 0 (SD = 0.1) of 4 REL components
during MET; and all 4 (SD = 0) of the REL components
and 0.7 (SD = 0.5) of the MET components during REL.
Yes
Table 1.   Details of MI fidelity monitoring (studies that reported monitoring only)  (Continued)
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Student ratings reported that therapists covered 14.3
(SD = 1.3) of 15 MET components & 1.6 (SD = 1.5) of 4
REL components during MET sessions. They report-
ed therapists covered 3.3 ( SD = 1.1) of the 4 REL com-
ponents and 6.3 (SD = 5.3) of the 15 MET components
during REL sessions.
Table 1.   Details of MI fidelity monitoring (studies that reported monitoring only)  (Continued)
BA:brief advice
HE: Health Education
M: mean
MD: mean difference
MET: Motivational Enhancement Therapy
MISC: Motivational Interviewing Skills Code
MI: Motivational Interviewing
MITI: Motivational Interviewing Treatment Integrity
n/a: not applicable
REL: muscle relaxation training
SC: smoking cessation
SD: standard deviation
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Study ID MI intervention de-
scription
Intervention inten-
sity (no. of sessions;
total duration)
Non-MI comparator description Compara-
tor intensi-
ty
Intensity
matched?
Pharma-
cotherapy
used?
Other common in-
tervention com-
ponents
Ahluwalia
2006
MI counselling us-
ing semi-structured
script
6 sessions; 2 h SC counselling providing informa-
tion & advice to develop a quit plan
6 sessions;
2 h
Yes NRT in half
each condi-
tion; place-
bo NRT in
other half
Tailored smoking
cessation booklet
Audrain-Mc-
Govern 2011
MET counselling 5 sessions; 3 h 15 min Structured brief advice, using '5As'
or '5Rs'
5 sessions; 1
h 15 min
No, com-
parator low-
er
n/a n/a
Bastian
2013
MI & adaptive coping
skills counselling +
self-directed mate-
rials. Skills training
informed by Trans-
actional Model of
Stress & Coping
6 sessions; 3 h Self-help materials - letter from on-
cologist encouraging quitting, quit
kit (including SC guide), individually
tailored booklet
n/a No, com-
parator low-
er
NRT Self-help materials
Battaglia
2016
MI counselling + writ-
ten SC information
12 sessions; 3 h 20
min
PTSD home telehealth programme +
electronic (Health Buddy) device
n/a No, com-
parator low-
er
NRT, bupro-
pion or
varenicline
PTSD home tele-
health programme
+ electronic (Health
Buddy) device
Bock 2008 MI counselling + self
help resources
5 sessions; 1 h 20 min Non-MI counselling calls + self-help
resources
2 sessions;
20 min
No, com-
parator low-
er
NRT 2 brief non-MI
counselling calls,
review of NRT use
instructions
Bock 2014 MI counselling + 5As
intervention
3 sessions; approx 1
h
5As intervention 1 session; 5
min
No, com-
parator low-
er
NRT 5As intervention
Butler 1999 Brief MI session 1 session; 10 min Brief SC advice 1 session; 2
min
No, com-
parator low-
er
n/a n/a
Catley 2016 MI counselling 4 sessions; length
unclear
1. brief advice
2. SC counselling based on clinical
guidelines
1. 1 session
2. 4 sessions
(lengths un-
clear)
Yes (health
education
intensity
matched) &
NRT or
varenicline
Self-help guide
Table 2.   Details of intervention & comparator content & intensity 
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No (brief ad-
vice - lower)
Colby 2005 MI counselling 2 sessions; 50 min Brief recommendation to quit + fol-
low-up call
2 sessions;
10 min
No, com-
parator low-
er
n/a SC pamphlet +
treatment referrals
information
Colby 2012 MI counselling. Par-
ticipants' parents al-
so discussed child's
quit attempt and
supporting it with re-
searchers, using MI
principles.
2 sessions for adoles-
cents + 1 for parents;
1 h adolescents; 15
min parents
Brief SC advice with follow-up ses-
sion
2 sessions
for adoles-
cents; 10
min (none
for parents)
No, com-
parator low-
er
n/a SC pamphlet +
treatment referrals
information
Cook 2016 MI counselling 4 sessions; 50 min 1. Behavioural smoking reduction
guidance
2. No treatment
1. 7 ses-
sions; 1 h 20
min.
2. No ses-
sions
1. No, higher
2. No, lower
NRT de-
pendent on
trial arm
(balanced
across arms
of interest)
n/a
Davis 2011 Mi counselling 1 session; 15 min Prescriptive interview regarding
smoking - firm & authoritative
1 session; 15
min
Yes n/a n/a
De Azevedo
2010
MI counselling 8 sessions; 1 h 40 min Brief SC advice 1 session; 15
min
No, com-
parator low-
er
n/a n/a
Demétrio
Fausti-
no-Silva
2018
MI taught to SC advi-
sors as additional re-
source to standard
CBT approach used
Average 3 sessions;
length unclear
Standard CBT approach advocat-
ed by Brazilian Ministry of Health's
smoking programme
Average 3
sessions,
length un-
clear
Yes n/a CBT counselling
approach
Ellerbeck
2009
1. High intensity MI
2. Moderate intensity
MI
1. 6 sessions every 6
min; length unclear
2. 2 sessions every 6
min; length unclear
n/a n/a n/a NRT or
bupropion
Welcome letter, in-
formation about
medication, smok-
ing cessation pam-
phlets, 6-month-
ly personalised
newsletter, period-
ic progress reports
with counselling
suggestions faxed
Table 2.   Details of intervention & comparator content & intensity  (Continued)
C
o
ch
ra
n
e
L
ib
ra
ry
T
ru
ste
d
 e
v
id
e
n
ce
.
In
fo
rm
e
d
 d
e
cisio
n
s.
B
e
tte
r h
e
a
lth
.
  
C
o
ch
ra
n
e D
a
ta
b
a
se o
f S
ystem
a
tic R
e
vie
w
s
M
o
tiv
a
tio
n
a
l in
te
rv
ie
w
in
g
 fo
r sm
o
k
in
g
 ce
ssa
tio
n
 (R
e
v
ie
w
)
C
o
p
yrig
h
t ©
 2019 T
h
e C
o
ch
ra
n
e C
o
lla
b
o
ra
tio
n
. P
u
b
lish
ed
 b
y Jo
h
n
 W
ile
y &
 S
o
n
s, Ltd
.
1
2
2
to participants'
physicians
Harris 2010 MI counselling 4 sessions; average 1
h 40 min
MI counselling focused on increasing
fruit & vegetable consumption
4 sessions;
average 1 h
40 min
n/a Pharma-
cotherapy
for highly
dependent
smokers
n/a
Helstrom
2007
MET counselling 1 session; length un-
clear
Information session on tobacco use
based on American Cancer Society
pamphlet
1 session;
length un-
clear
Yes n/a n/a
Hollis 2007 1. high intensity MI
2. moderate intensity
MI
3. low intensity MI
1. 5 sessions; at least
1 h
2. 2 sessions; at least
45 min
3. 1 session; 15 min
n/a n/a n/a NRT for half
of partic-
ipants in
each group
“Quit kit” including
SC booklet
Kelly 2006 MI counselling 1 session; 1 h SC counselling based on psychoedu-
cation model
1 session; 1
h
Yes n/a Written materials
Lewis 1998 Brief motivation-
al message to quit
smoking, with fol-
low-up counselling
incorporating CBT &
MI
5 sessions; approx 1
h
Brief motivational message to quit
smoking + SC pamphlet
1 session; 3
min
No, com-
parator low-
er
Placebo
NRT
Brief motivational
message to quit +
SC pamphlet
Lloyd-
Richardson
2009
MET counselling 5 sessions; at least 2
h
Brief assessment of quitting plans
with brief in-person follow-up
2 sessions;
approx 10 m
No, com-
parator low-
er
NRT n/a
Louwagie
2014
Brief MI session +
short standardised
SC message + SC
booklet
1 session; 15-20 min Short standardised SC message + SC
booklet
1 session; 1
min
No, com-
parator low-
er
n/a Short SC message +
SC booklet
Marshall
2016
MI counselling ses-
sion + audio quit ma-
terial + printed ma-
1 session; approx 25
min
Non-tailored printed materials +
quit-line details
n/a No, com-
parator low-
er
n/a Written materials +
quit-line details
Table 2.   Details of intervention & comparator content & intensity  (Continued)
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3
terials + quit-line de-
tails
Matuszews-
ki 2018
1. MI counselling +
control intervention
2. MI counselling in-
tervention + addi-
tional brief follow-up
1. 1 session; average
10 min
2. 2 sessions; average
15 min
Referral to patient resource centre +
quit-line brochure
n/a No, com-
parator low-
er
n/a Referral to patient
resource centre +
quit-line brochure
McClure
2005
MET counselling +
control intervention
4 sessions; 1 h Letter explaining association be-
tween cervical cancer & smoking +
SC booklet + quit-line details
n/a No, com-
parator low-
er
NRT or
bupropion
Letter explaining
association be-
tween cervical can-
cer & smoking, SC
booklet, quit-line
details
Naik 2014 MI counselling not reported No intervention (waiting list control) n/a n/a n/a n/a
NCT02645838 MI counselling 7 sessions; unclear-
over 20 min
Brief SC advice 1 session; 5
min
No, com-
parator low-
er
n/a n/a
Okuyemi
2013
MI SC and NRT ad-
herence counselling
6 sessions; average
1h 45 min
Brief smoking cessation advice + SC
guide
1 session;
10-15 min
No, control
lower
NRT SC guide
Rohsenow
2014
1. MI counselling ses-
sion
2. MI counselling ses-
sion + booster ses-
sions
1. 1 session; 45 min
2. 3 sessions 1h 5min
1. Brief advice using US AHRQ
method
2. Brief advice + 2 booster sessions
1. 1 session;
15 min
2. 3 ses-
sions; 35
min
No, com-
parator low-
er
NRT SC pamphlets, in-
formation on SC
skills groups & hard
candy
Rohsenow
2015
MI session + boost-
er sessions (half re-
ceived non contin-
gent payments &
half contingent pay-
ments)
4 sessions; approx 2
h
Brief advice using US AHRQ methods
(half received non contingent pay-
ments & half contingent payments)
4 sessions;
approx 55
min
No, com-
parator low-
er
NRT SC pamphlets &
hard candy
Sherman
2016
1. MI & Problem Solv-
ing Therapy coun-
selling
1. 7 sessions; approx
1 h 30 min
2. 2 sessions; approx
30 min
n/a n/a n/a NRT n/a
Table 2.   Details of intervention & comparator content & intensity  (Continued)
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4
2. Referral to state
Quitline (usually New
York state) - counsel-
lors trained in MI
Soria 2006 MI counselling 3 sessions; 60 min Brief anti-smoking advice 1 session; 3
min
No, com-
parator low-
er
Bupropion
for highly
dependent
smokers
n/a
Stein 2006 MI counselling 3 sessions; approx 1h Brief advice using 4As + self-help ma-
terials
2 sessions;
approx 5
min
No, com-
parator low-
er
NRT n/a
Tevyaw
2009
MET (half received
non contingent pay-
ments & half contin-
gent payments)
3 sessions; 2 h Progressive muscle relaxation train-
ing (half received non contingent
payments & half contingent pay-
ments)
3 sessions;
2 h
n/a n/a n/a
Vidrine 2019 1. Brief advice + text
messages based on
CBT & MI
2. Brief advice + texts
+ counselling calls
based on CBT & MI
1. 1 session; approx 5
min.
2. 11 sessions; ap-
prox 2 h
Brief SC advice 1 session;
approx 5
min
No, com-
parator low-
er
NRT Brief quitting ad-
vice, written mate-
rials, quit-line de-
tails
WoodruC
2007
Online virtual world
(The Breathing
Room) - participants'
avatars had MI group
counselling with oth-
er participants & the
counsellor within a
virtual shopping mall
setting
7 sessions; 5 h 15 min No treatment n/a n/a n/a n/a
Wu 2009 MI counselling + SC
self-help materials
4 sessions; 4 h Health education counselling + self-
help materials covering nutrition, ex-
ercise, and tobacco use
4 sessions;
4 h
Yes NRT n/a
Table 2.   Details of intervention & comparator content & intensity  (Continued)
5As: 'Ask, Advise, Assess, Assist, and Arrange'
5Rs: 'Relevance, Risks, Rewards, Roadblocks, Repetition'
AHRQ: Agency for Healthcare Research and Quality
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1
2
5
approx: approximately
CBT: Cognitive Behavioural Therapy
h: hour(s)
m: month(s)
min: minute(s)
MI: Motivational interviewing
MET: Motivational Enhancement Therapy
n/a: not applicable
NRT:nicotine replacement therapy
PTSD: post traumatic stress disorder
SC: smoking cessation
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A P P E N D I C E S
Appendix 1. CRS Search Strategy 2019
#1 (motivat* NEAR2 interview*):TI,AB,MH,EMT,KY,XKY,KW,XRT
#2 (motivat* NEAR2 enhanc*):TI,AB,MH,EMT,KY,XKY,KW
#3 (motivat* NEAR2 (session* OR counsel* OR practi* OR behav*)):TI,AB
#4 #1 OR #2 OR #3 AND (INREGISTER) [SET 1]
#5 motivation*:MH,EMT,XKY,KY,KW AND (INREGISTER) [SET 2]
Notes: Set 1 identifies the most relevant records. Set 2 identifies records with the keyword 'motivation' not otherwise identified in set 1,
and is over sensitive. Studies in both sets were screened for inclusion.
In lines 4 and 5 'motivat*' captures the variants of 'motivational' used in the original search strategy.
W H A T ' S   N E W
 
Date Event Description
23 May 2019 New search has been performed Updated with 16 new studies and with ten previously included
studies excluded due to changes in eligibility criteria
23 May 2019 New citation required and conclusions
have changed
New authors added. Conclusions have changed - evidence for
benefit of MI for smoking cessation is inconclusive - confidence
intervals now incorporate both benefit and harm. The certainty
of the evidence has changed from moderate to low, indicating
that new evidence is likely to have an impact on the effect esti-
mates and their 95% confidence intervals.
 
H I S T O R Y
Protocol first published: Issue 1, 2008
Review first published: Issue 1, 2010
 
Date Event Description
5 January 2015 New citation required but conclusions
have not changed
Authors have changed. Main conclusions remain stable, with on-
ly minor changes in subgroup findings
5 January 2015 New search has been performed Updated with 14 new included studies
5 September 2011 Amended Reference to companion review updated
10 February 2010 Amended Spelling correction in tables and change in
21 October 2008 Amended Converted to new review format
 
C O N T R I B U T I O N S   O F   A U T H O R S
AF, JL, NL, PA and TT all reviewed the previous version of the review and amended eligibility criteria.
AF, JL, NL, and TT assessed study eligibility and extracted data from eligible studies.
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
1. The cost-effectiveness objective has been removed.
2. We excluded pregnant women, as their particular needs and circumstances warrant them being treated as separate populations. They
are covered in another Cochrane Review (Chamberlain 2017).
3. We introduced a new eligibility criterion excluding studies incorporating additional non-MI components into the intervention group
that were not matched in the comparator group, in order to reduce bias.
4. We have now included comparators of all intensities; however, we controlled for this using subgroup analyses.
5. We have now included studies regardless of whether they carried out fidelity monitoring; however, we controlled for this using subgroup
analyses.
6. We excluded non-randomised controlled trials, to keep the quality of the evidence as high as possible.
7. We introduced secondary outcomes (mental health and quality of life) to assess whether MI for smoking cessation has any impact on
the well-being of participants.
8. We grouped the included studies into four separate comparisons rather than incorporating all studies into one meta-analysis.
9. We added additional prespecified subgroup analyses, splitting studies by 1) the relative intensity of the intervention and comparator
conditions; 2) participant motivation to quit; 3) and whether fidelity monitoring took place.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
Behavior Therapy   [*methods];   Hotlines;   Motivation;   Motivational Interviewing   [*methods];   Randomized Controlled Trials as Topic;
  Smoking  [*psychology]  [*therapy];  Smoking Cessation  [psychology]
MeSH check words
Humans
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